Document p2M7OkDVpn1LwxeJeKbJQ329B
DAY 1 - AGENT ORANGE TRIAL MOYER V. DOW
UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK
X
In re:
"AGENT ORANGE"
PRODUCT LIABILITY LITIGATION. : SUPPLEMENTAL DISCO^ERY'^RE-OUESTS
-------------------------- ----- x
Defendant Monsanto Company ("Monsanto"), by its
&attorneys Townley Updike, answers and responds as follows to
the supplemental discovery requests set forth in the June 9,
1982 letter of plaintiffs' counsel, Irving Like, Esq., to
defendants' counsel:
Supplemental Request 1 : Identify all representatives of defendants who
attended a dioxin meeting at The Dow Chemical Company facility in Midland, Michigan, on or about March 21, 1965. (Schedule I A .2 p p . 1, 2). Answer to Supplemental Request 1 :
No representative of Monsanto attended a dioxin meeting at The Dow Chemical Company in Midland, Michigan on or about March 21, 1965.
Supplemental Request 2 : Produce all documents related to such meeting.
(Schedule II, 2. (w) p. 13).
2008 -A O V
Answer to Supplemental Request 2 : The only documents in Monsanto's possession which
relate to such a meeting are those which were produced to both plaintiffs and defendants by defendant The Dow Chemical Company.
Supplemental Request 3 : Produce all documents, if any, indicating defendants
informed or disclosed to the U.S. the extent or level of dioxin contamination in the herbicides supplied to the U.S., and the means available for reduction of such contamination. (Schedule II, 2. (a)-(e), pp. 10, 11). Answer to Supplemental Request 3 :
Monsanto possesses no such documents dated on or before January 22, 1969, the date on which Monsanto apparently last shipped phenoxy herbicides to the United States government pursuant to a contract subject to the Government Contract Defense.
Supplemental Request 4 : Identify all representatives of defendants who made
such disclosure to the U.S. Government. Answer to Supplemental Request 4 :
Monsanto presently knows of no representative who disclosed to the United States government the extent or level of dioxin contamination in the herbicides supplied to the United States government, and the means available for the reduction of such contamination. However, R. Emmet Kelly communicated with government representatives concerning health
-2- 2009 0 -a o r*
effects to workers exposed to 2,4,5-T and its precursors, and John Mullendore communicated with government representatives concerning the dioxin content of chlorinated phenols.
Dated: New York, New York July 9, 1982
TOWNLEY & UPDIKE
TO: SEE ATTACHED SERVICE LIST
prneys for Defendant isanto Company Lexington Avenue New York, New York 10174 (212) 682-4567
2010
-3- 0 ' stW3
VERIFICATION STATE OF MISSOURI )
ss.: COUNTY OF ST. LOUIS)
J. R. Bley, Jr., being duly sworn, deposes and says that he is an assistant secretary of defendant Monsanto Company, a corpora tion; that he has read the foregoing Answers of Defendant Monsanto Company to Plaintiffs' Supplemental Discovery Requests and is familiar with the contents thereof; that deponent is without personal knowledge of the matters stated in the foregoing Answers, and is informed and believes that no officer or employee of Monsanto Company has personal knowledge of all such matters; that the foregoing Answers have been assembled by authorized employees and counsel of Monsanto Company, who have informed deponent that the foregoing Answers are true; and that to the best of deponent's knowledge those Answers are true.
Sworn to before me this / day of July, 1982
J. >i\ :a
J. R. Bley, Jr.
2011
0-
AFFIDAVIT OF SERVICE BY MAIL
STATE OF NEW YORK )
) SS. :
COUNTY OF NEW YORK)
ISABELLE GA N S , being duly sworn, deposes and says:
deponent is not a party to the action, is over 18 years of
age and resides at 2134-72nd Street, Brooklyn, New York. On
the 9th day of July
, 1982, deponent served the within
Answers of Defendant Monsanto Company to Plaintiffs'
Supplemental Discovery Requests upon the following attorney(s)
in this action:
SEE THE ATTACHED RIDER
at the above address(es) designated by said attorney(s) for that purpose by depositing a true copy of same enclosed in a postpaid properly addressed wrapper in an official depository under the exclusive care and custody of the United States Postal Service within the State of New York.
Sworn to before me this
9th day of July
, 198 2.
ISABELLE GANS
c^Q y-
Notary Publi^/
CNoCmoetmraQAtri.suyNFsaiGiloPliNenfEuidbLoeEJd.Aiixnc2pi,4PnNiS-r.4eeKtCs6awi5tAnMe8gYL3soaVoCrfCrcA4kNhoGuoC3Nwn0otA,uyYn1ot9yr8k3
2012
D -aw r
RIDER
SERVICE LIST
William Krohley, Esq. Kelley Drye & Warren 350 Park Avenue New York, New York 10022
Michael M. Gordon, Esq. Cadwalader, Wickersham & Taft One Wall Street New York, New York 10005
Leonard Rivkin, Esq. Rivkin, Leff, Sherman & Radler 100 Garden City Plaza Garden City, New York 11530
Judge Morton Silberman Clark, Gagliardi & Miller 99 Court Street White Plains, New York 10601
Thomas Beck, Esq. Arthur, Dry & Kalish 1230 Avenue of the Americas New York, New York 10020
David R. Gross, Esq. Budd, Larner, Kent, Gross,
Picillo & Rosenbaum 33 Washington Street Newark, New Jersey 07102
Dennis Rothman, Esq. Lester Schwab Katz & Dwyer 120 Broadway New York, New York 10005
Paul V. Esposito, Esq. Lewis, Overbeck & Furman 135 South LaSalle Street Suite 1060 Chicago, Illinois 60603
Irving Like, Esq. Reilly, Like and Schneider 200 West Main Street P.O. Box 218 Babylon, New York 11702
Victor J. Yannacone, Jr., Esq. Yannacone & Yannacone Post Office Drawer #109 Patchogue, New York 11772
2013 ~ 2 6 %
UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK
----------------------------------------------------------------------------------------------------------------------
IN CLEKA b ^rrlOE
U.S.DISTRICT COUR<f 0 N Y.
' JUL121982 *
"AGENT ORANGE" Product Liabilitv Litigation
MDhTiW.A.^+------ --P.M_________________
RESPONSE OF DEFENDANT DIAMOND SHAMROCK CORPORATION TO PLAINTIFFS' "SUPPLE MENTAL INTERROGATORIES" DATED JUNE 9, 1982___________
x
Defendant Diamond Shamrock Corporation ("Diamond Shamrock") hereby answers plaintiffs' "supplemental inter rogatories" dated June 9, 1982, served on Diamond Shamrock on June 15, 1982. Diamond Shamrock reserves the right to supplement or amend its answers, and to object to the admissibility as evidence of the answers or the subject matter thereof in any subsequent proceeding herein or the trial of this or any other action.
Interrogatory No. 1: Identify all representatives of defendants who attended a dioxin meeting at the Dow Chemical Company facility in Midland, Michigan, on or about March 21, 1965.
Answer:
Edward L. Chandler and Francis R. Kennedy attended, as
representatives of Diamond Shamrock*, a meeting concerning chlor-
acne at The Dow Chemical Company on March 24, 1965. Both Dr.
Chandler and Mr. Kennedy are further identified in the Responses
* Diamond Shamrock was formerly known as the Diamond Alkali Company. The current name was adopted when Diamond Alkali merged with The Shamrock Oil and Gas Corporation on December 19, 1967.
a-z6f?
2014 C cn ^
of Defendant Diamond Shamrock Corporation to Plaintiffs' Inter rogatories to Defendants (First Wave), dated February 13, 1981.
Representatives of other companies who appear to have been in attendance at the meeting on March 24, 1965 are identified in the documents referenced in Diamond Shamrock's answer to Interrogatory No. 2.
Interrogatory No. 2 : Produce all documents related to such meeting.
Answer: Interrogatory No. 2 requests production of documents that Diamond Shamrock already produced to plaintiffs for inspection and copying on June 25, 1982. Those documents are referenced in Diamond Shamrock's Index of Documents Responding to Plaintiffs' Interrogatories to Defendants (First Wave), Revised as of June 25, 1982 ("Diamond Shamrock's June 25, 1982 Index"). Diamond Shamrock, however, has also ascertained that one or more copies of the following documents relating to the March 24, 1965 meeting at The Dow Chemical Company were included in its June 25, 1982 production: (a) Memorandum dated March 25, 1965 from
E. L. Chandler to John Cort, Jr.; (b) Memorandum dated March 30, 1965 from
F. R. Kennedy to'J. S. Cort, Jr., and accompanying notes. Courtesy copies of the above documents (Doc. Nos. DS 0001260900012617) are enclosed.
-2-
2015
D -zof?
Interrogatory No. 3 - Produce all documents, if any, indicating defendants informed or disclosed to the U.S. the extent or level of dioxin contamination in the herbicides supplied to the U.S., and the means available for reduction of such contamination.
Answer : Interrogatory No. 3 requests production of documents that Diamond Shamrock already produced to plaintiffs for inspec tion and copying on June 25, 1982. Any documents responsive to Interrogatory No. 3 may be located by reference to the records identified in Diamond Shamrock's June 25, 1982 Index as responsiv to plaintiffs' Interrogatories Nos. 2B(v), 4D, 4 E , 4 F , 4G, 4K, 4q and 4T to Defendants (First Wave). Objection : Diamond Shamrock objects to Interrogatory No. 3 to the extent that it requests production of documents that relate to the time period subsequent to December 31, 1971, on the ground that it does not seek information relating to a relevant time period.
Interrogatory No. 4 : Identify all representatives of defendants who made such disclosure to the U.S. Government.
Answer : Pursuant to Federal Rule 33(c), the answer to Inter rogatory No. 4 may be ascertained by plaintiffs from the records produced by Diamond Shamrock for inspection and copying on June 25, 1982 and specified in Diamond Shamrock's June 25,
-3-
201.6
1982 Index as responsive to plaintiffs' Interrogatories Nos. 2B(v), 4D, 4 E , 4F, 4G , 4K, 4Q and 4T to Defendants (First Wave). The burden of ascertaining the answer to Interrogatory No. 4 is substantially the same for plaintiffs and Diamond Shamrock.
Objection: Diamond Shamrock objects to Interrogatory No. 4 to the extent that it requests information for the time period subsequent to December 31 1971, on the ground that it does not seek information relating to a relevant time period.
Dated: New York, New York June 30, 1982
Signature as to Objections
CADWALADER, WICKERSHAM &
:he Firm Attorneys for Defendant
Diamond Shamrock Corporation One Wall Street New York, New York 10005 (212) 908-7000
TO: ATTACHED SERVICE LIST HON. SOL SCHREIBER
-4-
y**
9 01
n -ijeo
STATE OP OHIO COUNTY OF CUYAHOGA
: ss.:
George A. Lawrence, being duly sworn, says that he is
Vice President and General Manager, Agricultural Chemicals Divi
sion, of defendant Diamond Shamrock Corporation; that he has read
the foregoing answers of Diamond Shamrock to plaintiffs' "supple
9,mental interrogatories" dated June
1982; and that the foregoing
answers to said interrogatories were prepared under his super
vision on the basis of records of Diamond Shamrock, information
furnished by present and former employees of Diamond Shamrock, and
in part on his personal .knowledge and to the best of his knowledge
information and belief, are true and correct.
Sworn to before me this 30th day of June, 1982.
Ge<y?ge A. Lawrence
2018
AFFIDAVIT OF SERVICE
STATE OF NEW YORK ) : ss .:
COUNTY OF NEW YORK )
MICHAEL M. GORDON, being duly sworn, deposes and says:
1. I am not a party to this action, am over 18 years
of age and reside at 12 West 72nd Street, New York, New York
10023-
9,2. On July
1982, I served the annexed Response of
Defendant Diamond Shamrock Corporation to Plaintiffs' "Supple
mental Interrogatories" Dated June 9, 1982 on each of the persons
named on the annexed list by depositing a true copy of same
enclosed in a postpaid properly addressed wrapper, in an official
depository under the exclusive care and custody of the United
States Postal Service within the State of New York.
Sworn to before me this day of July, 1982
Notary Pisbiic. State cf New York
No. 2'1-4SC`1701 Qualified in Kinqs County
Certificate filed in New York Count]
Commission Expires March 30, 19M
LISTING OF ATTORNEYS
FOR DEFENDANTS
&Leonard L. Rivkin
Rivkin, Leffj Sherman Radler (for DOW CHEMICAL)
100 Garden City Plaza Garden City, New York 11530
&Thomas Beck
Arthur, Dry Kalish, P.C. (for UNIROYAL)
1230 Avenue of th Americas New York, New York 10020
Morton B. Silberman Clark, Gagliardi & Miller
(for T H AGRICULTURE & NUTRITION COMPANY, INC.) The Inns of- Court 99 Court Street White Plains, New York 10601
John C. Sabetta Townley & Updike
(for MONSANTO) 405 Lexington Avenue New York, New York 10174
William Krohley Kelley Drye & Warren
(for HERCULES, INC.) 101 Park Avenue New York, New York 10178
David R. Gross
&Budd, Lam er , Kent, Gross
Picillo Rosenbaum (for THOMPSON CHEMICALS)
33 Washington Street Newark, New Jersey 07102
Howard Lester Lester, Schwab, Katz & Dwyer
(for HOFFMAN-TAFF) 120 Broadway New York, New York 10271
Paul V. Esposito Lewis, Overbeck & Furman
(for RIVERDALE CHEMICAL CO 135 South LaSalle Street Suite 1060 Chicago, Illinois 60603
&John M. Fitzpatrick
Dilworth, Paxson, Kalish Levy (for HOOKER PLASTICS & CHEMICALS CORP.
2600 The Fidelity Building Philadelphia, Pennsylvania 19109
Joan Bernott Department of Justice
(for THIRD PARTY DEFENDANT USA) Safeway Building, Room 904d 521 12th Street, N.W. Washington, D.C. 20530
COPIES OF ALL DOCUMENTS MUST BE SENT TO:_________________
Clerk of the Panel Judicial Panel on Multidistr
Litigation 1120 Vermont Avenue, N.W., Suite 1002 Washington, D.C. 20005
FOR PLAINTIFFS
Victor J. Yannacone, Jr. (lead counsel)
Yannacone & Yannacone Post Office Drawer #109 Patchogue, New York 11772
&Irving Like, Esq.
Reilly, Like Schneider 200 West Main Street Babylon, N. Y. 11702
2020 t)~ W 3
UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK ------------------------------------ x In re
"AGENT ORANGE" Product Liability Litigation
x
MDL No. 381
DIAMOND SHAMROCK 'S INDEX OF DOCUMENTS RESPONDING TO
PLAINTIFFS ' INTERROGATORIES TO DEFENDANTS (FIRST WAVE), REVISED AS OF JUNE 25, 1982
EXHIBIT B
CADWALADER, WICKERSHAM &. TAFT
One Wall Street
New York, N. Y. 10005
(212) 908-7000
2036 - 2 1 1 1
y*
DOCUMENT NUMBERS 0000000100000141
0000014200000148
00000149-
00000181
0000018200000225
0000022600000389
O O O O O 39O-
00000531
0000053200000646
0000064700000659
0000066000000672
SOURCE Files of F. G. Steward
Files of F. G. Steward
Files of F. G. Steward
Files of F. G. Steward
Files of F. G. Steward
Files of F. G. Steward
Files of F. G. St eward
Files of F. G. Steward
Files of F. G. Steward
FOLDER TITLE (OR OTHER FILE DESCRIPTION) Newark Product Files: Ester - Product & Samples
Newark Product Files: 2,4,5-T Reaction Section
Newark Product Files: Single Shot
Melt Analysis
Laboratory Procedures
Newark Product Files: Ester - Batch Process
Newark Product Files: Ester - Government Specifications & Orange
Newark - Plant Capacities & Conversion Data
Newark Product Files: Silvex Acid & Ester
-1-
INTERROGATORIES TO WHICH RESPONSIVE 2B(iii) and 41, J, P
2B(iii) and 41, J, P
2B(iii) and 41, J, P
2B(iii) and 41, J, P
2B(iii) and 41, J, K, P
2B(iii) and 41, J, P 2B(i) , (ii) ., (iii); 4 A , B , C(iv) [p .9] and 41, J, P
2B(iii) and 41, J, P
2B(iii) and 41, J, P
2037 ~2jza
2038
DOCUMENT NUMBERS 0000067300000701
0000070200000730
0000073100000745
0000074600000756
0000075700000837
0000083800000897
00000898-
00001017
00001018-
00001159
00001160-
00001300
SOURCE Files of F. G. Steward
Files of F. G. Steward
Files of F. G. Steward
Files of F. G. Steward
Files 0f
F. G. Steward
Files of F. G. Steward
Files of F. G. Steward
Files of F. G. Steward
Files of F. G. Steward
FOLDER TITLE (OR OTHER FILE DESCRIPTION) Newark Plant File: Melt-Approved Appropriation
2 ,4-D & 2 , 4 ,5-T Acetic Acids Process Studies by: E. Bak
Newark Production Files: TCP Quality
Newark Product Files: 2,4 ,5-T Quality
Newark Product Files: Dacamine - Foreign Production
Newark Product Files: Ester Operating Instructions
Operating Comments - 1966
Operating Comments - 1967
Operating Comments - 1 9 6 8
INTERROGATORIES TO WHICH RESPONSIVE
412B(iii) and
, J, P
4A , B, C [p .11] and. 4P
412B(iii) and
, J, P
412B(iii) and
, J, P
412B(iii) and , J , P
412B(ii i) and , J , P
412B(iii) and , J , P
412B(iii) and
, J, P
412B(iii) and , J , P
-2-
DOCUMENT NUMBERS
00001301-
00001412
0000141300001458
0000145900001511
0000151200001592
0000159300001648
0000164900001723
0000172400001798 to
o
CO 00001799CD 00001925
0000192600001979 So 3^
SOURCE Files of F. G. Steward
Files of F. G. Steward
Files of F. G. Steward
Files of F. G. Steward
Files of F. G. Steward
Files of F . G . Steward
Files of F. G. Steward
Files of F. G. St eward
Files of F. G. Steward
FOLDER TITLE (OR OTHER FILE DESCRIPTION)
2,4 - Dichlorophenoxyacetic Acid - Melt Washing & Drying
INTERROGATORIES TO WHICH RESPONSIVE
412B(iii) and , J, P
Operating Instructions
412B(iii) and , J, P
Newark Product Files: TCP - ML Recovery
412B(iii) and , J, P
Newark Product Files: TCP - Reaction Section
412B(iii) and , J, P
Newark Product Files: 2,4,5-T Operating Instructions
412B(iii) and , J, P
Projects & Approp. - Project Orange - Economics & Design
412B(iii) and , J, P
Newark Product Files: General Products
412B(iii) and , J, P
Projects & Approp. - 2,4-D & 2,4,5-T Expansion Approp. 6739 Basic Calculations
412B(iii) and , J, P
Newark Product Files: 2,4,5-T - Melt Wash & Dry
412B(iii) and , J, P
-3-
O -* !* 3
2040
DOCUMENT NUMBERS 0000198000002285
0000228600002357
0000235800002549
0000255000002699
0000270000002849
0000285000003102
0000310300003188
SOURCE
Ag Chem Division Document Storage
FOLDER TITLE (OR OTHER FILE DESCRIPTION)
Defense Supply Agency Contracts with Diamond Shamrock
Files of Joseph G . Smeraldi
U.S. Dept, of Commerce publication entitled "The Defense Materials System and Priorities" (Feb. 1967)
Ag Chem Division Document Storage
Agent Orange Monthly Production Reports 1968
Ag Chem Division Document Storage
Government Contract, F. R. Kennedy, C-1297
Ag Chem Division Document Storage
Government Contract, F. R. Kennedy, C-2893
Ag Chem Division Document Storage
Government Contract, No. DSA-400-67-C-8642
Ag Chem Division Document Storage
Government Contract, No. DSA-400-68-C-4708
INTERROGATORIES TO WHICH RESPONSIVE 2B(i), (ii), (ii i ) ; 4A, B, C(iv) [P .9 ] and 4P
4A , B [p .9 ]
2B(iii) and 4P
2B(i) , (ii) , (ii i); 4A, B, C(iv) [P .9 ] and 4P
2B(i), (ii ), (iii); 4A , B, C(iv) [P .9 ] and 4P
2B(i), (ii), (iii); 4A , B, C(iv) [P .9] and 4P
2B(i), (ii), (iii); 4A, B, C(iv) [P .9 ] and 4P
DOCUMENT NUMBERS
0000318900003214
OOOO3215-
00003309
OOOO3 3 IO-
00003392
0000339300003444
OOOO3445-
00003529
O O O O 3 5 3 O-
00003676
to O 00003677-
00003705
OOOO37O6-
00003922 C5 i Xi
SOURCE
Diamond Shamrock Corporate Library
FOLDER TITLE (OR OTHER FILE DESCRIPTION)
Engineering Dept. Files relating to Newark Plant Expansion Project
Ag Chem Division Document Storage
General
Ag Chem Division Document Storage
Orange
Ag Chem Division Document Storage
Ag Chem Division Document Storage
Files of F. R. Kennedy
2,4,5 TCP Crude Trichlorophenol Loose - No Folder
Files of F. R. Kennedy
Files of F. R. Kennedy
Orange - I . R . U.S. Army
-5-
INTERROGATORIES TO WHICH RESPONSIVE
2B(iii) and 4P
2B(i) , (ii) , (iii); 4A, B, C(iv) CP -93 and 4P
2B(i), (ii) , (iii); 4A , B, C(iv) [ p -93 and 4 P
2B(i ii) , (v) ; and 41, J, K, P
2B(iii) , (v) ; and 4D, J, K, P, Q
2B(i) , (ii) , (iii); 4A, B, C(iv) [p-93 and 4P
4P
2B(i) , (ii) , (iii); 4A, B, C( iv) CP -93 and 4P
D 'St> r
2042
i co =r rc=\T-j=ioSnoo oo oo oo
DOCUMENT NUMBERS 0000392300004188
0000418900004277
0000450500004618
0000461900004656
0000465700004872
0000487300004881
0000488200005004
0000500500005074
SOURCE Files of F . R . Kennedy
Files of F. R. Kennedy
Files of F. R. Kennedy
Files of F. R. Kennedy
Files of F. R. Kennedy
Files of F. R. Kennedy
Files of F. R. Kennedy
Files of F. R. Kennedy
Files of F. R. Kennedy
FOLDER TITLE (OR OTHER FILE DESCRIPTION) G o v 't . Butyl
Gov't. Inventory & Production Form Government Contract, No. DSA-400-68-C-5898
Ester and Butyl Work
Dacamine Bars
Products - Esters General Ester Unit Rehabilitation of
Products Esters - 2EH
Esters - Mixed -6-
INTERROGATORIES TO WHICH RESPONSIVE 2B(i) , (ii) , (i i i ) ; 4A , B, C(iv) [p .9] and 4P
2B(iii) and 4P 2B(i) , (ii) , (i i i ) ;
4A , B, C(iv) [p. 9 ];
and 4P
2B(iii) and 41, J, P
2B(iii) and 41, J, P
2B(iii) and 41, J, P
2B(iii) and 41, J, P
2B(iii) and 41, J, P
4A, B, C [p.11] and 4P
2043
DOCUMENT NUMBERS 0000507500005196
0000519700005441
0000544200005523
0000552400005648
0000564900005745
0000574600006013
0000601400006121
0000612200006155
0000615600006197
/
SOURCE Files of F. R. Kennedy
Files of F. R . Kennedy
Files of F. R. Kennedy
Files of F . R . Kennedy
Files of F. R. Kennedy
Files of F. R. Kennedy
Files of F . R . Kennedy
Files of F . R . Kennedy
Files of F. R. Kennedy
FOLDER TITLE (OR OTHER FILE DESCRIPTION) Products - Esters - Lo-V Volatility Rating
Esters
2,4-D Acid Recovery
2,4-D Acid Dryer, Drying of
2,4-D Expansion
2,4-D Acid New Process
2,4-D Plant Yields Process Improvement
2,4-D Recovery of DCP from M.L.
D&T Acid Suspensions
-7-
INTERROGATORIES TO WHICH RESPONSIVE 4A, B , C [p.1 1] and 4P
4A, B, C [p .11] and 4P
4a , B , C [p.11] and 4P
2B(iii) and 41, J , P 4A, B , C [p. 11] and 4P
2B(iii) and 4 1 , J , P 4A, B , C [p.11] and 4P
4A, B , C [p.11] and 4P
4A, B , C [p . 11] and 4P
a
DOCUMENT NUMBERS 0000619800006381
OOOO6382-
00006421
0000642200006514
0000651500006579
0000658000006639
0000664000006710
OOOO6 7 II-
000068 11
00006812ro 00006863
o
0000686400007026 i
P
SOURCE Files of F. R. Kennedy
Files of F. R. Kennedy
Files of F. R. Kennedy
Files of F. R. Kennedy
Files of F. R. Kennedy
Files of F. R. Kennedy
Files of F. R. Kennedy
Files of F. R. Kennedy
Files of F. R. Kennedy
FOLDER TITLE (OR OTHER FILE DESCRIPTION)
2 ,4-D & 2 , 4 ,5-T Filters
INTERROGATORIES TO WHICH RESPONSIVE
4A, B, C [p. 11] and 4P
Na2S0ij Recovery 2,4-D
4A , B, C [p. 11] and 4P
Esters - Mixed
2B(iii) and 4 I , J, P
Products Acetic Acid
2B(iii) and 4 I , J, P
Products - Chlorine Recovery
4A , B, C [p .11] and 4P
Drying of 2,4-D
4A, B, C [p.11] and 4 P
Sodium Salt
2B(iii) and 4 I , J, P
Esters - Iso-Octyl
U.S. Public Health Service
2B(iii) and 4P 3 and 4D, G, Q, T
-8-
DOCUMENT NUMBERS
0000702700007313
0000731400007382
0000738300007498
0000749900007500
0000750100007568
0000756900007802
0000780300007967
0000796800008210
HO
O 'f*
0000821100008282
C
t 00008283 V
5)o
<>C
SOURCE Files of F. R. Kennedy
Files of F. R. Kennedy
Files of F. G. Kennedy
Files of F. R. Kennedy
Files of F . R . Kennedy
Files of F. R. Kennedy
Files of F. R. Kennedy
Files of F. R. Kennedy
Files of F. R. Kennedy
Files of F. R. Kennedy
FOLDER TITLE (OR OTHER FILE DESCRIPTION) Products 2,4-D Misc. & Heat of Neutralization
Competitor Samples 1959 Competitor Samples 1957-58
4 #DMA-D Dinitro-OrthoIsopropyl-Phenol Complaint and Trade Reports Open
Tetrachlorobenzene
2,4,5-TCP Manufacturing
Trichlorophenol Reports
TCP Process Work
-9-
4 INTERROGATORIES TO WHICH RESPONSIVE 2B(iii); 4A , B, C [p.11] and 4P
4A , B, C [p .11] 4A , B, C [p. 11]
2B(iii) and 4P
4A , B, C [p. 11] and 4P
4A, B, C [p. 11] and 4P 2B(iii); 4A, B, C [p.11] and 4P 2B(iii); 4 A , B , C [p.11] and 4D, J, P, Q 4A , B, C [p .11] and 4D, J, P, Q
(empty folder)
2046 '2/19
DOCUMENT NUMBERS 0000828400008365
0000836600008374
0000837500008410
0000841100008513
0000851400008651
0000865200008662
0000866300008791
0000879200008959
0000896000009056
SOURCE Files of F. R. Kennedy
Files of F. R. Kennedy
Files of F. R. Kennedy
Files of F. R. Kennedy
Files of F . R . Kennedy
Files of F . R. Kennedy
Files of F. R. Kennedy
Files of F. R. Kennedy
Files of F. R. Kennedy
FOLDER TITLE (OR OTHER FILE DESCRIPTION) 2,4,5 - TCP Process File
2,4,5-Trichlorophenate
Production of TCP TCP - Process Development - Current
TCP General
TCP Start Up Products 2,4,5 - TCP (for sale)
Products TCP - Quality
Products 2,4,5-T Acid
-10-
INTERROGATORIES TO WHICH RESPONSIVE 4A, B, C [p.11] and 4D J, P, Q
4A , B, C [p.11] and 4D, J, K, P , Q
4A , B, C [p .11] and 4P
4A , B, C Cp .11] and 4D, J, P, Q
4A, B, C [p. 11] and 4D, P, Q
4A , B, C [p.11] and 4D, P, Q
4A , B, C [p.11] and 4D, P, Q
4A , B, C [p.11] and 4D , J, P, Q
2B( iii) and 4P
DOCUMENT NUMBERS__________ SOURCE
0000905700009130
Files of F . R . Kennedy
OOOO9 1 3 1 -
00009180
OOOO9 1 8 I-
00009200
Files of F . R . Kennedy
Files of F . R . Kennedy
0000920100009510
Files of F. R. Kennedy
0000951 100009555
Files of F. R. Kennedy
0000955600009636
Files of F. R. Kennedy
0000963700009696
Files of F. R. Kennedy
0000969700009762
Files of F. R. Kennedy
0000976300009843
Files of F. R. Kennedy
FOLDER TITLE (OR OTHER FILE DESCRIPTION) Products 2,4,5-T Acid - Dry
Products 2,4 ,5Trichlor-propionic
Product File 2,4,5-TP
Products Competitive Formulations
Product File Line Rider
Product Formulations - New
Products Organics
Products Tetrachlorobenzene Molten
Products MCP Sales and Uses
INTERROGATORIES TO WHICH RESPONSIVE 2B(iii); 4A , B, C [p.11] and 4K, P
2B(i ii); 4A , B, C Cp. 11] and 4P
2B(iii) and 4P
2B(iii); 4A , B, C [p 11 ] and 4P
2B(iii); 4A , B, C [p -11 ] and 4P
2B(i ii); 4A , B, C Cp. 1 1 ]
and 4P
2B(ii i); 4A, B, C [p.11] and 4P
2B(iii) ; 4A , B, C C p .11 ]
and 4D, P , Q
4A , B, C [ p 11] and 4P
2048
DOCUMENT NUMBERS 0000984400009848
0000984900009878
0000987900009885
0000988600009983
0000998400010297
OOOIO298-
00010464
0001046500010627
0001062800010953
I
SOURCE
Files of F. R. Kennedy
Files of F. R. Kennedy
Files of F. R. Kennedy
T.R. Evans Research Center Library Files
T.R. Evans Research Center Library Files
T.R. Evans Research Center Library Files
T.R. Evans Research Center Library Files
T.R. Evans Research Center Library Files
FOLDER TITLE (OR OTHER FILE DESCRIPTION)
Products Muriatic Acid
Trichlorophenol Dilution Process
Propionic Acid
Anal. & Res. Studies Ag . Chem. 2 ,4-D & 2 , 4 ,5-T
Formulation & Evaluation Ag . Chem . 2 ,4-D & 2,4 ,5-T
Process Miscl. Eng. Files Ag . C h e m . 2 ,4-D & 2,4 ,5-T
A g . Chem. Agent Orange
Ag . C h e m . 2 ,4-D & 2,4 ,5-T Gen. 1958-
-12-
INTERROGATORIES TO WHICH RESPONSIVE 4A, B, C [p .11] and 4P 4A , B , C [p .11] and 4D, J, P, Q
4A, B, C [p .11] and 4P 3, 4A , B , C [p .11] and 4D, E, Q, T
4A, B, C [p .11]
2B(iii), (v); 4A, B, C [p.11] and 41, J, P
4A, B, C [p .11] and 4K
4A, B, C [p.11] and 4E, P, Q
2049 P-2I3Z-
DOCUMENT NUMBERS 000109540001 1145
0001 114600011342
0001 134 30001 1618
00011619-
0001 1814
000118150001 1937
0001193800012065
0001206600012188
SOURCE
T.R. Evans Research Center Library Files
FOLDER TITLE (OR OTHER FILE DESCRIPTION)
A g . Ch e m . 2 ,4-D & 2 , 4 ,5-T Gen. July 1955-1957
T.R. Evans Research Center Library Files
Ag. Chem. 2,4-D & 2,4,5-T Gen 1945-June 1955
T.R. Evans Research Center Library Files
Ag. Chem. 2,4-D & 2,4,5-T
P r o c e s s e s - 19 6 1
T.R. Evans Research Center Library Files
A g . Ch e m . 2,4-D & 2,4, 5-T Processes 1949-1960
T.R. Evans Research Center Library Files
Ag . Chem. Tech. Service Gran.
T.R. Evans Research Center Library Files
A g . Chem. Tech. Service Granules Wright Pat.
Diamond Shamrock Corporate Library
Documents Relating to
February i960 Explosion
at Newark Plant
-13-
INTERROGATORIES TO WHICH RESPONSIVE 4A , B, C [p .11] and 4P
4A , B, C [p. 11] and 4D, P, Q
2B(ii), (iii); 4 A , B, C [p. 11] and 4D , I, J, P, Q 4A , B, C [p .11] and 4D, P, Q
4A, B, C [p.11] and 4P
4A , B , C [p . 11] and 4P
4H
2050 0-H 3S
DOCUMENT NUMBERS 0001218900012394
0001239500012554
0001255500012646
0001264700012669
0001267000012738
0001273900012788
0001278900012870
0001287100012965
0001296600013006
SOURCE
FOLDER TITLE (OR OTHER FILE DESCRIPTION)
Registration Files Labels Accepted for
of Regis. D e p t .,
Registration Under
A g . Chem. Division FIFRA
Files of F.R. Kennedy
Orange
Files of F.R. Kennedy
Chloroacne
Files of F.R. Kennedy
Loose Papers - No Folder
Files of F.R. Kennedy
2,4 ,5-T
Files of F.R. Kennedy
D/T Acid - Reports
Files of F.R. Kennedy
2 ,4-D
Files of F.R. Kennedy
2,4-D (Old)
Files of F.R. Kennedy
DCP
-14-
INTERROGATORIES TO WHICH RESPONSIVE 4L
2B(i), (ii) , (iii) ; 4 A , B , C (iv) [p . 9] and 4P 2B(iii), (v ) ; 3, and 4 D , F, G, I, J, K, P, Q, T 2B(iii), (v ); 41, J, K, P 2B(iii) and 41, J, P
2B(iii) and 41, J, P
2B(iii) and 41, J, P
4A, B, C [p .113 and 4P
4A, B, C Cp .113 and 4P
2051 O - a & f
DOCUMENT NUMBERS 0001300700013225
0001322600013246
0001324700013273
0001327400013391
0001339200013468
0001346900013533
0001353400013630
0001363100013648a
0001364900013691
SOURCE Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
FOLDER TITLE (OR OTHER FILE DESCRIPTION) Ester Program
Esters
Newark Esters
Operating Instructions Dichlorophenol
Operating Instructions 2,4-D Acid
Operating Instructions Butyl D & T
Operating Instructions Iso D & T
Operating Instructions BEP D & T
Operating Instructions Amines
-15-
INTERROGATORIES TO WHICH RESPONSIVE
2B(iii), (v) ; 4A, b C [p .11] and 41, J, K, P
4a , B, C [p .11] and 4P
4A, B, C [p. 11] and 41, J, K, P
2B(iii) and 41, J, P
2B(iii) and 41, J, P
J ,2B(iii) and 41,
P
2B(iii) and 41, J, P
2B(iii) and 41, J, P
2B(iii) and 41, J, P
ss/r-azso2
DOCUMENT NUMBERS 00013692000 13720
0001372100013739
0001374000013810
0001381100013888
0001388900013962
0001396300013994
0001399500014257
0001425800014267
0001426800014310
SOURCE Files of F .R . Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
FOLDER TITLE (OR OTHER FILE DESCRIPTION) Operating Instructions Ester Solvent Recovery
Operating Inst.
Products Phenol
Products Esters BEP D & T
Products Esters Iso-D
Products Esters Iso-T
Products Esters Butyl D & Butyl Carbitol Chloride
Products MCA Sales & Uses
MCA - Manufacturing
-16-
INTERROGATORIES TO WHICH RESPONSIVE 2B(iii) and 41, J , P 2B(i ii) and 41, J , P 2B(iii) and 41, J , P 2B(iii) and 41, J , P 2B(i i i) and 41, J , P 2B(iii) and 41, J , P 2B(iii) and 41, J , P
4A , B, C [p 11] and 4P 4A , B, C [p .11] and 4P
<yei~0
DOCUMENT NUMBERS
0001431100014313
0001431400014331
0001433200014357
0001435800014431
0001443200014494
0001449500014596
0001459700014602
0001460300014609
0001461000014651
SOURCE Files of F .R . Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
FOLDER TITLE (OR OTHER FILE DESCRIPTION)
MCA
INTERROGATORIES TO WHICH RESPONSIVE
4A , B, C [p .11] and 4P
Technical Reports G. H. Burris
Technical Reports J. Ginos
Newark Product Control Tests
Chromatograph and Chromatographic Procedures
2,4-Dichlorophenoxyacetic Acid Melt Washing and Drying
MCA
4A , B, C [p.11] and 4P 4A , B, C [p. 11] and 4P 4A , B, C [p .11] and 4K 4A , B, C [p.11] 2B(iii) and 4 1 , J, :P 4A, B, C [p.11] and 4P
Chloray Progress Reports Chloray Engineering
4A , B, C [p.11] and 4 D , K, Q
4 A , B, C [p.11] and 4P
-17-
2054 P 's/&7
DOCUMENT NUMBERS 0001465200014662
0001466300014675
0001467600014702
0001470300014710
0001471100014754
0001475500014812
0001481300014996
0001499700015056
0001505700015135
SOURCE Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
FOLDER TITLE (OR OTHER FILE DESCRIPTION) (documents re Chloray)
1975 Newark Comments Orange Reclamation Random Misc.
Health Survey '75
Environmental ControlNew Jersey Proposed IGI Process Sale Dacamine
Dacamine - 1969
Dacamine - 1968
-18-
INTERROGATORIES TO WHICH RESPONSIVE 4D, F, G, I, J, K, Q 4A , B, C [p.11] and 4K 4A , B, C Cp .113 and 4P 3 and 4G, T
4A , B, C [p.11] 2B(iii) and 41, J, P 4A, B, C Cp .11] and 4P 4A, B, C [p.11] and 4P 4A, B, C [p .113 and 4P
DOCUMENT NUMBERS
0001513600015182
0001518300015284
0001528500015350
0001535100015441
0001544200015594
0001559500015692
0001569300015703
0 or
ax
1
0001570400015869
0001587000016059
SOURCE Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
Files of F.R. Kennedy
T.R. Evans Research Center Library Files
FOLDER TITLE (OR OTHER FILE DESCRIPTION) Dacamine - 1967
Dacamine - 1966
Dacamine - 1965
Dacamine - 1964
Dacamine - 1963 and earlier Dacamine Work - 1969
Dacamine - Foreign
Spcification Manual Des Moines Herbicides No. 8 Gen Phnol. Trichloro
-19-
INTERROGATORIES TO WHICH RESPONSIVE 4A, B, C [P -11] and 4P
4A , B, C [p.ii] and 4P
4A, B, C [p. 1U and 4P
4A, B, C [P .1 1 ] and 4P
4A , B, C Cp .1 1] and 4P
4A, B, C [p. 1U and 4P
4A , B, C [p.11] and 4P
4A, B, C [p .1 1] and 4P
2B(i ii) ; 4A , B, C [p .11] and 4D, i , J, P;, Q
2056 0-313?
DOCUMENT NUMBERS 0001606000016122
0001612300016125
0001612600016141
0001614200016150
0001615100016175
0001617600016177
0001617800016182
0001618300016189
0001619000016198
SOURCE
T.R. Evans Research Center Library Files
FOLDER TITLE (OR OTHER FILE DESCRIPTION)
Phenol Dichloro
INTERROGATORIES TO WHICH RESPONSIVE
4A , B, C [p .11] and 4P
Diamond Shamrock Advertising Dept.
Heritage - Small Price Card
4B [p .11]
Diamond Shamrock Advertising Dept.
Diamond Shamrock Advertising Dept.
Heritage - Price Sheets
-
Heritage - Catalogs
4B [ p .11] 4B [p .11]
Diamond Shamrock Advertising Dept.
Heritage - Lawn Guide
4B [p. 11]
Diamond Shamrock Advertising Dept.
Heritage - 1968 Planning Kits
4B [p .11]
Diamond Shamrock Advertising Dept.
Heritage - Advertising 1969 Sheet
4B [p. 11]
Diamond Shamrock Advertising Dept.
Heritage - Price Sheets 1969
4B [p.11]
Diamond Shamrock Advertising Dept.
Heritage - Catalogs 1969
4B [p.11]
-20-
DOCUMENT NUMBERS
0001619900016205
0001620600016570
0001657100016582
0001658300016642
0001664300016648
0001664900016709
0001671000016731
0001673200016817
SOURCE
Diamond Shamrock Advertising Dept.
FOLDER TITLE (OR OTHER FILE DESCRIPTION)
Heritage House - 1969 "The cure for the common lawn"
INTERROGATORIES TO WHICH RESPONSIVE
4B [p. 11]
Files of Diamond
(Heritage House catalogs
Shamrock Corporate and sales literature)
Law Department
4B [p .11]
Files of Diamond
(Heritage House catalogs
Shamrock Corporate and sales literature)
Law Department
4B [p. 11]
Files of Diamond
(Heritage House catalogs
Shamrock Corporate and sales literature)
Law Department
4B [p. 11]
Files of P. Ben Grosscup
(draft product labels)
4B [p .11]
Ag Chem Division Document Storage
U.S. Government - General
2B(i), (ii); 4A , B [p .9]
Ag Chem Division Document Storage
F.R. Kennedy - Mail
2B(i), (i i ) ; 4A j B [p .9]
Ag Chem Division Document Storage
TCB
2B(iii), 4A , B, C [p .11] and 4P
I -21-
DOCUMENT NUMBERS 0001681800017117
0001711800017353
0001735400017418
0001741900017478
0001747900017619
000176*2000017694
0001769500017722
>
SOURCE
Files of General Manager, A g . Chem. Division
FOLDER TITLE (OR OTHER FILE DESCRIPTION)
Orange
Files of General Manager, A g . Chem. Division
Orange - Weldon Springs
Files of General Manager, A g . Chem. Division
Chloracne
Files of General Manager, A g . Chem. Division
Newark
Files of General Manager, A g . Chem. Division
NACA - Hearing on Effects of 2,4 ,5-T - 1970
Files of General Manager, Ag . Chem. Division
California, State of
Files of General Manager, A g . Chem. Division
Unico
-22-
INTERROGATORIES TO WHICH RESPONSIVE 2B(i), (ii), (iii); 4A, B, C(iv) [p .9] and 4K, P
2B(i), (i i ) , (iii); 4 A , B , C (iv) [p .9] and 4P
3 , 4A , B, C [p .11] and 4D, F, G, J, K, R, Q, T
3 and 4D, G, J, K, Q, R, T
3 and 4 F , K , Q , T
3 and 4F, Q, T
4F, Q
DOCUMENT NUMBERS 0001772300017738
0001773900017793
0001779-4 -- 00017824
OOOI7825OOOI7837
OOOI7838-
00017843
0001784400017847 to
o
CJT 00017848CD 00017849
>k)
SOURCE
Files of General Manager, A g . Chem. Division
Files of General Manager, A g . Chem. Division
Files of General Manager, A g . Chem. Division
Files of General Manager, A g . Chem. Division
Files of General Manager, A g . Chem. Division
Files of General Manager, A g . Chem. Division
Files of General Manager, A g . Chem. Division
FOLDER TITLE (OR OTHER FILE DESCRIPTION) Herbicides
Dacamine
Labelling
U.S.D.A.
Monsanto Company
"D"
"G"
-23-
INTERROGATORIES TO WHICH RESPONSIVE 4A [p. 11]
4A, B, C [p. 11] and 4J , P 4B [p.11]
4B [p.11]
4B [p.1 1]
2B( i )
2B( i)
DOCUMENT NUMBERS
O O O I 7 8 5 O-
00017851
0001785200017859
O O O I 7 86O-
00017976
00017977-
00018086
0001808700018164
0001816500018193
0001819400018254
00018255-
00018332
0001833300018360
SOURCE
Files of General Man age r, Ag . Chem. Division
FOLDER TITLE (OR OTHER FILE DESCRIPTION)
Dow Chemical Company
Files of General Manager, A g . Chem. Division
(Diamond Shamrock Chem. Co. Offers Newark Plant For Sale)
Files of Lawrence Cecil
Colombia Weedkiller Problems #1
Files of Lawrence Cecil
Colombia Weedkiller Problems #2
Files of Lawrence Cecil
Colombia Weedkiller Problems #3
Files of Lawrence Cecil
Colombia Weedkiller
Claim Folder 1968
Files of Lawrence Cecil
Colombia Weedkiller
Claim Folder 1967
Files of F.R. Kennedy
Explosion and Fire Newark Plant
Files of Mktg.
Phenoxy Task Force
& Sales Manager,
A g . Chem. Division
-24-
INTERROGATORIES TO WHICH RESPONSIVE
2B(ii)
41, P
4D, F, Q, T
Q,4D, E, F,
T
4D, F, Q
4D, F, Q
4D, F, Q
4H
3 and 4E, K , T
p - n i 1/
2061
DOCUMENT NUMBERS 0001836100018640
0001864100018828
0001882900019038
OOOI9039-
00019277
OOOI9278-
00019323
0001932400019414
0001941500019555
0001955600019576
SOURCE
FOLDER TITLE (OR OTHER FILE DESCRIPTION)
Files of Mktg.
Phenoxy Task Force
& Sales Manager,
A g . Chem. Division
Files of Mktg.
Phenoxy Task Force
& Sales Manager,
A g . Chem. Division
Files of Mktg.
Phenoxy Residue Studies
& Sales Manager,
A g . Chem. Division
Files of Mktg. & Sales Manager, A g . Chem. Division
NACA Phenoxy Herbicide Task Force
Files of Mktg.
2,4-D and 2,4,5-T
& Sales Manager,
A g . Chem. Division
Files of Mktg.
Dow - 2,4-D
& Sales Manager,
A g . Chem. Division
Diamond Shamrock Health & Envir. Affairs Dept.
Chloracne 1956-68
Former Files of Alex Hlynsky (at T.R. Evans)
2,4-D -25
INTERROGATORIES TO WHICH RESPONSIVE
3 and 4E, K, T
3 and 4E, K, T
3 and 4E, K, T
K,3 and 4E,
T
2B(iii) ; 4A , B, C [p .11] and 41, J, P
4A, B, C [p.11] and 4P
3 and 4D, F, G, K, Q, R, T
4A, B, C [p.11] and 4P
DOCUMENT NUMBERS 0001957700019582
0001958300019632
0001963300020492
0002049300020569
00020570-
OOO21607
O OO 2 1 6 O8-
00021794
O
<IOT>o 0002179500021841
SOURCE
Former Files of Alex Hlynsky (at T.R. Evans)
Former Files of Alex Hlynsky (at T.R. Evans)
T.R. Evans Research Center Library Files
T.R. Evans Research Center Library Files
T.R. Evans Research Center Library Files
Files of Diamond Shamrock Patent Dept.
Files of Diamond Shamrock Patent Dept.
FOLDER TITLE (OR OTHER FILE DESCRIPTION) 2,4,5-Trichlorophenoxy Acetic Acid, 2,4,5-T
Agricultural Chemicals 1953 (Includes MCP Process)
(responsive pages from research notebooks)
(research reports)
(progress reports)
U.S.A. Patent Application Serial No. 582,809 Hydrolysis of Polychlorobenzenes
Canadian Patent No. 722,210
-26-
INTERROGATORIES TO WHICH RESPONSIVE 4A, B , C [p.11] and 4P
4A, B , C [P 11] and 4P
4A, B , C [p.11] and 4P
4A , B , C CP .11 ] and 4P 4A , B , C [p.1 1 ] and 4P 4A, B , C [p .11 ] and 4K
4A, B , C [p.1 1 ] and 4K
?/7/if-(7g9 o 2
DOCUMENT NUMBERS 0002184200022032
0002203300022115
0002211600022296
0002229700022346
OOO22347-
00022471
0002247200022499
0002250000022536
0002253700022554
SOURCE
Files of Diamond Shamrock Patent Dept.
FOLDER TITLE (OR OTHER FILE DESCRIPTION)
German Patent No. 1,222,934
Files of Diamond Shamrock Patent Dept.
Swiss Patent No. 413,858
Files of Diamond Shamrock Patent Dept.
U.S. Patent No. 3,257,453, Process For Preparing Halophenoxycarboxy1ic Acids
Files of Diamond Shamrock Patent Dept.
Canada Patent No. 764,486 Process For Preparing Halophenoxycarboxylic Acids
Files of Diamond Shamrock Patent Dept.
German Serial No. P 15 43 515.1, Filed March 31, 1966
T.R. Evans Research Center Library Files
Toxicity General
Former Files of Edgar A. Lavergne (at T.R. Evans)
(1972 proposal re herbicide disposal)
Former Files of Alex Hlynsky (at T.R. Evans)
(1960 research) -27-
INTERROGATORIES TO WHICH RESPONSIVE 4A, B, C [p. 11] and 4D, F, K , Q 4A, B, C [p. 11] and 4K
4A , B, C [p- 11] and 4P
4A, B, C [p.11] and 4P
4A , B, C Cp -1 1 ] and 4P
3 and 4D , F, G, Q
4A , B, C [p. 11] and 4K
4A , B, C CP .11 ] and 4P
A tV-Of
DOCUMENT NUMBERS 0002255500022587
0002258800022626
0002262700022628
0002262900022674
0002267500022725
0002272600022818
0002281900023033
OOO23034-
00023039
SOURCE
Former Files of L.E. Limpel (at T.R. Evans)
FOLDER TITLE (OR OTHER FILE DESCRIPTION)
Correspondence on 2,4-D Volatility and Herbicide Testing, New Diamond Formulations
T.R. Evans Research Center Library Files
(responsive pages from research notebooks)
Engineering Study (memo re 1966 expansion
Files (T.R. Evans) of Newark Plant)
Engineering Study Agent Orange Distillation Files (T.R. Evans) Process Group Central File
T.R. Evans Research Center Library Files
U.S. Government Army Biological Labs BTI Porter
T.R. Evans Research Center Library Files
U.S. Government Army Biological Labs Gen
Ag Chem Division Document Storage
2,4-D Patents - used
Diamond Shamrock Health & Envir. Affairs Dept.
(material safety data sheets)
INTERROGATORIES TO WHICH RESPONSIVE 4A, B, C [p .11] and 4P
4A, B, C [p .11] and 4P
4A, B, C [p .11] and 4D, P, Q 4A , B, C [p .11] and 4K
4A, B, C (iv) [p .9]
and 4A , B, c Cp -1 1 ]
4A, B, C (iv) [p .9]
and 4A , B, c Cp .11 ]
4A, B, C [p .11] and 4P
4A, B, C [p .11] and 4P
-28-
DOCUMENT NUMBERS 0002304000023095
OOO23O96-
00023174
OOO23175-
00023203
0002320400023347
0002334800023388
OOO23389-
00023557
0002355800023615
OOO2 3 6 I6-
00023709
OOO2 3 7 IO-
00023841
SOURCE Files of F .G. Steward
Files of F.G. Steward
Files of F.G. Steward
Files of F.G. Steward
Files of F.G. Steward
Files of F.G. Steward
Files of F.G. Steward
Files of F.G. Steward
Files of F.G. Steward
FOLDER TITLE (OR OTHER FILE DESCRIPTION) Lit. Reprints Medically Related
Newark Product Files: Na 2,4-D Production
Newark Product Files: Ester-Color Reductions
Newark Product Files: TCP Purification
Operating Instructions (documents from same folder as Nos. 00001413-1458)
Newark Product Files: 2,4-D Operating Instructions
Newark Product Files: 2,4-D Quality
Newark Product Files: 2,4-D Filtrations and Process Efficiency
Newark Product Files: 2,4-D Reaction and Mole Ratio
-29-
INTERROGATORIES TO WHICH RESPONSIVE 3 and 4D, F, K, Q , T
2B(iii) and 41, J , P
2B(iii) and 41, J , P
2B(iii), (v ) ; 4 A , B, C, [p .11] and 4 1 , J , K, P 2B(iii), 4 A , B, c , [p.11] and 4 1 , J , P
2B(iii) and 41 , J , P
2B(iii) and 41, J , P
2B(iii) and 41, J , P
2B(iii) and 41, J , P
DOCUMENT NUMBERS
0002384200023990
0002399100024199
0002420000024237
0002423800024243
0002424400024333
0002433400024373
0002437400024477
0002447800024646
to 0 00024647CT3 00024728 05
1
0002472900024760
Xj
-
SOURCE Files of F . G . Steward
Files of F.G. Steward
Files of F.G. Steward
Files of F.G. Steward
Files of F.G. Steward
Files of F.G. Steward
Files of F.G. Steward
Files of F.G. Steward
Files of F.G. Steward
Files of F.G. Steward
FOLDER TITLE (OR OTHER FILE DESCRIPTION) Newark Product Files: 2,4-D Melt Wash and Dry
Monthly Operating Comments
Safety Industrial Hygiene
Safety Notices
Chloracne
Chloracne Urinalysis Tests 10-15
Chloracne General 10-12 1963
Chloracne and P-Dioxin
Operating Comments 1969
Newark Product Files: TCP Operating Instructions
-30-
INTERROGATORIES TO WHICH RESPONSIVE 2B(iii) and 41, J, P 2B(iii) and 41, J, P 4A, B, C [p. 11] and 4P 4A , B , C (p .11] and 4P 3 and 4E, Q, T 3 and 4G, Q, T 3 and 4G, Q, T 3 and 4G, K, Q, T 2B(iii) and 41, J, P 2B(iii) and 41, J, K, P
DOCUMENT NUMBERS 0002476100024793
0002479400024805
0002480600024828
0002482900025023
0002502400025136
SOURCE Files of F.G. Steward
Files of F.G. Steward
Files of F.G. Steward
Files of F.G. Steward
Files of F.G. Steward
FOLDER TITLE (OR OTHER FILE DESCRIPTION) Physical Properties
Newark Monthly Reports
Newark Plant
Newark Product Files: Na 2,4-D Drying
Newark Product Files: 2 ,4-DCP
INTERROGATORIES TO WHICH RESPONSIVE
4A, B, c [p .1 1 3 and. 4P
2B(iii) and 41, J, P
J,2B(iii) and 41,
P
J,2B(iii) and 41,
P
2B(i ii) and 41, J, P
to
O OT
-a
-31-
<?s/v~
AFFIDAVIT OF SERVICE
STATE OF NEW YORK ) ss .:
COUNTY OF NEW YORK )
MICHAEL M. GORDON, being duly sworn, deposes and says:
1. I am not a party to this action, am over 18 years
of age and reside at 12 West 72nd Street, New York, New York 10023-
2. On June 25, 1982, I served the annexed Diamond
i
Shamrock's Index of Documents Responding to Plaintiffs' Inter-
j
I
rogatories to Defendants (First Wave), Revised as of June 25, 1982,
on each of the persons named on the annexed list by depositing a
true copy of same enclosed in a postpaid properly addressed
wrapper, in an official depository under the exclusive care and
custody of the United States Postal Service within the State of
New York.
Sworn to before me this
No. 2.1-4664761 Qualified in Kinqs County CCeertritfiifcicaata filed in New York County
2 0 8 8 -Z/*-)
LISTING OF ATTORNEYS
FOR DEFENDANTS
Leonard L. Rivkin F.ivkin, Leff, Sherman & Radler
(for DOW CHEMICAL) 100 Garden City Plaza Garden City, New York 11530
Thomas Beck Arthur, Dry & Kalish, P.C.
(for UNIROYAL) 1230 Avenue of the Americas New York, New York 10020
Morton B. Silberman Clark, Gagliardi & Miller
(for T H AGRICULTURE & NUTRITION COMPANY, INC.)
The Inns of Court 99 Court Street White Plains, New York 10601
John C. Sabetta Townley & Updike
(for MONSANTO) 05 Lexington Avenue New York, New York 1017^
William Krohley Kelley Drye & Warren
(for HERCULES, INC.) 101 Park Avenue New York, New York 10178
David R. Gross Budd, Larner, Kent, Gross Picillo & Rosenbaum
(for THOMPSON CHEMICALS) 33 Washington Street Newark, New Jersey 07102
Howard Lester Lester, Schwab, Katz & Dwyer
(for HOFFMAN-TAFF) 120 Broadway New York, New York 10271
Paul V. Esposito Lewis, Overbeck & Furman
(for RIVERDALE CHEMICAL CO 135 South LaSalle Street Suite 1060
Chicago, Illinois 60603
John M. Fitzpatrick Dilworth, Paxson, Kalish & Levy
(for HOOKER PLASTICS & CHEMICALS 2600 The Fidelity Building Philadelphia, Pennsylvania 19109
CORP.
Joan Bernott Deoartment of Justice
(for THIRD PARTY DEFENDANT USA) Safeway Building, Room 90^D 521 12th Street, N.W. Washington, D.C. 20530
COPIES OF ALL DOCUMENTS MUST BE SENT TO:_________________
Clerk of the Panel Judicial Panel on Multidistr
Litigation 1120 Vermont Avenue, N.W. Suite 1002 Washington, D.C. 20005
FOR PLAINTIFFS
Victor J. Yannacone, Jr. (lead counsel)
Yannacone & Yannacone Post Office Drawer #109 Patchogue, New York 11772
Irving Like, Esq. Reilly, Like & Schneider 200 West Main Street Babylon, N. Y. 11702
UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK
In re "AGENT ORANGE"
Product Liability Litigation
U. S.DISTRICI
j UM 1 1 UM
TlMt AJiA------- x PAL______
MDL No. 381
RESPONSE OF DEFENDANT DIAMOND SHAMROCK CORPORATIO TO PLAINTIFFS INTERROGATOR NO. 3 TO DEFENDANTS (FIRST WAVE) x
Defendant Diamond Shamrock Corporation ("Diamond Shamrock") pursuant to Pretrial Order No. 26 dated December 26, 1980, Pretrial Order No. 33 dated February 24, 1982, and the agreement with counsel for plaintiffs of May 27, 1982, hereby answers Interrogatory No. 3 of plaintiffs' Interrogatories to Defendants (First Wave), served January 2 3 1981. Diamond Shamrock reserves the right to supplement or amend its answer, and to object to the admissibility as evidence of the answer or the subject matter thereof in any subsequent proceeding herein or the trial of this or any other action.
Interrogatory No. 3 : Identify by name and last known address, and if retired so state and supply the last known address of each and every person, scientific, medical, or otherwise, retained by or known to this defendant or known by this defendant to have been retained by or known to any of the other defendants who has studied, evaluated, or reported or directly or indirectly communi
cated any findings referable to whatever effects were so found upon animals or human beings resulting from exposure, directly or indirectly, in the formulation, design, manufacture, and produc tion, of phenoxy herbicides such as 2,4,5-Trichlorophenoxy Aliphatics containing but not limited to the synthetic organic
3 ,chemical 2, 7,8-Tetrachlor Dibenzo p-dioxin (TCDD or "Dioxin")
and other herbicides containing Polychlorinated Dibenzo-p-dioxins (PCDDs) and Polychlorinated Dibenzo furans (PCDFs) including the ultimate users and those expected to be exposed to same.
Answer :
Dr. Irving L. Applebaum Director of Medical Education
and Consultant in Medicine Newark Beth Israel Hospital 201 Lyons Avenue Newark, New Jersey
Mr. William F. Barthel Chief, Toxicology Laboratory
Pesticides Program Department of Health, Education and Welfare Public Health Service National Communicable Disease Center Atlanta, Georgia
Dr. Donald J. Birmingham Medical Director - Chief Dermatology Section Occupational Health Research and
Training Facility Department of Health, Education and Welfare Public Health Service 1014 Broadway Cincinnati, Ohio
Dr. Jacob Bleiberg (Deceased, 1974)
Dr. Roger Brodkin 769 Northfield Avenue West Orange, New Jersey
Hazleton Laboratories, Incorporated Falls Church, Virginia
Dr. E. Hurtado State of New Jersey Department of Health Trenton, New Jersey
2071 D-AI5#
Industrial Hygiene Foundation Mellon Institute 4400 Fifth Avenue Pittsburgh, Pennsylvania
of America,
Inc.
Dr. Marcus M. Key Dermatology Section Occupational Health Research and
Training Facility Department of Health, Education and Welfare Public Health Service 1014 Broadway Cincinnati, Ohio
Dr. Richard W. McBurney Staff Vice President Diamond Shamrock Corporation 717 North Harwood Street Dallas, Texas
Dr. Norman Olivier Department of Health, Education and Welfare Public Health Service Cincinnati, Ohio
Dr. Alan P. Poland Toxicology Laboratory Pesticides Program Department of Health, Education and Welfare National Communicable Disease Center Atlanta, Georgia
Dr. Paul Possick Department of Health, Education and Welfare Public Health Service Cincinnati, Ohio
E. Lynn Schall Chief, Occupational Health Program State of New Jersey Department of Health Trenton, New Jersey
Dr. Donald Smith Department of Health, Education and Welfare Public Health Service Atlanta, Georgia
2072 J0-2/5S
-3-
Objection : Diamond Shamrock continues to object to Interrogatory No. 3 to the extent that it: (a) requests information for phenoxy herbicides that do not contain 2,4,5-trichlorophenoxyacetic acid, 2,4-dichlorophenoxyacetic acid, or an ester, amine, salt or other form thereof; and (b) requests information for the time period subsequent to December 31 1971. See Defendants' Objections to Plaintiffs' First Wave Interrogatories, dated January 23, 1981, at pages 3-4.
Dated: New York, New York June 16, 1982
Signature as to Objections:
CADWALADER, WICKERSHAM & TAFT
U/ QJ .zj
sv i A Member of the Firm
77W r
Attorneys for Defendant
Diamond Shamrock Corporation
One Wall Street
New York, New York 10005
(2 1 2 ) 9 0 8 - 7 0 0 0
TO: ATTACHED SERVICE LIST HON. SOL SCHREIBER
-4- 2073 /O-Z'-r6
STATE OF OHIO
)
COUNTY OF CUYAHOGA )
George A. Lawrence, being duly sworn, says that he is Vice President and General Manager, Agricultural Chemicals Divi sion, of defendant Diamond Shamrock Corporation; that he has read the foregoing answer of Diamond Shamrock to plaintiffs' Interroga tory No. 3 to Defendants (First Wave); and that the foregoing answer to said interrogatory was prepared under his supervision or the basis of records of Diamond Shamrock, information furnished by present and former employees of Diamond Shamrock, and in part on his personal knowledge and to the best of his knowledge, infor mation and belief, is true and correct.
Sworn to before me this day of June, 1982.
Notary P u b l i c ^ LAWRNhoNtaGri,: fNu.jiG.rA; NG,i./Actotorney
My commission fias no exprrsiion w*m . Section 147,03 R. C.
2074 p j j s - ?
AFFIDAVIT OF SERVICE
STATE OF NEW YORK ) : ss .:
COUNTY OF NEW YORK )
MICHAEL M. GORDON, being duly sworn, deposes and says:
1. I am not a party to this action, am over 18 years
of age and reside at 12 West 72nd Street, New York, New York 10023-
2. On June 17, 1982, I served the annexed Response of Defendant Diamond Shamrock Corporation to Plaintiffs' Interrog atory No. 3 to Defendants (First W a v e ) on each of the persons named on the annexed list by depositing a true copy of same enclosed in a postpaid properly addressed wrapper, in an official depository under the exclusive care and custody of the United States Postal Service within the State of New York.
Michael M. Gordon
toy-Oualif'sJ in Kin3s County
Ccrtifisa'.n .ieri in Now York Couni Commission expires l/erch 30, 198^
2075
LISTING OF ATTORNEYS
FOR DEFENDANTS
Leonard L. Rivkin Rivkin, Leff, Sherman & Radler
(for DOW CHEMICAL) 100 Garden City Plaza Garden City, New York 11530
Thomas Beck Arthur, Dry & Kalish, P.C.
(for UNIROYAL) 1230 Avenue of the Americas New York, New York 10020
Morton B. Silberman Clark, Gagliardi & Miller
(for T H AGRICULTURE & NUTRITION COMPANY, INC.) The Inns of Court 99 Court Street White Plains, New York 10601
John C. Sabetta Townley & Updike
(for MONSANTO) 405 Lexington Avenue New York, New York 10174
William Krohley Kelley Drye & Warren
(for HERCULES, INC.) 101 Park Avenue New York, New York 10178
David R. Gross Budd, Larner, Kent, Gross Picillo & Rosenbaum
(for THOMPSON CHEMICALS) 33 Washington Street Newark, New Jersey 07102
Howard Lester Lester, Schwab, Katz & Dwyer
(for HOFFMAN-TAFF) 120 Broadway New York, New York 10271
Paul V. Esposito Lewis, Overbeck & Furman
(for RIVERDALE CHEMICAL CO. 135 South LaSalle Street Suite 1060 Chicago, Illinois 60603
John M. Fitzpatrick Dilworth, Paxson, Kalish & Levy
(for HOOKER PLASTICS & CHEMICALS CORP. 2600 The Fidelity Building Philadelphia, Pennsylvania 19109
Joan Bernott Department of Justice
(for THIRD PARTY DEFENDANT USA) Safeway Building, Room 904d 521 12th Street, N.W. Washington, D.C. 20530
COPIES OF ALL DOCUMENTS MUST BE SENT TO:
Clerk of the Panel Judicial Panel on Multidistric
Litigation 1120 Vermont Avenue, N.W. 'Suite 1002 Washington, D.C. 20005
FOR PLAINTIFFS
Victor J. Yannacone, Jr. (lead counsel)
Yannacone & Yannacone Post Office Drawer #109 Patchogue, New York 11772
Irving Like, Esq. Reilly, Like & Schneider 200 West Main Street Babylon, N. Y. 11702
2076
YANNACONE & YANNACONE
Professional Corporation Victor J. Yannoconc (DccM) Victor John Yannacone, jr. W. Keith K avenagh, Ph.D. Michael T. Sullivan
Townley & Updike, Esq s. Chrysler Building 405 Lexington Avenue New York City, New York 10017
ATTENTION: John C. Sabetta, Esq.
re: Depositions of Monsanto employees
Dear counselor:
UbL
/
Attorneys and Counselors at Law
Workers Compensation Division: Retirement & Socinl Security Division:
Medical-Legal & Litigation Division: General Practice Division:
Environmental, Consumer & Public Interest Law Division:
Area Code 516 475-0231 (nights also) 654-0231 654-2299 654-2222 654-2662
INf CiLERlK'SOFdFICcU. S. DISTRICT COURT E.D. N-Y.
MAY1 q1382
JIME A.M.-- P.M...
In MDL 381 document 628, "Answers of Defendant Monsanto Company to Plaintiffs' Interrogatories to Defendants (First Wave)" in.-response to MDL 381 document 570, you stated that certain "lists of Monsanto and Government employees will be provided to plaintiffs as Supplemental Answers to plaintiffs' Interrogatories Numbers 2 and 4 within a reasonable time hereafter and as soon as possible after they have been compiled." No such lists have been provided to date and we submit that a series of exhibits consisting of merely six digit document numbers is not substantial compliance with our Interrogatories (document 570).
PLEASE TAKE NOTICE that by this letter we request the production of certain present or former employees of defendant Monsanto Company for depositions commencing Tuesday 25 May 1982 at 10:00 AM in the United States Courthouse at Uniondale, and request that each of said witnesses bring with them whatever documents may be necessary to refresh their recollection as to the information sought by Plaintiffs in those Inter rogatories designated 3 in document 134, and 2.A. through 2.B, 4.A. through 4.C., 4.I.J., 4.P, 4.K, 4.L., 4.N.O., in document 570, and 2.1
through 2 .4 , 3 . 1 through 3.82, 4.1 through 4.14 in document 568.
The specific employees or former employees we request you to produce for oral deposition and a brief description of their titles and positions are :
Dan J. FORRESTAL, former director of Public Relations Edward A. O'NEAL, JR., retired Chairman of the Board Tom K. SMITH, JR., former General Manager, Agricultural Chemicals Division Charles H. SOMMER, J R . , retired Chairman of the Board Frederick W. HATCH, Agricultural Products Consultant, 19581960 Monte C. THRODAHL, Director, Group Vice President Dr. R. Emmett KELLY, retired Director, Medical Department Elmer P. WHEELER, Medical Department
We would prefer to commence our examinations with the deposition of Mr. Forrestal, followed immediately by Mr. Smith.
2077 o -^ n >
Post Office D raw er 109
Patchogue, New York 11772
YAN N ACO N E & YAN N ACO N E _s4 ttorneyi a n d d o u m e io n a t odeaw~
Townley & Updike, E sq s.
2- -
18 May 1982
We are willing to accept other present or former employees of Monsanto Company with actual knowledge of the matters on which information is specifically sought:
1. 2,4,5T;
The manufacture of phenoxv herbicides, in particular
2. The sources and extent of dioxin contamination of those herbicides ;
3. The extent of knowledge within Monsanto about such contamination;
4. The notice given, if any, to the United States Department of Defense about the dioxin contamination of the phenoxy herbicides;
5. The extent of knowledge within Monsanto about the toxicity of the dioxin contaminants of chlorinated phenols;
6. The warnings given, if any, to the United States Department of Defense about the toxicity of dioxins.
We expect our examinations to be conducted in consecutive fashion and proceed to completion whereever possible in a single day. We would appreciate your cooperation toward this end.
BY HAND: 18 May, 1982 Townley & Updike; Special Master By Hand: 19 May, 1982 All counsel at Pre-Trial Conference by mail 19 May 1982 to remainder of counsel of JDL 381 Service List telephone notice 18 May 1982 to Joan M. Bernott, Esq., U.S. Dept, of Just
2078 O - 3 - l <*!
UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK
In re
: MDL No. 381
"AGENT ORANGE" Product Liability Litigation
: NOTICE OF DEPOSITION UPON ORAL EXAMINATION
FILED
IN CLERK'S OFFICE A U. S. DISTRICT COURT E.D. N.Y,
MAY17i382 rT
TIME A.M. P.M.
PLEASE TAKE NOTICE that, pursuant to Rules 30 and
(of the Federal Rules of Civil Procedure, defendants will take the
I deposition upon oral examination of the United States Army Medical
Research Institute of Chemical Defense, by an officer, director or
managing agent thereof having knowledge of the documents described
in the attached Schedule of Documents, before a Notary Public or
some other official authorized by law to administer oaths at the
United States Courthouse, Uniondale Avenue at Hempstead Turnpike,
Uniondale, New York at 10:00 A.M. on May 21, 1982. The examination
will continue from day to day until completed. You are invited
to attend and cross-examine.
PLEASE TAKE FURTHER NOTICE that pursuant to the Federal Rules of Civil Procedure the person to be examined is commanded
I x/<o 2- !
to produce at said examination the documents requested in the attached Schedule of Documents. Dated: New York, New York
May 17, 1982 CADWALADER, WICKERSHAM & TAFT
ByU )l4vM { & A Member of the Firn/ Attorneys for Defendant
Diamond Shamrock Corporation One Wall Street New York, New York 10005 (212) 908-7000 TO: SEE ATTACHED SERVICE LIST
-2-
-9-1(.3
iI I!
1 I'
| i
I!lI! ii ii SCHEDULE OF DOCUMENTS 1
j|
Ii
|| In accordance with the definitions and instructions set :!i1 iiforth in Defendants' Phase I First Wave Interrogatories (First
!l
!!S e t ) dated January 15, 1981, a copy of which is annexed hereto as |j ||Exhibit A, you are to produce the following documents for inspeci!
Ijtion and copying by defendants at the time, date and place set
|jforth in the accompanying subpoena duces tecum and ad testificanc
jj(or at such other time, date and place as may be agreed upon): !i j| || 1. All trip reports prepared by Dr. Fritz Hoffman,
.i
|!former Chief of the Agents Research Branch of the U.S. Army
I;Chemical Research Laboratory, or by anyone else in or about 1962
which refer or relate to dioxin or to an incident at a European
Ifactory where certain workers' health was allegedly affected by a
chemical compound later identified as dioxin.
;i
|i || 2. All minutes, memoranda, notes, outlines and other !i
;J
||documents which refer or relate to any oral presentation made by
i}D r . Fritz Hoffman to employees of the U.S. Army's Biomedical Il j Laboratories and Chemical Laboratories in or about 1962 concernir
i a visit by Dr. Hoffman to Europe, during which reference was made I , to dioxin or to an incident at a European factory where certain |! |!workers' health was allegedly affected by a chemical compound
later identified as dioxin. | ,j
H1j 3- All minutes of the meetings of Review Point 1, j!Review Point 2 and Review Point 3 at Edgewood Arsenal (hereinafte
I I 2 0 8 1 O 'Z J t e 1/
"the Review Points"), and all recommendations, memoranda, notes and other documents prepared by or for members of the Review Points, which refer or relate to dioxin.
All documents that refer or relate to a sample of dioxin received by John J. Callahan of the Toxicology Division of the U.S. Army's Biomedical Laboratories in the early 1960's.
5- All documents that refer or relate to research, testing, experimentation, toxicity studies or other work concerni dioxin undertaken by or under the auspices of John J. Callahan, Dr. Edmund Owens, Dr. Bernard P. McNamara, or by any other employee of the U.S. Army's Biomedical Laboratories and Chemical Laboratories.
6. All documents that refer or relate to proposed research, development, testing or evaluation of dioxin in the Chemical Research Laboratory of the U.S. Army's Chemical Labora tories, including all communications to or from Dr. Bernard Jandorf or Dr. Benjamin Witten concerning such research, develop ment, testing or evaluation.
7- All files or former files of John J. Callahan, Ron Castle, Dr. Milton Christianson, Dr. Charles Hasset, Dr. Fritz Hoffman, Dr. Richard Horton, Dr. Bernard Jandorf, Dr. Kazuo Kimura, Elmer Lee, James Lennox, Dr. Bernard P. McNamara, Dr. Edward Metcalf, Jacob Miller, Lester Miller, Dr. Edmund Owens, Dr. Seymour Silver, Dr. Van M. Sim, Dr. Thomas Simmons, Dr. Walter
2082 - a /c .r
-2-
E. Sultan, Dr. William H. Summerson, Dr. Benjamin Witten or any other employee of the U.S. Army's Biomedical Laboratories and Chemical Laboratories which refer or relate to dioxin.
8. All documents relating to any communications to or from the U.S. Army Chemical Corps Intelligence Agency, including all communications to or from Dr. Nathan Gordon, which refer or relate to dioxin. i
9. All documents relating to any communications to or from the U.S. Public Health Service, including all communications to or from Dr. Boris Oshoroff, which refer or relate to dioxin, trichlorophenol, 2,9,5-trichlorophenoxyacetic acid, 2,9-dichlorophenoxyacetic acid, or an ester, amine, salt or other form thereo including Agent Orange, Agent Pink, Agent Purple and Agent Green.
10. All documents, not called for in response to para
9,g r a p h s 8 or
relating to any communications to or from any
|person which refer or relate to dioxin, trichlorophenol, 2,9,5-
|trichlorophenoxyacetic acid, 2,9-dichlorophenoxyacetic acid, or ar
|ester, amine, salt or other form thereof, including Agent Orange, 1
Agent Pink, Agent Purple and Agent Green.
i
11. All copies of studies, reports, publications and
other literature which refer or relate to dioxin, trichlorophenol,
2,9,5-trichlorophenoxyacetic acid, 2,9-dichlorophenoxyacetic acid,
or an ester, amine, salt or other form thereof, including any of
the following:
-3- 2083 0 -M U
(a) Kimmigj J., Schulz, K.H.: Chlorierte aromatische zyklische ther als Ursache der sogenannten Chlorakne, Naturwissenschaften 44,337-338 (1957);
(b) Kimmig, J .3 Schulz, K.H.: Berufliche Akne (sog. Chlorakne) durch chlorierte aromatische zyklische ther, Dermatologica 115,540-546 (1957);
(c ) Schulz, K .H .: Klinische und experimentelle Unter suchungen zur tiologie der Chloracne, Arch. Klin. Exp. Dermatol. 206,589-596 (1957);
(d) Bauer, H., Schulz, K.H., Spiegelberg, U.: Berufliche Vergiftungen bei der Herstellung von Chlorphenol-Verbindungen, Arch. Gewerbepathol. Gewerbehyg. 18,538-555 (1961);
(e) Sandermann, W., Stockmann, H., Casten, R.: Uber die Pyrolyse des PentachlorDhenols, Chem. Ber. 90,690-692 (1957);
(f) Bleiburg, J., Wallen, M . , Brodkin, R., Appelbaum, I .L .: Industrially acquired porphyria, Arch. Dermatol. 89,793-797 (196*4).
12. All documents that refer or relate to a me
held to discuss and evaluate the toxicity of 2,4-D and 2,4,5-T
compounds on April 26, 1963 at Edgewood Arsenal, Maryland, includ
ing all minutes of said meeting and all data, reports, medical
literature, appendices and other documents referred to in the
minutes.
13- All organization charts for each laboratory,
division, branch, committee and other unit of the U.S. Army's
Biomedical Laboratories and Chemical Laboratories at Edgewood
Arsenal for the period from January 1, I960 to January 1, 1972.
14. All documents not called for in response to the
preceding paragraphs that are responsive to Defendants' Phase I
-4-
i
First Wave Interrogatories (First Set) dated January 15, 1981 (Exhibit A hereto), but which have not yet been produced to the parties by the United States of America in In re "Agent Orange" Product Liability Litigation, MDL No. 381.
I 1 I
1Il
I1
O C - W s
: UEANSITTEEDRN STDAI STTERS I CDTI S TORFI CNTEWCOYUORRKT it --------------------------------------------------------
|
!In re
| "AGENT ORANGE"
product Liability Litigation
MDL No. 381 DF(FIERIFRSESTNTDWASANEVTTES)'_I_NP_TH__EA_RS_RE__O_GI_A__T_O__R_I_E_S x
j. PLEASE TAKE NOTICE t h a t , p u r s u a n t to Rule 33 o f t h e i; 'Federal R u le s o f C i v i l P r o c e d u r e and P r e t r i a l O rd er No. 26, f i l e d i1.;`December 29, 1980, t h e u n d e r s i g n e d d e f e n d a n t s demand t ha t t h e j-United S tates of America and each p l a i n t i f f herein serve and f i l e
: answers to each of the follow ing I n t e r r o g a t o r i e s under .oath on or
i;' b e f o r e F e b r u a r y 13, 1981, i n a c c o r d a n c e w i t h t h e d e f i n i t i o n s and
: i n s t r u c t i o ns attached hereto and made a p a rt hereof.
INTERROGATORIES
s. * >*,
J-sm* S S t'>i mJ?
RANEDSEAERVCAHL,UADTEIOVNELOOPFMHENETR,BITCEIDSETSING
,
\r L-L.L.
1. I d e n t i f y s e p a r a t e l y each u n it o f the United S t a t e s , las defined herein , including those l is te d on Appendix A h ereto , irthat engaged during the p erio d p r i o r to Jan u ary 1, 1972 in any .activities relating to the research, development, testing or evaluation of herbicides for potential use in connection with ]m i l i t a r y a c t i v i t i e s , and as to each su ch u n i t , d e s c r i b e : I a. The n ature and e x te n t of i t s involvement in such activ ities; and
]j
j b. The d u ra tio n of i t s involvem ent in such a c t i v i ties .
2. As t o each s e p a r a t e u n i t o f t h e U n it e d S t a t e s [identified in the response to Interrogatory 1, identify each
2 O 8 6 0 - `2 / i *
I
person in charge of or with resp o n sib ility for any of i t s activ IIi i t i e s r e l a t i n g to t h e r e s e a r c h , d e v e l o p m e n t, t e s t i n g or e v a l u a t i o n 'of herbicides for potential use in connection with m ilitary |a c tiv itie s .
i!! 3 . Give an o r g a n i z a t i o n c h a r t f o r each s e p a r a t e u n i t
:o f t h e U n ited S t a t e s i d e n t i f i e d i n t h e r e s p o n s e t o I n t e r r o g a t o r y 1 for each p e r i o d p r i o r t o J a n u a r y 1, 1972 d u r i n g which i t was i.ii n v o l v e d i n a c t i v i t i e s r e l a t i n g t o t h e r e s e a r c h , d e v e l o p m e n t , I t e s t i n g o r e v a l u a t i o n o f h e r b i c i d e s f o r p o t e n t i a l use in c o n n e c -
li
!tio n with m ilita ry a c t i v it i e s .
1 U. Identify each communication, meeting, contract or : o th er tra n s a c tio n between the United S ta te s and any of the defen-
! cants herein, or any o fficer, agent, employee or other person actI,-i n g o r p u r p o r t i n g to a c t on b e h a l f o f a d e f e n d a n t , t h a t c o n c e r n s
or relates to any research, development, testin g or evaluation of I:h e r b i c i d e s p r i o r t o J a n u a r y 1, 1972 f o r p o t e n t i a l u s e in c o n n e c -
ition with m ilitary activ ities.
5. Id en tify each document c o n stitu tin g , memorializing,
disclosing, referring or relating to each communication, meeting,
contract or other tran sactio n id e n tifie d in the response to In te r-
! r o g a t o r y ii.
i
,'
! 6. Identify each project concerning the research, development, testing or evaluation of herbicides for potential
i :
use in connection with m ilitary ac tiv itie s, including those
p ro je c ts l i s t e d on Appendix B h e re to .
7. As t o eac h p r o j e c t i d e n t i f i e d i n t h e r e s p o n s e t o I n t e r r o g a t o r y 6 , i d e n t i f y each document t h a t c o n s t i t u t e s , memo rializes, discloses, refers or relates to the results of research,
-2-
\ 2087
I i
idevelopm ent, t e s t i n g or ev alu atio n t h a t was conducted pursuant tc I. t h a t p r o j e c t .
B. PSARPNODECCUDIFREIELCMIAVEETNRITOY,N,PORFOSEHDLUEERCCTBTIIOCIONIDN, E, SSHPUIPRMCEHNATSE,
' 8 . Identify separately each unit of the United States,
hIijI:;'at
s h
a
d t
efined h engaged
erein, during
including those li the period prior
ste to
d on Appendix A January 1, 1972
he in
reto, any
;a c tiv itie s re la tin g to .the s p e c ific a tio n , se lectio n , purchase, (Ip r o c u r e m e n t , p r o d u c t i o n , sh ip m en t o r d e l i v e r y o f h e r b i c i d e s f o r
i'( p o t e n t i a l use in c o n n e c t i o n w ith m i l i t a r y a c t i v i t i e s , and a s to
-each such unit, describe:
; a. The n a t u r e and e x t e n t o f i t s in v o l v e m e n t i n sue
|:a c tiv itie s ; and
! b. The d u r a t i o n o f i t s i n v o lv e m e n t in such a c t i v i
ties .
L! 9 As t c each s e p a r a t e u n i t o f t h e U n ite d S t a t e s identified in the response to Interrogatory 8 , identify each
person in charge of or with re sp o n sib ility for any of i ts a c tiv itie s relating to the specification, selection, purchase, procure ;ment, production, shipment or delivery of herbicides for potentia
ii use i n c o n n e c t i o n w i th m i l i t a r y a c t i v i t i e s .
10. Give an organization ch art for each separate unit of the United States identified in the response to Interrogatory f o r each p erio d p r i o r to January 1, 1972 during which i t was involved in activities relating to the specification, selection,
purchase, procurement, production, shipment or delivery of herbi cides for potential use in connection with m ilitary activ ities.
-3-
i
2088^-^y/
I
iii o t h e r
11. Id e n tify each communication, transaction between the United States
meeting, contract or and any of the defen-
!iji;ida ac nt itns
g
h
e o
r r
e
in, pur
or por
t
any ing
officer, agent, to act on b eh alf
employee or other person of a defendant, that con-
lilicerns or r e l a t e s t o t h e s p e c i f i c a t i o n , s e l e c t i o n , p u r c h a s e , p r o -
j;:I i
|ic u r e m e n t, p r o d u c t i o n , s h ip m e n t or d e l i v e r y o f h e r b i c i d e s p r i o r t o !;
i. 'Jaacntuiavriyt
i
1, es
.
1972
for
potential
use
in
connection with m ilitary
|:
!'I: 12. I d e n t i f y each document c o n s t i t u t i n g , m e m o r i a l i z i n g , |!i
;:disclcsing, referring or relating to each communication, meeting, ;
^contract or other transaction identified in response to Interro-
j gatory 11.
j:jl. U nited
13States
Identify each herbicide p r i o r to January 1, 1972
used or te s te d by for potential use
the in con-
i
i
!j[
|ii .n e c ti o n w ith m i l i t a r y a c t i v i t i e s , and w i th r e s p e c t t o each such
'ii h e rWb i c i d e :
i
i!-, a. S t a t e t h e d a t e s d u r i n g which i t was used a n d / o r j:
l|IiIte s te d ;
ji
b. Identify each geographical location at which it
|was used an d /o r tested.; and
c.Identify thesuppliersand/ormanufacturers,
:
;and s t a t e theamounts co n tracted forby theUnited S ta te s and the j
i!amounts d e l i v e r e d to t h e U n ite d S t a t e s by eac hsuch s u p p l i e r a n d /o r '
m anu factu rer...
i
II 14. For t h e p e r i o d from J a n u a r y 1, 1961 t o J a n u a r y 1,
|
j
1972, ide ntify each person in charge of, with re sp o n sib ility for,
o r who p a r t i c i p a t e d i n o r was c o n s u l t e d w i th r e s p e c t t o :
a. Selecting, contracting with or makin
tin su pp liers and m anufacturers of h erb icid es for p o te n tia l use in
-4-
2089
Ii
jccnnection with m ilitary activities; b. Preparing, evaluating, selecting, modifying or
j!a p p r o v i n g t e c h n i c a l s p e c i f i c a t i o n s f o r each h e r b i c i d e s e l e c t e d , !purchased or procured by the United S ta te s for p o te n t i a l use in (connection with m ilitary activities; i| c . P r e p a r i n g , e v a l u a t i n g , s e l e c t i n g , m o d i f y in g or approving labeling specifications for each herbicide selected, :purchased or procured by the United S ta te s fo r p o te n tia l use in ' connection with m ilita r y a c t i v it i e s ; and 1 d. Preparing, evaluating, selectin g , modifying or approving shipping and financial sp ecifications for each herbicic 's e l e c t e d , purchased or procured by the United S ta te s fo r p o ten tia. 'use in connection with m ilitary a c tiv itie s .
I.' 15- For t h e p e r i o d from J a n u a r y 1, 1 9 6 1 t o J a n u a r y 1, ' 1972, id e n tify each document that d e s c rib e s , . refe rs or re la te s to ] a. The s e le c tio n of, c o n tra c ts with, or the makin; 1.o f c h a n g e s i n s u p p l i e r s and m a n u f a c t u r e r s o f h e r b i c i d e s f o r potential use in connection with m ilitary a c tiv itie s;
b. The p rep aratio n , e v a lu atio n , s e le c tio n , m odifi cation or approval of technical specifications for each herbicide selected, purchased or procured by the United S ta te s fo r p o te n tia l use in connection with m ilitary activ ities;
c. The p re p a ra tio n , e v a lu a tio n , s e le c tio n , m odifi cation or approval of labeling specifications for each herbicide se le c te d , purchased or procured by the United S ta te s for p o te n tia l use in connection with m ilita ry a c tiv itie s ; and
d. The p re p a ra tio n , e v a lu a tio n , s e le c tio n , m odifi cation or approval of shipping and fin an cia l sp e c ific a tio n s for each h e rb ic id e s e le c te d , purchased or procured by the United States for potential use in connection with m ilitary activ ities.
-5-
O -Z/73
2090
2
!
lj
| 16. For th e p e rio d from J a n u a ry 1, 1961 to Jan u ary ii; i , 1972, i d e n t i f y each p e rs o n in c h a r g e o f , w i th r e s p o n s i b i l i t y
! f o r , o r who p a r t i c i p a t e d i n or was c o n s u l t e d w ith r e s p e c t t o :
i a. Contacting and negotiating with suppliers and
t!m a n u f a c t u r e r s c o n c e r n i n g c o n t r a c t s f o r , and t h e p u r c h a s e or p r o -
Iicu rem e n t o f h e r b i c i d e s f o r p o t e n t i a l use i n c o n n e c t i o n w ith
|;m ilita ry a c t i v it i e s ;
b. Evaluating, considering or determining conform
jiiI..-: is
ty pe
o ci
r f
i
comp catio
lia ns
n
c f
e o
r
by e
a
s c
u h
ppl he
i r
e b
r i
s c
i
and de
s
manu elect
fac ed,
t
u
r p
ers urc
h
wit ase
h d
technical or procured
i 'cy t h e U n ited S t a t e s f o r p o t e n t i a l use i n c o n n e c t i o n w ith m i l i t a r y
i' a c t i v i t i e s ;
c. Evaluating, considering or determining conformjI,i t y o r c o m p l i a n c e by s u p p l i e r s and m a n u f a c t u r e r s w ith l a b e l i n g
,;bs yp
ecif the
i
cation United
s
S
f t
or ate
each s fo
r
he p
rb ot
icide entia
l
s
ele use
c
ted in
, c
p on
urch nect
ased ion
or with
procure m ilita
d ry
iI.!. a c t i v i t i e s ;
I-; d. E v a l u a t i n g , c o n s i d e r i n g o r d e t e r m i n i n g c o n fo rm -
ii i t y o r c o m p lia n c e by s u p p l i e r s and m a n u f a c t u r e r s w ith s h i p p i n g and
jfinancial specifications for each herbicide selected, purchased or
procured by the United S tates for p o te n tia l use in connection with
:m ilitary a c t i v it i e s ; and
e. Evaluating, considering or determ
ance by s u p p lie rs and m anufacturers of any c o n tra c ts for h e rb i
cides s e le c te d , purchased or procured by the United S ta te s for
potential use in connection with m ilitary activ ities.
17. For th e p e rio d from J a n u a ry 1, 1961 to J a n u a ry 1, 1972, id e n tify each document that d escribes, re fe rs or re la te s to:
a. Contracts and neg o tiatio n s with sup and manufacturers concerning contracts for, and the purchase or
-6-
i
procurement of herbicides for p o ten tial use in connection with
1!ij m i i i t a r y
activities; b. The
evaluation,
consideration
or
determination
|o f conformity or compliance by suppliers and manufacturers with I' t e c h n i c a l s p e c i f i c a t i o n s f o r each h e r b i c i d e s e l e c t e d , p u rc h a s e d or
procured by the United S tates for p o te n tia l use in connection with
'military activities;
I: I
c. The ev alu atio n , c o n s id e ra tio n or determ ination
of conformity or compliance by su p p lie rs and m anufacturers with
ij.:i p
lab roc
eling ured
specifications for each herbicide selected, purchased or by the United S tates for p o te n tia l use in connection with
| military activities;
!I: d. The e v a l u a t i o n , c o n s i d e r a t i o n or d e t e r m i n a t i o n I|'o f c o n f o r m i t y o r c o m p lia n c e by s u p p l i e r s and m a n u f a c t u r e r s w ith i!' s h i p p i n g and f i n a n c i a l s p e c i f i c a t i o n s f o r each h e r b i c i d e s e l e c t e d ,
j. purchased or procured by the United S ta te s fo r p o te n tia l use in
' c o n n e c t i o n w i th m i l i t a r y a c t i v i t i e s ; and I;I e . The e v a l u a t i o n , c o n s i d e r a t i o n o r d e t e r m i n a t i o n I; o f p e r f o r m a n c e by s u p p l i e r s and m a n u f a c t u r e r s o f any c o n t r a c t s f o r
jherb icid es s e le c te d , purchased or procured by the United S tates i; f o r p o t e n t i a l use in c o n n e c t i o n w i t h m i l i t a r y a c t i v i t i e s .
18. For th e p e rio d from J a n u a ry 1, 1961 to Jan uary 1, i1972, i d e n t i f y each p e r s o n i n c h a r g e o f , w i t h r e s p o n s i b i l i t y f o r , o r who p a r t i c i p a t e d in o r was c o n s u l t e d w ith r e s p e c t t o :
a. The im plem entation, a p p lic a tio n or use of the iD efen s e P r o d u c t i o n Act o f 1950, t h e D e fe n s e M a t e r i a l s Sys tern, o r any r e g u l a t i o n s , o r d e r s , p r o c e d u r e s , d i r e c t i v e s o r p r i o r i t y r' a t i n g s issued or available pursuant thereto, in connection with the pro duction, procurement, purchase or shipment of herbicides for use in connection with m ilitary activ ities.
-7-
2092O - ^ n r
I
| 1 9 . For th e p e r io d from J a n u a ry 1, 1961 t o J a n u a r y 1, I; 1 9 7 2 , i d e n t i f y eac h document t h a t : ii! a. D i s c u s s e s , r e f e r s o r r e l a t e s t o t h e i m p le m e n ts
i' t i o n , a p p l i c a t i o n or use o f t h e D efense P r o d u c t i o n Act o f 1950,
Jthe Defense M aterials System, cr any regulations, orders, proce
d u res, directives or priority ratings issued or available pursuer it h e r e t o , i n c o n n e c t i o n w i t h t h e p r o d u c t i o n , p r o c u r e m e n t , p u r c h a s e
or shipment of herbicides for use in connection with m ilitary 1: a c t i v i t i e s ; and
b. Contains a reference to the Defense Production
i.!
Ac o
t r
of ders
,
1950, proc
e
the dur
Defense es, dire
c
Mater tives
ials or
System, priority
or any reg u latio n s, ratings issued or
a v a ila b le pursuant th e re to , and which was prepared in connection
with the production, procurement, purchase or shipment of herbi
cides for use in connection with m ilitary a ctiv ities.
C. DUSISEP,OSAAPLPLOICFATHIEORN3ICAINDDES
20. Identify separately each unit of the United States
as d efin ed h e re in , in clu d in g those l i s t e d on Appendix A h e re to , i t h a t engaged d u rin g t h e p e r i o d from J a n u a ry 1, 1 961 t o J a n u a r y 1, |'.1972 i n any a c t i v i t i e s r e l a t i n g to t h e u s e , a p p l i c a t i o n ( i . e . , 1 d i s p e r s a l ) o r d i s p o s a l o f h e r b i c i d e s i n c o n n e c t i o n w i th m i l i t a r y a c tiv itie s in Southeast Asia, and as to each such u n it, describe:
!
| a. The nature and ex ten t of i t s involvement in such a c t i v it i e s ; and
b. The duration of i t s involvement in such a c tiv i ties.
21. As t o eac h s e p a r a t e u n i t o f t h e U n ite d S t a t e s id en tified in the response to Interrogatory 20, id entify each
-8-
2093 Q - Z I 7 6
!l
i
person in charge of or with resp o n sib ility for any of i t s activli i t i e s r e l a t i n g to t h e u s e , a p p l i c a t i o n o r d i s p o s a l o f h e r b i c i d e s jin connection with isilitary a c tiv itie s in Southeast Asia.
i
Iij 22. Give an o r g a n i z a t i o n c h a r t f o r each s e p a r a t e u n i t
ljIcf t h e U nited S t a t e s i d e n t i f i e d in t h e r e s p o n s e t o I n t e r r o g a t o r y
20 f o r each p erio d between Jan u ary 1, 1961 and J a n u a ry 1, 1972 'I>'d u r in g which i t was i n v o l v e d in a c t i v i t i e s r e l a t i n g t o t h e u s e ,
application or disposal of herbicides in connection with militar;
j:Inactivities in Southeast Asia.
I 23. Identify each communication, meeting or other trar. action between the United S ta te s and any o f the d e fe n d a n ts h erein |:o r any o f f i c e r , a g e n t , employee or o t h e r p e rs o n a c t i n g o r p u r p o r t ping to act on behalf of a defendant, th a t concerns or r e l a t e s to II' t h e u s e , a p p l i c a t i o n o r d i s p o s a l d u r in g t h e p e r i o d from J a n u a r y 1 i 1S6 * t o J a n u a r y 1, 1972 o f h e r b i c i d e s i n c o n n e c t i o n w i th m i l i t a r y I'; a c t i v i t i e s i n S o u t h e a s t A s i a .
j 2^. Identify each document describing, refe rrin g or relating to each communication, meeting or other transaction iden t i f i e d in the response to In terro g ato ry 23|I 25- I d e n t i f y each p e rs o n in c h a r g e o f , w ith r e s p o n H s i b i l i t y f o r , o r who p a r t i c i p a t e d in o r was c o n s u l t e d w ith r e s p e c t to:
i a. Evaluating, considering or determining whether
land th e p u rp o ses f o r which h e r b i c i d e s would be used in c o n n e c tio n iwith m ilita ry a c tiv itie s in Southeast Asia;
b. Evaluating, considering or determining which I h e r b i c i d e s would be used in c o n n e c t i o n w i th m i l i t a r y a c t i v i t i e s in Southeast Asia;
-9-
2094 a-x>77
! c. Developing, considering, evaluating, selecting,
modifying, issuing and approving procedures, g uidelines, in s tru c tio n s , d ir e c tiv e s , orders or ru les and reg u latio n s re la tin g to the time, place and manner of ap p licatio n of each herbicide used in
Jic o n n e c tio n w ith m i l i t a r y a c t i v i t i e s in S o u t h e a s t Asia; d. Developing, considering, evaluating, selecting, imodifying, issuing and approving procedures, g u id elines, in stru c !,; t i o n s , d i r e c t i v e s , o r d e r s o r r u l e s and r e g u l a t i o n s r e l a t i n g t o t h e iconditions for and a ll other co n sid era tio n s p ertain in g to the !<application of each herbicide used in connection with m ilitary
iactivities in Southeast Asia;
h
!! d. E v a l u a t i n g , c o n s i d e r i n g or d e t e r m i n i n g t h e
^effectiveness, usefulness and ta c tic a l or s tra te g ic value of each
1h e r b i c i d e used in c o n n e c t i o n w i th m i l i t a r y a c t i v i t i e s in S o u t h e a s t
;lAsia; and
ij
e. Evaluating, considering or determining whether
jto suspend, modify or discontinue the application of any herbi
cide used in connection with m ilitary a c tiv itie s in Southeast
!A s i a .
26. I d e n t i f y each document t h a t c o n s t i t u t e s , memojrializes, discloses, describes, refers or relates to:
a. The e v a lu a tio n , c o n s id e ra tio n or determ ination of whether and the purposes for which h erb icid es would be used in connection with m ilitary ac tiv itie s in Southeast Asia;
b. The development, c o n s id e ra tio n , e v a lu a tio n , se lectio n , m odification, issuance and approval of procedures, g u id elines, in s tru c tio n s , d ir e c tiv e s , orders or ru les and reg u la tio n s re la tin g to the time, place and manner of a p p licatio n of each herbicide used in connection with m ilitary a c tiv itie s in Southeast Asia;
-10-
2095
| c. The development, c o n sid e ra tio n , e v a lu a tio n ,
l's e l e c t i o n , m o d i f i c a t i o n , i s s u a n c e .and a p p r o v a l o f p r o c e d u r e s ,
j g u id elin e s, in s tr u c tio n s , d ir e c tiv e s , orders or rules and regula-
j tio n s re la tin g to the co n d ition s for and a ll other co n sid eratio n s ;! p e r t a i n i n g t o t h e a p p l i c a t i o n o f each h e r b i c i d e used i n c o n n e c t i o n
; with m ilitary a c tiv itie s in Southeast Asia;
' d. The e v a lu atio n , c o n sid e ra tio n or determ ination
' o f the e ffe c tiv e n e s s , u sefulness and t a c t ic a l or s tr a te g ic value
i of each herbicide used in connection with m ilitary a c tiv itie s I1'i n S o u t h e a s t A s ia ; and
!l e. The e v a l u a t i o n , c o n s i d e r a t i o n or d e t e r m i n a t i o n
| of whether to suspend, modify or discontinue the application of
any nerbicioe used in connection with m ilita ry a c tiv itie s in
: Southeast Asia.
0
! D. HEALTH EFFECTS AND DIOXIK
iI: 27. For t h e p e r i o d p r i o r t o J a n u a r y 1, 1972, i d e n t i f y
Keach p e rs o n i n c h a r g e o f , w i th r e s p o n s i b i l i t y f o r , o r who p a r t i c i i pateo in or was consulted with respect to:
a. Evaluating, considering or determining the
|toxicity or health effects of dioxin, 2,4,5-trichlorophenoxyacetic
II:.''
a
cid, invol
2, ved
4
i
d n
i
c t
h h
l i
o s
r
oph act
enox ion;
y
a
c
e
t
i
c
acid
or
any
o'f
the
herbicides
b. Evaluating, considering or determining matters
relating to the synthesis, analysis, identification, origin,
destructio n or removal of dioxin; and
c. Evaluating, considering or determining matters
relating to the presence or possible presence of dioxin in 2,4,5-
trichlorophenaxyacetic acid, 2 ,4-dichlorophenoxyacetic acid or any
of the herbicides involved in this action.
-11-
2 0 9 6 0-A I7
Il
II! 26. For t h e p e r i o d p r i o r t o J a n u a r y 1, 1972, i d e n t i f y each document that discusses, mentions, refers or relates to: | a. The t o x i c i t y or h e a lth e f f e c t s of d io x in , 2,4, 5-trichlorophenoxyacetic acid, 2 ,4-dichlorophenoxyacetic acid i or any o f t h e h e r b i c i d e s i n v o l v e d i n t h i s a c t i o n ; ! b. The s y n th e s is , a n a ly s is , i d e n t i f i c a t i o n , o rig in ,. !. d e s t r u c t i o n o r removal o f d i o x i n ; anc ij:j c . The p r e s e n c e o r p o s s i b l e p r e s e n c e o f d i o x i n in Ji|'.!2, 4 , 5 - t r i c h l o r o p h e n o x y a c e t i c a c i d , 2 , 4 - d i c h l o r o p h e n o x v a c e t i c a c i c or any c f tn e h e r b i c i d e s inv o lv ed in t h i s a c t i o n .
1 DEFINITIONS AND INSTRUCTIONS
1. The fo llo w in g d e f i n i t i o n s ap p ly h e r e i n : a. "Dioxin" means a ll polychlorinated dibenzo-p-dicxir.s (PCDDs) and a i l p o ly c h lo r in a te d d ib e n z o fu ra n s (PCDFs).
1 b. "Document" i s used in t h e b r o a d e s t p o s s i b l e s e n s e
;;and means any w r i t t e n or g ra p h ic m a tte r o f whatever kind or n a t u r e ,
ijor any o t h e r means o f p r e s e r v i n g t h o u g h t s o r e x p r e s s i o n ( i n c l u d i n g , jj
without lim itatio n, tape recordings and/or tran scriptio ns thereof),! l!and a l l t a n g i b l e t h i n g s from which i n f o r m a t i o n can be p r o c e s s e d or j;
.'transcribed, whether originals, copies or drafts (including withiout lim itation, non-identical copies), however produced or repro
duced. Note that a document with handwritten or typew ritten notes,j
: ed itin g o r o t h e r m a r k s , e t c . , i s not and s h a l l n o t be deemed i d e n - 1;
!j t i c a l t o one w i t h o u t such n o t e s , m ark s, e t c .
"Documents" a l s o |!
Imeansa l l g r a p h i c , m e c h a n i c a l , o r e l e c t r o n i c r e p r o d u c t i o n s , r e p r e - !| i s e n t a t i o n s , r e c o r d i n g s , o r c o m p i l a t i o n s o f d a t a o f any k i n d , i n i
cluding but not limited to, drawings, charts, graphs, motion pic
ture films, microfilms, microfiles, photographs, tape recordings,
-12-
Q-3LU
I
jviaeotap es, any tra n s c rip ts or p rin to u ts produced therefrom , and .11 d r a f t s o f any o f t h e f o r e g o i n g .
i'It! c . " D r a f t " means any e a r l i e r , p r e l i m i n a r y , p r e p a r a t o r y
'or t e n t a t i v e v e r s i o n o f a l l , o r p a r t o f t h e document, w h e th e r or not such d r a f t was superseded by a l a t e r d r a f t , and whether or not the terms of the d ra ft are the same as, or d if f e r e n t from the terms of the final document.
d. "Herbicide" means any substance containing 2 trichlorophenoxyacetic acid, 2, A-dichlorophenoxyacetic acid, or an e s te r, amine, s a l t or other form th e reo f, including Agent Orange, Agent Pink, Agent Purple, Agent Green and any other herbicide involved in this action.
I!
e. " I d e n tif y " when used with re fe re n c e to a n a tu ra l person means s ta te : ! ( i ) h is f u l l name and p re s e n t a d d re ss (o r i f h is
p re s e n t ad d ress i s not known, h is l a s t known | ad d ress); and I ( i i) his present (or, i f his present is not known,
h is l a s t known) job, p o sitio n , rank, and/or p ro fes sio n al a f f i l i a t i o n s , and the same inform ation for the time of the acts or other matters to which the Interrogatory is addressed.
f. " Id e n tify " when used with referen ce to any person other than a natural person means sta te :
( i ) th e f u l l name t h e r e o f ; (ii) the nature of the activ ity engaged in; ( i i i ) the address and p rin c ip a l place of business; and (iv) i f applicable, the ju risd ictio n under the laws
13-
C-AIT/
I
of which i t has been organized and the date of such organization.
g. " I d e n t i f y " when used w ith r e f e r e n c e to a document
Im e a n s
state: (i)
i t s nature ( e .g ., l e t t e r , telegram , memorandum,
ch art, report, l i s t , e tc .), date, ana the identity
of the author and addressees;
( i i ) th e i d e n t i t y o f each person who signed th e
document and each p e r s o n who p a r t i c i p a t e d in
preparing the document;
(iii) its title or heading;
(iv) i t s substance; and
(v) its present (or, if the present is not
known, the l a s t known) lo c atio n and cu sto d ian ,
h. " I d e n tif y " when used with re fe re n c e to a cocmunica'tio n , meeting or transaction means sta te :
(i) its nature (e.g., telephone conversation, face-to-face conversation or meeting, letter, memorandum, e t c .) ; ( i i ) the date and place th e re o f (and i f a t e l e phone conversation, the place each participant was lo c a te d ); (iii) the identity of each person participating in, present during, or witness to, all or any part the reo f; and (iv) the substance thereof.
i . " I d e n t i f y " when used w ith r e f e r e n c e t-o a h e r b i c i d e means s ta te i t s f u ll chemical form ulation and any trade or other names by which i t is known.
-14-
!
j . " I d e n tif y " when used with refe ren ce to a p ro je c t or
m i l i t a r y o p e ra tio n means s t a t e any names by which i t was known, |!i;i t s p u rp o s e or g o a l , t h e d a t e s i t began and ended, t h e l o c a t i o n s
!! a t which i t was c o n d u c t e d , and i d e n t i f y s e p a r a t e l y p e r s o n s :
l*I;''
( i ) who ap p ro v ed or a u t h o r i z e d i t s u n d e r t a k i n g ; ( i i ) who were r e s p o n s i b l e f o r o p e r a t i o n a l
management; and
i ( i i i ) who were r e s p o n s i b l e fo r e v a l u a ti n g i t s
i results.
Ii1 II
k. " I d e n t if y " when used in any context o th e r than
f inabove set forth means describe the pertinent act, work, situ a
t i o n , event, e tc ., as fu lly as possible, and id e n tify each person
i; i n any way i n v o l v e d t h e r e i n and each document or co m m u n icatio n ifi i n which such a c t , work, s i t u a t i o n , e v e n t , e t c . , i s r e c o r d e d ,
described, discussed or otherwise referred to.
I1'1 1. "Labeling sp ecificatio n s" means those portions of
i'cs
o h
ntr all
a
ct be
specifications for a product that direct made on the product or i t s c o n ta in e r.
what
markings
j m. " P e r s o n " means any n a t u r a l p e r s o n , i n d i v i d u a l , p a r t - j
fnership, company, corporation, government body or any other entity.i
I; !
j n. "Shipping and fin an cial sp ecific atio n s" means those j
'\\iipp
o a
r c
t i.o kin
n g
s
a
of nd
contract specifications for a product that direct the manner of shipping for the product and th a t pertain to
!
I.ith e p r i c e and payment t e r m s .
j o. "Technical sp ecificatio n s" means those portions of I c o n t r a c t s p e c i f i c a t i o n s t h a t d e t a i l t h e c h e m ic a l o r o t h e r co m p o s i
tio n , performance and production standards of the product.
I -15-
2100 0-A n3
I
tt
I I
j p. " U n i t e d S t a t e s " means THE UNITED STATES OF AMERICA
land its offices, departments, bureaus, agencies, representatives, i department h e a d s , ag en cy h e a d s , b u re a u c h i e f s , a g e n t s , a t t o r n e y s ,
: employees, or any other persons, acting or purporting to act for,
o r on b e h a l f o f THE UNITED STATES OF AMERICA, u n d e r t h e a u t h o r i t y
ii or c o n t r o l o f THE UNITED STATES OF AMERICA, o r any one o r more o f
j;1t h e f o r e g o i n g . !j q . "You" means t h e U n ited S t a t e s , as d e f i n e d ab o v e, and
j;i each p l a i n t i f f h e r e i n .
j'
i! 2 . Each I n t e r r o g a t o r y i s t o be an sw ered t o t h e e x t e n t
:of a ll inform ation available to you, including a ll documents anc
II, o t h e r s o u r c e s o f know ledge w i t h i n your p o s s e s s i o n , c u s t o d y or c o n tro l, or within the possession, custody or control of your ii 'attorneys, w h e r e v e r l o c a t e d , and i n c l u d i n g your docum ents p la c e d .in independent storage fa c ilitie s.
3- Unless o th erw ise in d ic a te d , each I n t e r r o g a t e r y r e
q u e s t s in fo rm a tio n fo r the period p r i o r to January 1, 1972, i n
cluding a ll inform ation available from documents dated, prepared,
Isen t or r e c e i v e d , in whole or in p a r t , p r i o r t o J a n u a ry 1, 1972.
i'I n a d d i t i o n , h o w ev er, when any document r e f e r s o r . r e l a t e s t o t h e
p eriod p r i o r to Jan u ary 1, 1972, you should in c lu d e th e inform a-
ijIIwt ihoenn
from tha t document in your response without lim ita tio n the document was dated, prepared, sent or received.
as
to
. Each Interrogatory that refers to any group of per sons is to be answered separately and with p a r tic u la r ity as to each member of any such group.
5- Each In te rro g a to ry th a t r e f e r s to h e rb ic id e s is to
-16-
2101 P-ai/
I
be answered separately and with p a r tic u la r ity as to each ap p lic
able herbicide.
t
|
j 6. Except where ex p licitly indicated otherwise, each |
jIn te rro g a to ry h erein should be construed independently and not by j
reference to anv other paragraph for the purpose of lim itatio n. j
i'
I
|
iI;. i s
not
7. If now known
the answer or you are
to all or otherwise
any not
part able
of to
an Interrogatory ' answ er f u l l y , so !|
|state in response to suchInterrogatory or partthereof, state
j
i the r e a s o n s , and f u r n i s h w h a te v e r r e s p o n s i v e i n f o r m a t i o n i s now I
;known or otherw ise a v a ila b le . i! 8. I f any p r i v i l e g e i s cla im e d a s t o any i n f o r m a t i o n
! I:
j called fo r, or as to any document required tc be id e n tifie d by an j
^Interrogatory:
i
(i) state the nature of the privilege claimed
j (e .g ., a tto rn e y -c lie n t, work product, e tc .);
i
(ii) state tne basis for claiming theprivilege as to the specificinformation or document;
; j
(iii) if the privilege is claimed with respect t o any i n f o r m a t i o n , i d e n t i f y ea c h p e r s o n who has
j knowledge o f such i n f o r m a t i o n , o r t o whom such inform ation has been communicatedin any way, at
j
any time; and (iv) i f the p rivilege is claimed as to any document, identify such document.
j
i !
9- C ertain of the I n t e r r o g a t o r i e s h erein seek d is c l o sure th a t goes beyond the iss u e s d efen d an ts contend should be tried in Phase I. Defendants have nevertheless included such Interrogatories because the issues for Phase I tria l have not yet
2102
ii:
Iibeen d e f i n e d by t h e C o u r t . D e f e n d a n t s r e s e r v e t h e i r r i g h t to modify or supplement these Interrogatories to the extent required :by the C o u rt's determ in atio n s as to the standards and elements of jthe government contract defense.
ji, 10. "And" as w e l l as " o r " s h a l l be c o n s t r u e d e i t h e r itl d i s j u n c t i v e l y o r c o n j u n c t i v e l y a s - n e c e s s a r y to b r i n g w i t h i n t h e : scope of the s p e c ific a tio n a i l responses which might otherw ise be
i^ c o nstru e d t o be o u t s i d e i t s s c o p e . "Each" s h a l l be c o n s t r u e d t o
include the word "every" and "every" s h a ll be construec to include ;the word "each". "Anv" s h a ll be construed to include the word I;-' " a l l " and " a l l " s h a l l be c o n s t r u e d t o i n c l u d e t h e word "a n y ".
iI:MI n c l u d i n g " s h a l l be c o n s t r u e d t o i n c l u d e t h e p h r a s e " w i t h o u t
limitation" .
D ated : NJ aewn uYa royrk.15New19YS o1rk
RIVKIK, LEFF 4 SHERMAN
GBA(15y0at10tro6dT)erGhnneae7Aryd^DCse6Moinw-te7yfmg5o,CCb0yrhei0Ntr/eyDem^woeiPfcfYeal antlohzdraekCa nomFt 1pi1ar5nmy30~
jjiji
CADWALADER, WICKERSHAM 4 TAFT ;
BNOA(y2entw1DetUo2ia))rWYmnojae7oArlyAn8kl ds5,M^-SeU1SNfmt0orheib0weare0mer tAYDroooecfrfkke
nt ndCeaonrFtpxotjrafa 10005
2
ti
^
o
4
n
y
-,.
j '!
I
-.18-
210 3
I
KELLEY DRYE A WARREK
AN35etw0Ht oerYPrnacoerurykklse,
sANfvoIeewnrncueoDYroeprfkoe
nr adtaendt 10C22
( 212) 752-5800
TOWNLEY A UPDIKE
N4(20ew512)LYeo6xr8kin2, g--^Nt o5enw67 YAovreknue10017 CLARK, GAGLIARDI A MILLER
WTA9(99hth1eTtio4Chte)rIoonnmuenP9rpys4tlssa6o--oSinn8ff-t Hros9e,0rCae0yoNwDuearewtrfde
n dCahnetm ical York 10601
Co.
iJ
DILWORTH, PAXSON, KALISH A LEVY
P2(26h10Hi50loa)odTk5heee^rl p6-Fhc3nii0aed0,me0liPci taeyln nBcsoyumlivlpdaainnnyiga 19109
ARTHUR, DRY A KALISH
NAB(12ye2tw1U3t 2o0n)YrinAroe4ovry8kAyes,9nau-Ml4e,Nfe5oem1wroID0n>fecYDrd.toeh.orfekfe_
n
dt haen t F A10m0e2r0i
i r m*> cas
-19-
2104 Q -ztrr
MDL SERVICE LIST
B'JDPDIC, ILLLAORNLERR, OSKEENNBTA,UMGROSS,
.-a/p/le/NBA3(23yet0Ttwo1Wha)roranmkse6,phy2Asis2onNn-Mge7wfteHooCmn0rJhb0eieeDrSrmsteeiorfcyefeaenlstd0t n7ae1nC0to2Fr
ine por
a
t
i
o
r
.
LESTER, SCHWAB, KATZ h DWYER
CUlft/nBNA(12ye2tw10Ht o2o)rBYfnrfoeo9mryakk6ads,LnwM--aNf6eTyoe6mawr1of1efDYr, oeoIrfnkfecn.tdha1en02t 7F1irm
-20-
2105 Q - A *
APPENDIX A
EXECUTIVE BRANCH
I . Department, of Defense
A. D efen s e Sup p ly Agency
1. DRiecfhemnsoendG, eVn ei rrga li n Si au pply C e n t e r
a . Danidr ePc rt oo dr autcet i oonf P r o c u r e m e n t
2. Contract Administration Services
a. Office of Contracts Compliance
b. SOefrfvi ci ce es s oRf eCgioonntsr a c t A d m i n i s t r a t i o n
B. Defense Advanced Research P r o j e c t s Agency
C. D ep artm e nt o f t h e Army
1. F o r t D e t r i c k , Maryland
a. Biological Laboratories
2. Edgewood Arsenal, Maryland
a . WL aebapoornast oDr ieevselo- pmCehnetmiacnadl PErnogciensese r iLnagb o r a t o r y j
b. Office of Procurement and Production
ji
3. Camp Drum, New York
j
4. Dugway, Utah Proving Grounds D. D e p a rtm e n t o f t h e Air Force
1. E g li n A ir Force Base, F l o r i d a
!
]
ji
a. Armament Development and Test Center 2. Brooks Air Force Base, Texas
i j
a. LOacbcourpaattoi or yn a l and E n v i r o n m e n t a l H e a l t h
3. W right-Patterson Air Force Base, Ohio
a. Aerospace Research Laboratories
b. A ir F o rce L o g i s t i c s Command
2106 0 -a ./2 f
if. D i r e c t o r a t e o f A erospace F u e ls a. Kelly Air Force Base, Texas b. TArearonssppaocret a Ft iuoenl s BFraine cl dh O f f i c e s -
5. Surgeon General 6. O p e r a t i o n RANCH HAND E. Department o f the Navy 1. GNauvlaflp oCr to, n sMt riuscstiisosni p pBia t t a l i o n C e n t e r F. M i l i t a r y A s s i s t a n c e Command i n Vietnam
1. "203 Committee"
G. I n s t i t u t e f o r D efense A nalyses 1. P r o j e c t AGILE
I I . Department of Commerce A. B u s i n e s s and D efen se S e r v i c e s A d m i n i s t r a t i o n 1. Chemicals and A llie d P r o d u c ts D i v i s i o n 2. Office of In d u strial M obilization
I I I . Department of Agriculture A. O f f i c e o f S c i e n c e and E d u c a t i o n 1. A g r i c u l t u r a l R e se arch S e r v i c e a. Pesticide Regulation Division b. CCrroopps RPersoe at erccht i oDni vRi seisoena rc- h Branch c. Texas and Puerto Rico operations d. PBlealntts vIinl dl eu,s t rMyarSytlaant ido n B. Advisory Committee on 2 ,^ ,5 - T C. F o r e s t S e r v i c e
IV. Department of Health, Education and Welfare A. P u b l i c H e a l t h S e r v i c e 1. SNcaiteinocneasl I n s t i t u t e o f E n v i r o n m e n t a l H e a l t h a. NRIeEsHeSa r cLha bTorriaatnogr il ee s, N o rth C a r o l i n a
A-2
2107 DAlfff
I
2. Food and Drug A dm inistration
i|V D epartm ent o f S t a t e A. American Embassy, R e p u b lic o f Vietnam
I
!V I . D ep artm e nt o f t h e I n t e r i o r
IVII E x e c u t i v e O f f i c e o f t h e P r e s i d e n t A. O f f i c e o f C i v i l and Defense M o b i l i z a t i o n
I- 3 . C o u n c il on E n v iro n m e n ta l Q u a l i t y i C. N a t i o n a l S e c u r i t y Council
1. C entral I n t e l l i g e n c e Agency D. O f f i c e o f S c ie n c e and T ech n o lo g y
1. AP adnveils ooryn HCoemr bmi cititdeee s o f t h e P r e s i d e n t ' s S c ie n c e
INDEPENDENT AND QUASI-OFFICIAL AGENCIES
i'VIII. i!
N atio n al Academy of Sciences A. l"AoBgCi c aClomamnditteceh"em(iaca cl o mw ma riftater ee ) t o i n v e s t i g a t e b i o B. Committee on the E f f e c t s of H e rb ic id e s in Vietnam
IX. National Research Council
!x. Environmental P ro tectio n Agency A. A d v is o ry Committee on 2 , 4 , 5 - T
MISCELLANEOUS
IXI. D e p a rtm e n t o f War A. War R e s e a rc h S e r v i c e
A-3
!
2108 Q -ztf/
Appendix B
2109
APPENDIX B
: 1. P r o j e c t s c o n c e rn in g th e t e s t i n g o f h e r b i c i d e s f o r p o t e n t i a l use d u r in g World War I I ;
2. P r o j e c t s u n d e r t a k e n a f t e r World War I I which were I' c o n d u c t e d i n g r e e n h o u s e s a n d / o r P u e r t o Rico;
| 3. Projects conducted at or involving Fort D etrick,
M ary la nd , E g l i n A ir F o rc e B ase, F l o r i d a and Camp Drum, New York; li i b. P rojects rendering a s s is ta n c e to or undertaken in cooperation with foreign nations, including specifically the 1: U n i t e d Kingdom;
l'I1i w it h
a
5- P ro je c ts undertaken pursuant to or in con n ectio n r e q u e s t by t h e D ep artm e n t o f D efen se in or ab o u t May
i:11 9 6 1 t o d e t e r m i n e t h e f e a s i b i l i t y o f h e r b i c i d e o p e r a t i o n s i n
i|Vietnam; 6. Projects concerning the possible manufacture of h e rb ic id e s by or under the d ir e c t co n tro l of the United S ta te s at Weldon Springs, M issouri, Muscle Shoals, Alabama or elsewhere;
7. O p e r a t i o n HADES;
*
8. O p e r a t i o n RANCH HAND; and
9. P r o j e c t AGILE.
k-H 0--2IU
AFFIDAVIT OF SERVICE STATE OF NEW YORK )
gs .* COUNTY OF NEW YORK )
MICHAEL M. GORDON, being duly sworn, deposes and says:
1. I am not a party to this action, am over 18 years
jof age and reside at 12 West 72nd Street, New York, New York
10023.
ili 2. On May 17, 1982, I served the annexed Notice of
i jDeposition Upon Oral Examination on each of the persons named on the annexed list by depositing a true copy of same enclosed in a I postpaid properly addressed wrapper, in an official depository junder the exclusive care and custody of the United States Postal
2111 Q -Z.I9Y
LISTING OF ATTORNEYS
FOR DEFENDANTS
&Leonard L. Rivkin
Rivkinj Leff, Sherman
Radier
(for DOW CHEMICAL)
100 Garden City Plaza
Garden City, New York 11530
Thomas Beck
Arthur, Dry & Kalish, P.C.
(for UNIROYAL)
1230 Avenue of the Americas
New York, New York 10020
Morton B. Silberman Clark, Gagliardi & Miller
(for T H AGRICULTURE & NUTRITION COMPANY, INC.)
The Inns of Court 95 Court Street 'White Plains, New York 10601
John C. Sabetta-
Townley Uodike (for"MONSANTO)
^05 Lexington Avenue .New York, New York 1017^
William Krohley .Kelley Drye & 'Warren
(for HERCULES, INC.) 350 ^ark Avenue New York, New York 10022
John M. Fitzpatrick Dilworth, Paxson, Kalish & Levy
(for HOOKER PLASTICS & CHEMICALS COF.P .)
26OQ The Fidelity Building
Philadelphia, Pennsylvania 19109
Joan Bernott Deo art men t of Justice
(for THIRD PARTY DEFENDANT USA)
Safeway Building, Room 90AD
'Washington, D.C. 20530
David R. Gross Budd, Larner, Kent, Gross, Picillo & Rosenbaum
(for THOMPSON CHEMICALS) 33 Washing ton Street New ark, Ne w Jersey 0 710
( &How ard Les ter
Les f^"V ) 3 c , C hwab , Katz
D-
for HOF FMAN -TAFF)
120 Bro adv;y Mew Yor , New York 1027
LiPau 1 V. Esposi to 6W is, Ove rbec k & Fur man (for RIV ER DA LE CHEM ICA
135 Sou th LaSa Ile Str eet
--Sui 06 i060
Chi cago 3 T--3.1 cis 60 60 ^
COPIES OF ALL DOCUMENTS MUST BE SENT TO:
Clerk of the Panel Judicial Panel on Multidistr
Litigation 1120 Vermont Avenue, N.W. Suite 1002 Washington, D.C. 20005
FOR PLAINTIFFS
Michael V. Corrigan Simpson, Thacher & Bartlett
(for-ANSUL CO.) One Battery Park Plaza New York, New York 10004
Victor J. Yannacone, Jr. (lead counsel)
Yannacone & Yannacone Post Office Drawer #109 Patchogue, New York 11772
2112 6 - s . i t r
IT re: The Dow Chemical Co., et al.
\ DATE
EPA ATTORNEY
Michael S. Winer ,,Dorothy E. Patton
Kevin Lee WITNESS
7-11-79 Prehearing Conference (Second)
10-17-79 12-4-79 1-9-80
Prehearing Conference (Third) Prehearing Conference (Fourth) Prehearing Conference (Fifth)
1-23-80 2-20-80 2-29-80
Prehearing Conference (Sixth) Prehearing Conference (Seventh) Prehearing Conference (Eighth)
3-14-80
Ronald L. Thomas Anne Barton
3-17-80 Dr. Dawn Goodman
3-18-80 3-26-80 4-3-80 4-4-80 4-8-80
Dr. Roy E. Albert Administrative Conference (Special) Dr. Diane Kay Courtney Dr. Diane Kay Courtney (Resumed) Mary Burr Paxton
4-9-80
Dr. Gary D. Hodgen Wilbur P. McNulty
4-10-80 Michael I. Luster
*****Confidential ********
FIFRA DOCKET NO. 415, et al.
THE DOW CHEMICAL COMPANY ATTOR
Edward W. Warren Kirkland & Ellis
PP OF TRANS
EXHIBIT
1 - 117 1 93 1 - 148
1 91 1 - 105 1 - 113 1 - 102 1 - 205 **165 -205**
206 - 460
No.-l 8, 9, 10 11, 1001 1002, 10 1004
12 - 18 20 - 31 1005.100 1007.100 1009
464 - 4528 1 - 106
Nos. 32-- --
548 - 774 779 - 850 868 -1103
lies1108 -
1164 - 1202
EPA 41 Dow's 1010, 10' Dow's 1012-102
EPA's 8?
EPA 82 Dow 1026
thru 103 1015-1
EPA 91-10 4 Dow - 102 7*
1209 - 1265
EPA 110-1
Dow - 102 & 1037
2114
P-Rirf
FIFRA DOr "T NO. 415, et al
In re The Dow Chemical Company, et al.
-2-
DATE 4-11-80 4-16-80
WITNESS Dr. Renate D. Kimbrough William M. Upholt
PP OF TRANS.
1271 - 1311 1330 - 1430
4-17-80 Dr. Morton Beroza
1440 - 1657
4-18-80
Robert A. Maxey Thomas E. Dixon
1665 - 1729 1731 - 1861
4-22-80
Robert W. Baughman Frederick W. Kutz
4-23-80 4-24-80
Aubrey E. Dupuy,Jr. Dr. Gunter Zweig
Robert L. Harless
4-25-80 4-30-80
Robert L. Harless Thomas 0. Tiernan
Dr. Michael L. Gross
5-1-80
James J. Boland
1877 - 1961 1964 - 2047
2059 - 2177 2177 - 2213 2221 - 2469
2475 - 2532 2533 - 2693 2700 - 2902
2911 - 3101
EXHIBIT
EPA 124 -130 EPA 139 & 14r Dow 1038,103e 1040,1041 , 1( 1043,1044 & 1045
EPA 141-163 & 150-1
DoV/ 1046,10 1048,10*& 1050
EPA 165,166, 167,169,170183 & 176-1
Dow 1053,105 1055,1056 & 1057
EPA 184 -199 Dow 1058-106 EPA 200,131Dow 1065 ?<
EPA 200 -211 Dow 1068-107
EPA 2 1 2 - 2 2 Dow 1078 -1C
1086 -1C
EPA 211-222 Dow 1078-110-
EPA 223 - 2. Dow 1109-111-
PA 229 - 23 Dow 1113 & n
2115
In re The Dow Chemical Co., et al.
-3-
DATE 5-2-80
WITNESS Michael J. Dellarco
5-6-80 Michael J. Dellarco Charles Lewis
5-7-80 Charles Lewis
5-8-80
Lester Baker William Edgar Matthews Richard Petrie
5-9-80
Richard Petrie Wilbur D. Wise Emil Regelman
5-12-80 George W. Keitt
5-13-80 George W. Keitt William Loy John Anderson
5-14-80 John Anderson Bernard Smale
5-15-80 Thomas Harrison Thomas Ellwanger Gisela Green
5-16-80 Dr. Daniel Elam
FIFRA DC ET NO. 415, et al.
PP OF TRANS. 3110 - 3358
3387
3500
3510 - 3626
3632 -- 3865
3872 _ 3928 3929 - 3984 3985 - 4131
4137 _ 4168
4177 - 4223
4235
4365
4371 _ 4592
4598 - 4669 4700 - 4812 4812 - 4859
4865 - 4959 4980 - 5145
5156 - 5311 5312 - 5386 5387 - 5431
5439 - 5555
EXHIBITS
EPA 234 thru 241 1115, 1116, 1117 EPA 242 thru 286 EPA 248 - 293 Dow 1117 - 1121
EPA 294 - 328 Dow 1122 & 1123
EPA 242 - 247 296-321, 321a 322-331
Dow 1124
Dow 1126 - 1129
EPA 333 - 364 365 - 386 424 - 426 481a, 382a. 383a
EPA 387 - 390 395 - 423
DOW 1130-1132 1133 wi thdrc 1134-1138 & 1140
EPA 431-432, 44 434-455 & 4
DOW 1141 - 1144
EPA 457-461 460c & 460c
DO 1145
2116
V 1- aj i
DATE 5-20-80 5-21-80 5-22-80
5-23-80 5-27-80 5-29-80
5-30-80 6-3-80 6-5-80
6-6-80 6-12-80 6-17-80 6-18-80 6-24-80 6-25-80
6-27-80
WITNESS Ugo E. Pezzi
-4-
Dr. Jack D. Griffith Dr. Jack D. Griffith
Dr. Thomas J. Keefe
Robert C. Duncan Ian C.T. Nisbet
Bonnie Hill Administrative Session Neil T. Skill
James R. Yowell
Frank J. Beck, Jr. Connie J. Stone Dr. Rainer Frentzel-Beyme Kirk T. Kitchin Joseph F. Holson
Michale L. Gross (recalled) Robert L. Harless (recalled)
Dr. George Streinsinger
FI FRA DOCKET NO. 415, et al. 2,4,5-T & Silvex Cancellation
PP. OF TRANS. 5561 - 5726
5734 - 5983 5988 - 6318
6324 - 6587
6594 - 6707 6725 - 7001
7009 - 7106 7110 - 7159 7167 - 7235
7244 - 7330 7381 - 7451 7459 - 7499 7505 - 7710 7763 - 7786 7792 - 7954
7970 - 8142 8143 - 8168
8185 - 8459
2117
EXHIBIT EPA 464 - 467 DOW 1146-1152
EPA 468-472 DOW 1153 EPA 468 -472 DOW 1158 &
1162 - 117
EPA 476 Dow 1171, 1172
EPA 476-478
EPA 494 DOW 1173 - 117:
1177 - 117:
EPA 483 - 493a-
EPA 462 & 463 DOW 1132
EPA 495 - 512 DOW 1180 - 118. EPA 513 - 534
EPA 535 - 540 DOW 1183 EPA 541 - 558 EPA 559 - 561 DOW 1184 - US'
EPA 223A, 562 i
i 563
DOW 1192-1204
EPA 564 - 573 DOW 1206
O'3.9.00
O'
r ket No. 415, et al. 2,^,5-T & Silvex Cancellation
-5-
DATE 6-30-80 7-1-80
7-3-80
WITNESS Conference Arthur W. Galston
Dr. Matthew Meselson
7-7-80 * 7-9-80
* 7-10-80
01av Axel son
Patricia Clary Irene Durbin
Gail Slentz
PP. OF TRANSCRIPT 8466 - 8483 8495 - 8588
8633 - 8787
8821 - 9098 18 - 101
103 - 157 '' 165 - 231
EXHIBITS
--
EPA 579 - 583 DOW 1210
EPA 584,585 & 586 DOW 1211 & 1212
EPA 587 - 599 DOW 1213 - 1219
EPA 600 - 621 DOW 1220-1224 EPA 622 - 631 DOW 1225 - 1229
7-15-80 7-16-80 7^17-80
Jere Christner Dr. Logan Norris Dr. Logan Norris
9132 - 9316 9327 - 9520 9526 - 9716
7-21-80 7-22-80 7-23-80 7-24-80
7-25-80 8-27-80 9-3-80 9-4-80
9^5-80
Lavell 0. Stanger
9725 - 9852
Dr. Alvin L. Young
9903 - 10092
Dr. Alvin L. Young (resumed)10105 - 10341
Dr. Alvin L. Young (resumed)10365 - 10392
Rodney W. Bovey
10401 - 10532
Rodney W. Bovey (resumed) 10537 - 10565
Conference David Graham
David Graham (Resumed) Roy J. Smith
Dr. Roy J.' Smith, Jr.
10570 - 10626 10642 - 10851
10860 - 10933 10962 - 11069
11076 - 11269
USDA - 650 - 653 DOW 1230 and 1231
Nos. 654 - 663 DOW 1232, 1233, 123
USDA 654 - 663 DOW 1237,1238, 1239
1240 EPA 664 - 667
DOW 1241-1245 EPA 668 - 675
EPA 676,685-689 DOW 1246 & 1247
DOW 1248 - 1259 EPA 691-736-1 DOW 1260 /
EPA 736 - 750 DOW 1261 - 1266
** Field Hearings held Eugene, Oregon
DOCKET NO. 41F, et al. 2,4,5-T & Sil c Cancellation
t 9-10-80 9-15-80
9-22-80 9-23-80
WITNESS Louis T. Bouse Robert A. Squire
Administrative Conference Roy E. Albert
PP OF TRANS 11283 - 11343 11349 t 11448
11452 - 11485 11491 - 11685
9-24-80 9-25-80 9-26-80
Roy E. Albert Philip C. Kearney Administrative Conference
11691 - 11812 11818 - 12025 12027 - 12031
9-29-80 3-29-80 9-30-80
Lennart Hardell Lennart Hardell Lennart Hardell
(Morning Session) 12052 - 12148 (Afternoon Session)12150 - 12247
12265 - 12542
10-1-80 10-7-80
Richard R. Monson Gunter Zweig
12550 - 12680 12693 - 12883
10r8-80 10-9-80 10-10-80
William D. Schutte Emil Regelman
David A. Graham Kenneth V. Thimann Robert R. Bumb
Robert R. Bumb (Resumed)
10-14-80 David T. Buzzelli
12892 - 13053 13054 - 13203
13210 - 13298 13299 - 13349 13351 - 13440
13447 - 13638
13644 - 13873
EXHIBITS
EPA 751 - 75
EPA 759. r 7 DOW 1267-127
EPA 32A-37, 574-578 DOW 1 2 7 1 - 1 1283 thru 12
EPA 148A EPA 757, 758 DOW 1290 129'
EPA 775
EPA 762 - 111
775 & 77c DOW 1298 - 12
EPA 773 & 11L
DOW 1319,EPA -
EPA 776 DOW 1320-1322
1324-1327
EPA 777 DOW 1328 - 132
EPA 698a, 800805a&b
DOW 1337 - 134
EPA 806 - 809 DOW 1349 - 136
EPA 810 - 812 DOW 1365 - 12
2119
-7-
DATE 10-15-80
10-16-80
WITNESS
Robert Kilpatrick (Recalled) Richard J. Kociba
Richard J. Kociba (Resumed) Francis J.C. Roe
10-17-80 Francis C.J. Roe (Resumed)
10-21-80 10-22-80
James G. Wilson James G. Wilson (resumed)
10-27-80 Bernard A. Schwetz
10-28-80 Bernard A. Schwetz (Resumed)
10-29-80 Ewen G. McQueen Colin N. Park
10-30-80 Colin N. Park(Resumed) E. Marshall Johnson
10-31-80 Dr. Sheldon L. Wagner Alan Agresti
11-3-80 11-4-80
Administrative Session Dr. Michel A. Ibrahim
11-5-80 11-6-80 11-7-80
Ralph R. Cook Philip Cole Philip Cole (Resumed
11-10-80 Dr. Giuseppe Reggiani
FI FRA DOCIf ' NO. 415, et al. 2,4,5--T & oil vex Cancellation
PP 1DF TRANS 13879 - 13922 13922 - 14058 14063 - 14166 14167 - 14219 14224 - 14371
14383 - 14492 14498 - 14609
14615 - 14821
14827 - 15112
15118 - 15190 15201 - 15317 15323 - 15350 15351 - 15554 15560 -- 15665 15683 -- 15820 15822 - 15838
15843 - 15943
15949 - 16088. 16094 - 16258 16266 - 16502
16508 - 16680
EXHIBITS EPA 813 - 821
EPA 822 - 828 DOW 1376 - 1383
EPA 829 - 841 DOW 1381-1390
DOW 1391 - 1395
EPA DOW
842 - 844 1391 - 1395
l
1397 - 1402
EPA 11'
DOW 1403 - 1406 1407 withdraw
EPA 845 - 850 DOW 1408 - 1414
EPA 854
EPA 851 & 852 DOW 1415 - 1431
EPA 855 & 856 DOW 1432 - 1436
EPA 857 & 858 DOW 1437 - 1440 EPA 859 DOW 3.441 - 1443
EPA 860, 860a & 86C DOW 14|4 - 1457
EPA 861a
2120
rj -10.03
FIFR'1 Docket No. 415, et al. 2,4, f & Silvex Cancellation
-8 -
1 _J CO 1 CO O
DATE 11-12-80
WITNESS
Guiseppe Reggiani (Resumed) H. Tuchmann-Duplessi
H. Tuchmann-Duplessi (Resumed) V. K. Rowe
11-14-80 V.K. Rowe (Resumed)
PP OF TRANS.
16686
16842
16844 _ 16873
16877 - 17038
17039
17064
17069 - 17237
11-17-80 Kenneth D. Crow
17242 - 17349
11-18-80 Otto Hutzinger
17357 - 17516
11-19-80 Ralph T. Ross 11-20-80 Ford L. Baldwin 11-21-80 John L. Merrill 11-25-80 Lewis A. Shadoff
17528 - 1-668 17673 - 17785 17790 - 17955 17963 - 18095
11-26-80 Steven H. Lamm
18109 - 18208
12-2-80 12-3-80
Henry Freiser Henry Freiser (resumed)
12-4-80 Hyland R. Johns
12-5-80 Dr. John C. Ramsey
18213 - 18350 18355 - 18576 18585 - 18703 18713 - 18930
EXHIBITS
EPA 861,A,B,C, - 8 DOW 1459 - 1471
EPA 864, A, B, 865 866, DOW 1472-1480
EPA 865 & 866 DOW 1481 - 1487 EPA 867,867a - 8 6 DOW 1488 - 1493
EPA 870 & 871 DOW 1493 - 1504
EPA 872 - 874 DOW 1505 - 1510
EPA 875, 876 (A-I L-T)
EPA 877 - 885A-Z DOW 1511 - 1516 EPA 886- 888 DOW 1517 - 1527
FPA 853 DOW 1528a&b, 1529:
1530a&b
EPA 889 DOW 1531 & 1532
EPA 890 & 891 DOW 1533 & 1534
EPA 892 - 895 DOW 1335 1556
2121
-9-
FI FRA DOCKE' 0. 415, et al. 2,4,5-T/Silvex Cancellation
ATE 12-8-80
WITNESS Richard Wilson
12-9-80
12-10-80 12-11-80
Dr. Richard Wilson (Resumed) Dr. Michael Newton
Dr. Michael Newton (Resumed)
Michael Newton (Resumed) Werner H. Braun
12-12-80 12-15-80 12-16-80
12-17-80 1-27-81
Werner H. Braun (Resume)
Philip G. Watanabe Philip G. Watanabe(Resumed) Perry J. Gehring Perry J. Gehring (Resumed)
Dr. Michael L. Gross
1-30 81 2-3-81 2-4-81
Joseph S. Carra Robert G. Heath John C. Bailar, III
2-9-81
Lennart Harden
2-11-81 Dr. Robert M. Delvin
2-26-81 2-27-81
Julie K. Gorte Phillip Soil ins
-3-81
David A. Perry
PP OF TRANS. 18939 - 19201
19209
19357
19365 - 19447
19453 - 19679
19685 _ 19861
19861
19926
19932 - 20167
20174 - 20377 20383 - 20406 20407 -- 20649
20655 - 20893
20900
21042
21046 - 21156
21164 - 21205
21210
21319
21426
21664
21670 - 21821
21847 - 22005 22014 - 22170
22179 .-- 22287
EXHIBITS
EPA 892 - 895 DOW 1549 - 15
EPA 896 & 896 DOW 1557 - 15
EPA 897 - 901 DOW 1561 1562 rejected 1563 - 1568 EPA 902 - 904 DOW 1569 - 15:
EPA 905a&b, 906-911
DOW 1578 - 15: EPA 912-918 DOW 1596 - 16' EPA 930, 931
& 932 DOW 1611 - 161
EPA 935
EPA I486
EPA 936 & 937 DOW 1618 - 16
1624 a-e 1625
EPA 956 - 958 956A, DOW 162163V
EPA 925 & 926 DOW 1632 - 16
Dow 2000-200^
.4 o s .' 1612, 16
4000, 4001A-G 4002, 4003
Nos. 2007 & 2
2122
p- 0-0
- 10 -
FIFRA DOCKL NO. 415, etal. 2,4,5-T & Silvex Cancellation
DATE 3-4-81
WITNESS James B. Hart, Jr.
3-5-81
John Hoffman
3-6-81 3-12-81 3-13-81
James Michael Frazier Richard C. Koven Richard C. Koven (resumed)
3-17-81
Chris Maser
3-18-81
Howard Horowitz
3-19-81 -20-81
4-10-81 7-28-81
Howard Horowitz Hugh Mobley Administrative Session Administrative Sessision
PP OF TRANS. 22295 - 22401 22409 - 22540
22545 - 22621 22628 - 22839 22844 - 22996
23017 - 23117 23133 - 23336
23343 - 23440 23453 - 23631 23637 - 23641 23643 - 23648
EXHIBITS
EPA .2009 S 201C DOW 4004 & 4005
EPA 2011 - 2013 DOW 4006 & 4007
EPA 2014
DOW 4008 thru 40
EPA 2016 & 2016a DOW 4008 - 4014 EPA (Chapt. 6 of
Exh. 655) DOW 4015, 4011(a EPA 2017 thru 202
DOW 4016, 4017, 4008
EPA 2027 - 2042 DOW 4016 - 4021 EPA*.2043 - 2052 DOW 4022 - 4026
i
2123
\
C\i t-H cvj
V -'X T ko'I
LAWRENCE SILVERSTEIN - Kimberly Moyer vs. Dow Chemical - March 9-10,1993 Page 1 to Page 170
Associated Reporting, Inc. (317)631-0940
CONDENSED TRANSCRIPT PREPARED BY:
25AT1IPwsnEFhsdoAooaiMaXnsctn:eiaaO:artphek(o3ide(ol1t3iRSsS71,eq)t7rIpu)2Neoa36err1t3t,ei-1nS64C-g66u0e,02i9tnI104ent40ec9r.40
2125
iD - A o <S
BSA LAWRENCE SILVERSTEIN - Kimberly Moyer vs. Dow Chemical - March 9-1 0,1 99 3__________ x m a x
Page 1
Page 4
(D STATE OF FLORIDA)
) SS'
P) COUNTY OF ORANGE)
IN THE CIRCUIT COURT FOR ORANGE COUNTY, FLORIDA
(3) KIMBERLY MOYER, as Personal)
(D
(2)
0) (4) (5)
LAWRENCE G. SILVERSTEIN,
having been first duly sworn to tell the truth,
thewholetruthand nothing butthetruth, relatingtosaidmatter, wasexaminedand
testified as follows:
Representative of the Estate of)
(4) ROBERT W. MOYER, II, D eceased,)
(5) ) Plaintiffs, )Case No. Cl 89-8657
)Di\c 32 Thompson
m(6) vs. )
)
DOW CHEMICAL COMPANY, e ta l.,)
) (8) Defendants. )
0) The deposition upon oral examination of (10) LAWRENCE G. SILVERSTEIN, a deponent produced and
(11) sworn to before me, Aprille Rigsbee Lucas, RPR, a
(6) DIRECT EXAMINATION,
(?) (8)
0 Would yQoUu EsStaTteIOyNouSrBnYamMeR,.pSleCaHsUe.LER:
(9) (10)
A 0
LWahwart eIsnycoeuGr p. Sreilsveenrtsatedidnr.ess?
(11) A Home a d d ress is Carm el, Indiana, 790-A Indian
(12)
03) (H)
Q HTorwaillos,nIgs hthaevestyroeueltivaedddIrnetshse, I4n6d0ia3n2a. polis area, sir?
(is)
(16)
A 0
SOifnthc eis Oyecat or,b1e9r912s?t
(17) (is)
AQ 'P9r2io, rctoorrtheactt.where did you live?
(12) Notary Public at large in and for the State of (13) Indiana, taken on behalf of the Plaintiff at (14) DowSanco, 9001 Purdue Road, Quad III, (15) Indianapolis, Marion County, Indiana, on March 9, (16) 1993, at 10:00 a.m,, taken pursuant to the Florida (17) Rules of Civil Procedure in the above-captioned (18) matter. (19) ASSOCIATED REPORTING, INC. (20) TWO MARKET SQUARE CENTER
(19) A Midland, Michigan.
(20) O How long had you lived In M idland, M ichigan?
(21) (22)
QA 3A7reyyeoaursp,rwesitehntalyceomupplloeyteimd?eouts lor transfers.
(23) A Y e s, sir.______________________ _______________
O) 0 What company employs yPoaug?e 5
(2)
P)
0AWThheereFisartlhoawt cEonmvpiraonnymloecnatateldE?ngineers, Incorporated.
(21) 251 EAST OHIO STREET (22) SUITE 940 (23) INDIANAPOLIS. INDIANA 46204_________________________
(4) A It's at 9202 North Meridian Street in
(5) (6)
0 WInhdaitaInsaypooulirsp. osition w ith that company?
Page 2
(7) A I am director of Industrial hygien e, sa fe ty and
(1) A P P E A R A N C E S (2) FOR THE PLAINTIFF: Richard D. Schuler, Esq. (3) Schuler, Wilkerson, Halvorson & ) Williams, P.A. (5) 1615 Forum Place
(8) (9) (10)
Q
Wtrahiantitnygp.e o f company is Farlow Engineers, Incorporated?
Environm
ental
(11) A They are a consulting engineering firm that
(12) sp ecializes in hazardous w a ste site evaluation and
(6) West Palm Beach, FL 33401 (7) FOR THE DEFENDANT Alan F. Wagner, Esq. (8) DOW CHEMICAL: Carlton, Reids, Ward, 0) Emmanuel, Smith & Cutler, P A (10) Rrst Florida Bank Building (11) P.O. Drawer I90
(13) (14) (is)
0
Arenmd Dow
eydouia,tpiornio.r C hem ical
to working w Company?
ith
F
arlow
,
w
o
rke
d
w
ith
(16) (17) (18)
AQ YWehse,nsidri.d you cease working w ith Dow Chem ical Company?
(12) Tallahassee, FL 32302 (13) FOR THE DEFENDANT H. Roger Lutz, Esq. (14) HELENA CHEMICAL Lutz, Webb, Bobo & Baitty, P.A. (15) Two North Tamiami Trail (16) Sarasota, FL 34236 (17) INDEX (18) PAGE (19) DIRECT EXAMINATION, (20)_________Questions by Mr, Schuler 4____________________
Page 3
(19)
(20) (21) (22)
A 0
ADfetecreDmebceermobf e1r9o7f91. 979, can you g hOisrtiof ryyouo fwyeoruerreemtirpeldo,ymteellnmt we itthhavt.a
rivioeums
ec
oamlipttlaenie
s?
(23) A I w as m anager of Industrial h ygien e fo r th e Dow______
Page 6
(1) Corning Corporation from D ecem ber 19 79 to
(2)
P)
(4)
0 DMSeoidpwltaeCnmdom,bMeinrigc1hsCitgo,ar1pn9,o9Irs0at,iitownnhoiets?nalIsroetloirceadt.e*d" In
(1) (2) (3) (4)
EXHIBITS PAGE Plaintiffs Exhibit 1 - Chloracne Problem, Biochem's Contribution 73
(5) (6) (7) (8)
A 0
ACnodr is a
rifeIcrtecall correctly, Dow 50 percentjo in t venture
C om ing b e tw ee n
C o rp Dow
oration C hem ical
Corporation and Coming Corporation?
(5) Plaintiff's Exhibit 2 - Memo dated 3-29-65 101 (6) Plaintiffs Exhibit 3 - 'Chloracne in the Dow
0)
(10)
QADYideyso. u transfer from Dow Chem ical to Dow Coming?
(7) (8) (9) (10)
(11) (12) (13)
Trichlorophenol Plant* Circa, 1964 115
Plaintiffs Exhibit 4 - Memo entitled Hazard of Monsanto T Add 132 Plaintiffs Exhibit 5 - Notes to J.E. Johnson dated 11-25-69139 Plaintiffs Exhibit 6 - Letter from F.D. Axe dated 4-22-66 140
(11)
(12)
(13)
(u)
(15) (16)
(17)
A 0
AY ne ds . le Chem
t me go back to yo ical Company, and
ur te
h ll
istory me a
w ith little
D b
ow it about
your educational background before you started
with the company and then the history o f your
various positions with the company, Dow Chemical
I'm talking about now, not D ow Coming.
(14)
Plaintiffs Exhibit 7 - Letter on Fallow Environmental
(18) A Well -
((1165))
Engineers, Inc. letterhead 145 Plaintiffs Exhibit 8 - Silverstein resume' 145
(17) Plaintiffs Exhibit 9 - Artide entitled Mortality
(18) Experience of Employees Exposed to
(19) _________2,3,7,8-Tetrachlorodibenso-p-dixoin (TCDD) 156_____
(19) MR. WAGNER: I'll object to the breadth,
(20) since that covers about 40 years, but g o ahead and (21) give him an overview. (22) A Educational background Is a B ach elor o f Arts
(23) d egree In chem istry, 1954, S tate University o f N ew
(317) 631-0940
2126
b s a ____________LAWRENCE SILVERSTEIN - Kimberly Moyer vs. Dow Chemical - March 9-10,1993__________ x m a x
Page 7
(1) York, Binghamton, New York; M aster's d egree In (2) radiation biology, University of R och ester in New
(3) (4)
0 TYhoerkMians1te9r5's5w. aIsbiengwanha-t discipline?
(5) A The university called it radiation biology. It's
(6) more accurately radiation safety. I began work
00 with Dow Chemical Septem ber 1st, 1955, a s an
(8) entry-level Industrial hygienist and radiation
(9) safe ty specialist.
(10) In 1960 I transferred to the T exas (11) division a s chief industrial hygienist, returned (12) to Midland in 1962 a s an industrial hygienist in
(13) th e sam e laboratory situation. In 1 9 7 0 1 becam e
(14) safe ty and Industrial hygiene m anager for the Dow
(is)
(16)
0 TMhiadtlawnads idniv'6is7i?on, now called Michigan division.
(17) (18)
A 0
I7s0a?id
'70.
(19) A Y e s. In 1971 I w ent back to health and
(20) environmental s cie n ce s a s an industrial hygienist. (21) 1 9 7 6 ,1transferred to the Dow B adische Com pany In (22) Williamsburg, Virginia, a s director o f industrial
(23) hygiene, returned to Midland in 1978 a s m anager of
Page 8
(1) industrial hygiene research and m anager of the (2) Industrial hygiene lab.
(3) MR. WAGNER: That's B-A-D-l-S-C-H-E.
(4) A Then in D ecem ber of 1979 it ca tch es up to w here I
(5) (6) (7) (8)
0
Ftrroamnsf1e9r7r0e,diftomDy nouwmCboerrnsianrge. correct, here, 1971 to 1976 you were present or employed
farot m
Midland, Michigan, correct?
(9) A Y es.
(10)
(11) (12)
(13)
(14)
0
And from in d u s tria l
1971 through hygienist, did
1976, in your capacity you have any
as
an
responsibility fo r industrial hygiene in the
manufacturing process for 2,4-D or 2,4,5-T or
Silvex o r their components?
(is) MR. WAGNER: I object to the form.
(16) A To the b est of m y recollection, I had no primary
(17) responsibility for manufacturing operations during
(18)
(19)
(20) (21)
0
Dthoaytotiumkenopwerwiohdo. would have had responsibility for the industrial hygiene aspect o f the manufacturing
process for those chemicals?
(22) MR. WAGNER: Same objection.
(23) A You are challenging my memory, of course. I_____
Page 9
(1) believe about 1972 Dr. Ralph Langner becam e the (2) Michigan division industrial hygiene m anager, so
(3) he would have had the b a sic responsibility for
(4)
(5)
0 Dt hr.a Rt alph?
(6) (7)
AQ LL-aAn-Ngn?er, d eceased .
(8) (9) do)
A 0
yLWo-uAha-kNtnwo-Gwa-s,Nhw-iEsith-pRtoh.seiticoonmdpuarninyg?
th
a
t
tim
e
p
erio
d,
if
(11) A To the best of my memory, he w a s m anager of
(12) industrial hygiene for the Michigan division, w as
(13) (u) (is)
Q Ythoeu tmitelen.tioned this Michigan division before. What was the Michigan division?
(16) A It's the production division of Dow Chem ical
(17)
(18)
(19)
0
DloocayoteudkinnowMiwdhlaantdo,thMeircdhiivgisaino.ns are located M idland, Michigan, other than the M ichigan -
in
(20) A It's corporate headquarters for th e com pany, so
(21) there are many corporate o ffices and functions
(22)
(23)
Q Hgoaivnegyooun ethveerr es.een a flow chart o r a diagram o f_____
(1) the corporate organizatPioangien 1M0ichigan?
(2)
(3)
(4)
0 Danudrin7g5t?hMeRt.imWeAwGNe'EreRt:alAkitnagnaybpoouitn,tbientwtimeeen? 70
(5) (6) (7)
A 0
IW1d9ho7on5w?'toruelmd eymoubrebro. ss
have
been
between
1970
and
(8)
0) (1o)
A Q
AHnadroifldm head of
Rem. Horoyyslee.rves industrial hyg
me correctly, Dr. Hoyle iene in the seventies?
w
as
(11) (12)
(13)
(H)
A 0
YFreosm. were
1970 to 75, h at Midland, M
ow many industrial ichigan, Involved in
hyg the
ie
n
ists
manufacturing process?
(15) MR. WAGNER: I object to the form.
(16) A Wow, there m ay have been four or five, but not
(17)
(18)
(19)
0 Ofdukelalpytoi,mswiteiho,entnooImfsDpyro.rkReecoowwlileteh?c-tiohnav. e you reviewed the
(20) (21) (22)
(23)
A 0
DNro..Rowe in d u s tria l
mentioned that he hygiene division in
thought, in the the seventies,
there were ten to 15 industrial hygienists. Does________
(1) that refresh your recollePcatiogne a11t all?
(2) MR. WAGNER: Let me object to the form.
(3) That question is different than the one you've
(4) asked, but -
(5) A It d o esn 't help a whole lot, b e ca u se I w a s trying
(6) to remember a s b est I could, you know, from my
(7) (8) (9)
(10)
0 Tipnhedarust'ssotnrfiinaaell h.eyxWgpieheroniieswntescrteeh,athatenyodoutIhrgeearcvfaoelulybrooaucr kfmivbeyetbweesetngu ess. 1970 and 75?
(11) MR. WAGNER: Let me, a s a point of
(12) clarification, because it's the problem with your
(13) initial question then followed up by Dr. Rowe, you
(14) initially asked about hygienists involved in
(15) production, and then made reference to Rowe's
(16) answer about how many industrial hygenists in the
(17) industrial hygienists' division. I don't know if
(18) that's a greater number, but is your question how
(19) many industrial hygienists were there in the
(20) safety and industrial hygiene department, separate (21) and apart from whether or not they were involved (22) in the production end of it?
(23) _______MR. SCHULER: Correct.____________________
Page 12
0 ) A You fellows have thoroughly confused me. Would
(2)
(3) (4) (5)
0
WyohuatrIe'mstatrtyeintghetoqfuinedstoiount, ,Mprl.eSaislvee?rstein, is what was the number o f industrial hygienists
*
that
worked under Dr. Hoyle from 1970 to 75?
(6) A That's a bit clearer, and I think my four or five
(7) (8) (9) (10)
Q AisntdhaesbheesatdI ocaf nIndduo.strial hygiene during that tim e period. Dr. Hoyle - was industrial hygiene part o f the biom edical research lab?
(11) A Oh, another memory stretcher, it w a s part of the
(12) biochem ical research department w hen I joined in
(13) the fifties. Som ew here in the time period you
(H) mentioned the name w as chan ged to health and
(15) environmental research, I believe. Biochem ical
(16)
(17) (is)
0 /r7ue0nsedaaenrrdscth7an5ids, .inf yoWot huboikodnmoidweDd?irc. aHl,ocyalererefuplodrtitsotibnecttwioene.n
(19)
(20)
A 0
IDsrD. Dr.oHnoDyle. Isritsilhl a, lfiover ?part
of
that
period,
anyway.
(21) (22)
A Q
AY ne sd.
where
is
he
located,
if
you
know?
(23) A Probably on the eighth tee about now._____________
0*
bsa LAWRENCE SILVERSTEIN - Kimberly Moyer vs. Dow Chemical - March 9-10,1993
(1) 0 Not In M idland, M ichigaPna?ge 13
(2) A Delray B each, Florida. Actually it's too early
(3) for th e eighth tee.
(4) P) (6)
0 Nyoouwr,setolf,gweht boaacrek ttohemoythoethreforuqruoersftiivoen, other than Industrial hygienists In the department?
(7) A To the b est of my recollection, Arnold Schaffer,
(5) S-C-H-A-F-F-E-R, Richard D. Olson -
0) MR. WAGNER: O-NorE-N?
(10) A O -N . The D is important b ecau se there's a Richard
(11) A. there, too. G eo rge Florez, I believe w as one (12) of our group at that time, and Edward J.
(13) Schneider, S-C-H-N-E-l-D-E-R. Oh, Donald Rapp,
(U) (is)
(16)
(17) (is)
0
DR-idA-aPn-yPo. f these individuals, Mr. Schaffer, Mr. Olson, Mr. Florez, Mr. Schneider, Mr. Rapp, have
responsibility for Industrial hygiene In the
production o f Sllvex or 2,4,5-T or 2,4-D?
09) A To th e b e st of my recollection, each of those
(20) folks had som e responsibility for som e area, but
(21) no o n e had total responsibility for th e Michigan
(22)
(23)
Q Wdihveisnioyno.u say each had some responsibility, do you
(1) recall what the breakdoPwangoef1th4at responsibility
(2) w as?
(3) (4) (5) (6)
A Q
NWoh.at were y time period
obuetrwdeuetines1a9n7d0
arensdp1o9n7s5ib?iliAtiensdinif
tthheayt
changed,let me know that, too.
(7) MR. WAGNER: I object to the breadth.
(8) A My recollection of that particular time period Is
(9) that my main effort w as In two projects. O ne w as
(10) called Dow Environmental Health Services, a (11) consulting-for-fee effort to offer industrial (12) hygien e and anumber of other service s to
(is) industry. I w as the lead industrial hygienist for
(u) that effort, which w a s headed up by Arnie
(15) Schaffer.
(16) The other role I played w as a s chief (17) health physicist, which is radiation safety
(is) officer for the Dow Nuclear S erv ices program,
(19) w hich offered Dow service s to th e nuclear power
(20)
pi)
(22)
(23)
0
NInodwu,sbtrayc.k In the 1960s, and I have some memoranda here that I'm going to show you in a minute, you
apparently were given some responsibilities with
(1)
(3)
regard to doing some InPdaugsetri1a5l hygiene work retrgicahrldorinogphtheenpolr,occoersrsecfot?r the manufacture of
(4) MR. WAGNER: Iobject to the form.
(5) (6)
A Q
YWehso.
in
itia
lly
assig
ne
d
you
those
resp
on
s
ib
ilitie
s
?
(7) A Harold R. Hoyle.
(8)
0)
QrDesopyoonuskibniloitwiesw?hy you were selected fo r those
(10)
(11) (12)
AQII cdoounl'dt woannltyygouuetossg, uceosnsj,ebctuut rIfeyaotut'vheisgpoot iant. reasonable estimate, I want to hear it.
(13) A I w a s a g o o d Industrial hygienist, and I w as
(14)
(is)
(16)
(17)
(18)
(19)
Q Otahkveaayri,elassbopluoen.ndssibrielitaiessonoarbalses. igAnneddpsroiomreto being given responsibilities with regard to the production o f trichlorophenol and potential TCDD contamination, what were you doing before you were assigned those
(20) tasks?
(21) MR. WAGNER: I object to the form of the
(22) question, no predicate.
(23) A To th e b e st of my recollection, In the early_______
Page 16
(1) sixties I w a s doing industrial hygiene in the (2) Midland division production plant, and doing
(3) radiation safety for the division and for the
(4) (5) (6) (7) (8) (9)
0
Wcoemreptahneyre. any industrial hygienists p rior to your assignment In the sixties that had been assigned
to the production o f trichlorophenol in terms o f
m onitoring the safety o f the workers in that
production?
(10)
(11) (12)
03)
AQIWfidrshotaatnwsostaigsrenthmmeeermnetabIsneortnh. a-t
w e ll, area
what year, do you recall?
le
w
t me go back. Your as approximately
(u) (is)
(16)
(17)
A 0
B19e6fo4r.e 1964 had you ever had any resp with regard to Industrial hygiene for the
o
n
sib
ilitie
s
production o f trichlorophenol?
(18)
(19)
AQ NOor t2t,4h,a5t-TI?recall.
(20) (21)
A 0
SNlolvtetxh?at
I recall.
(22)
(23)
A Q
OI dro2n,4't-Dre?m__e_m_b_e_r_. __________________________
Page 17
(1) (2)
(3)
(4)
A 0
IHadsapodenyc'otturoewfmtoherekmepbdroeadrtutahclatliowt neitihothftheaern.yinadgursictruialtul hraygl iene
chemicals prior to 1964?
(5) A I don't remember sp ecifics on that. I m ay have,
(6) (7) (8)
0
Hbuadt Iyjouustindvoenst'itgraetecadllaanny ycasspeesciofficchplororajcencet to 1964?
p rio r
(9) (10)
A 0
AItnhdindkooynoeu
triemcea,llywehaehn.
that
w
as?
(11) (12)
A 0
ASobmouetti1m96e3,
oohr s, oa?year
or
so
before,
maybe.
(13) (14) (15)
A 0
PRroiourgtholyth, aytetaimhe. ha o f chloracne at any
dDyoowupinlavnetsst?ig
ated
any
cases
(16) MR. WAGNER: I object to the form.
(17)
(18)
(19)
(20) (21)
A 0
PNroiot rtotom1y96r4ecoorl'l6e3c,tidoon.you know if there Individual industrial hygienist that was
w
as
any
responsible for m onitoring the production o f
trichlorophenol or 2,4-D, 2,4,5-T or Sllvex?
(22) MR. WAGNER: I object, asked and
(23)_________ answered.___________________________
Page 18
(1) (2)
AQ NNoo,. you don't know?
*"
(3) A No, I don't know, If I understood your question,
(4) yeah.
P) (6) (7)
0
Okay. In 1963, when investigate a case o f
you were first asked to chloracne, what was that
in
connection with, what process?
(8) (9)
0A AItnwdaws haadt iisffIetrtehnet6p-Xrostcaensdsscfaolrl?ed Dow 6-X.
(10) A I believe it stood for hexachlor - oh, my
(11) go o d n ess, hexachloro, I want to s a y phenoxy, but
(12) that doesn 't fit, b e ca u se you ca n 't put six
(13) chlorines in that. It w a s a hexachlorophenolic
(14) (is)
Q Aconmd dpoiduynodutwharitteIacnaynnreoptonrtasmweithforreygoaurdattotthhiast?point,
(16)
(17)
08)
(19)
A 0
INdoown, 'wt hreemn eymoubwere.re assigned investigate chloracne in 1964,
hboywDdr.idHyooyuleptoroceed
to do that?
(20) A Well, I visited the plant to o b serve th e a ction s
(21) of the em ployees, which is the standard initial
(22)
(23)
Q Sstoeypoiunwinednut stotrtihael hpylagnitesn, ethienmvessetlvigeast?i_o_n_. ________
2127
(317) 631-0940
LAWRENCE SILVERSTEIN - Kimberly Moyer vs. Dow Chemical - March 9-10,1993__________ x m a x
Page 19
(I )
K
A 0
DI
sidp
yeonut
qa
uc
tiutea
laly
bhiatvoef
atinmoeffiIcnet
hinatthpelapnlat,nyt?ea
h.
0)
(4)
A 0
NWoh,aIt
deilsden'dt idhayvoeu adno?office
In
the
plant.
(5) A Proceeded to do som e air sam pling and wipe testing
(6) PO
Q Aonfytthhiengplealnstee?nvironment.
(8) A I'm pretty su re that l issued a quick report,
(9) b e ca u se w e had an urgent situation, s o I must have
(10)
(11)
Q Awnryitttheinngaerlseepothrta.t yIoduorne'ct arell?member for sure.
(12) A I'm not su re what you want, but if you give me a
(13)
(u) (is)
Q I'smpencoitfiscu-re what you did. That's why 'm asking the question.
(is) A Well, that w as p h ase one. Is there a question on
(17)
(18)
(19)
Q Itfhtehafltowoars? phase one, what else did you do, what was phase two?
(20) A My recollection Is that my next assignm ent w a s a s
(21) sa fe ty officer in the plant, with the
(22) responsibility for assuring s a fe operation.
(23) Anything that happened In the plant, I had to________
Page 20
(1) sp ecify s a fe ty precautions and make sure people
(2)
(3)
(4)
0
Wf ohlleonwyeodu tshaeymin. to?
the
plant,
what
are
you
referring
(5) (6)
A 0
TRheeferbruinigldtiongtrihcohulosrionpghtehneolp?roduction
process.
(7) (8) (9)
A 0
SWthpaaestcatihpfiepcraeliellmdy.otore?
than
one
physical
building
that
(10) A No.
(I I ) MR. WAGNER: T h at-
(12) THE DEPONENT: I'm sorry, I-
(13) MR. WAGNER: That's all right. So we're
(14) dear, you meant was there more than one building
(15)
((1176))
0
O ther thparnotdhuedbnugildtrinicghltohraotphheenhaold? responsibility for, right, producing trichlorophenol?
(18)
(19)
(20)
0A EThitahte'sr wwhaayt,Ituhnedaenrsstwooerd iysonuor .answer to be. What was the building number, do you recall?
(21) (22)
(23)
A 0
AItnwdaasft1e9r9bebcuoilmdiinngg.a safety officer and instituting safety precautions and making
sure_________
(1) (2)
(3)
(4)
there was compliance, Pwaagseth2e1re any other duty that you discharged in connection with the responsibility to review industrial hygiene for trichlorophenol manufacture?
(5) A I w a s involved in a number of things in that w hole
(6) situation, both so m e laboratory studies and
(7) investigating other buildings in th e division, and
(8) I just do not rem em ber timing, you know, on that,
(9) but I do rem em ber that I w as w andering around
do) d 1) d 2) (13)
O
Idsooinnge ootfhtheer tdhuintgiess,thaast ywoeulld. id exposure levels o f the workers
Itno
tchheepclkan
t
to
TCDD?
(14) MR. WAGNER: Iobject to the form.
(15)
(16) (17) (18)
AQ WAnedll,wtahsaitt wonaes oonf yeooufr rmesyproenspsoibnilsitiiebsiltiotiecso,rryeecst. operating procedures where excessive exposures may be occurring?
(19) MR. WAGNER: I object to the form.
((220D)
(22)
(23)
A At what time period now? During my health officer
QdOuktaieys. , Ayneds.was it part o f your duties and responsibilities to identify areas where_______________
(1) difficulties with exposurPeamgeay2o2ccur?
(2)
(3)
(4) (5)
A 0
AYneds.did you also sen/e the toxicology departm
as kind ent and
o f a llason m edical d
between ep artm ent
and production?
(6) MR. WAGNER: I object to the form,
(7) vague.
(8) (9)
(1o)
(H)
A Q
YPeriso.r to 1964, chloracne in a
hDaodwthweorerkeevrewrobrekeinngawcitahse
o
f
trichlorophenol that you're aware of?
(12) (13)
(14)
(15)
A 0
PNroio.r to 1964, chloracne in
awDeroewyowuoarkwearrwe
oorkf ainngy
wcaitshethoef
finished product of 2,4,5-T?
(16)
(17)
QA IOdrSoitnvoetxr?emember.
(is) (19)
AQ IOdr2o ,n4't-Dre?m em b er.
(20) (21) (22)
(23)
A 0
IIndtohne'tcroeumrseemobfyeor.ur career at Dow Chem you aware o f any cases of cancer In Dow
ical, are w o rke rs
that were exposed to trichlorophenol in the
(1) manufacturing process?Page 23
(2)
P)
A 0
SNaom. e
question
w ith
regard
to
2,4,5-T?
(4) (5)
A 0
SNiolv.ex?
(6) (7)
A O
2N,o4.-D
?
(8) (9) (10)
(11)
((1132))
A 0
ANso.a practical matter, back workers that came down w
iitnh
1th9e64c,hwloirtahctnhee,seh
o
w
would you first become aware o f that? Would they
go to the medical department first, to report this
before you became aware of it? How did that work?
(14) MR. WAGNER: I object to the form.
(is) A The answ er is y es, they would have go n e to
(16)
(17)
(18)
(19)
0
Amneddsicoaml.ebody, would somebody in the m edical department then contact you to make you aware
o
f
the problem?
(20) A No, they would have -
(21) MR. WAGNER: I object to the form, calls
(22)
(23)
Q How wofuolrdsypoeucucloamtioentoanbdevaawgauree aosf tthoetipmroe.blem ?
Page 24
(1) MR. WAGNER: Same objection.
(2)
0(4))
A 0
SForotmheHmaerodlidc
aHl doeyplea.rtm
ent
w
ould
con
tact
h
im
?*
MR. WAGNER: Same objection, calls for
(5) speculation.
(6) (7) (8)
A 0
YAneds. then he wo investigate it, is
uthldattethlleyowua, yaint dwtohuelnd
ywoourkw?o
uld
(9) MR. WAGNER: I object to the form.
(10) (11) (12)
(13)
AQ YHeosw. many cases, to your recollection, o f chloracne were there from the exposure to trichlorophenol in 1964?
(14) A I don't know, for a particular year, how m uch w e
(15)
(16) (17)
0
Chaand.you give recollection?
m
ean
estim ate,
to
the
best
o f your
(18)
(19)
(20)
A 0
DBeidfoyroeuthhaeveevoecncta, saibonoutot 6s0e,eaesacIhreocnaell oitf.the workers that came down with the chloracne?
(21) (22)
(23)
A Q
DI didonth'terwemorkeemrsbethratthcaat.me down w ith the continue to work In the plant generally, o
rcwhelorreacne
LAWRENCE SILVERSTEIN - Kimberly Moyer vs. Dow Chemical - March 9-10,1993__________x m a x
(D they transferred somewPheargeeo2r5what?
p) p)
A 0
TDhoeyyocuornetcina
ull tehde
tnoawmoerskoinf atnhyeopfltahnet,w
orkers?
() A Wow. Just one.
(5) Q Who was that?
(6) MR. WAGNER: Let me stop you for a
(7) moment, because I'm concerned about the medical
(8) privilege, and in releasing confidential medical
0 ) information about that person, and I have not yet
(10) gotten a direction from Dow as to whether or not
(11) they want pursued by certiorari or not the court's (12) decision to require release of those names.
03) I don't - Dick, why don't you go ahead.
(14) At this point I'm going to instruct you not to
(is) answer, but I'm going to ask you to let me know
(16) the person's name before w e get out of here today,
(17) and Iwon't restrict Mr. Schuler from asking you
(is)
(19) (20) ' "V (21) (22)
questions about that person, what he was doing, what position he had, anything else he wants to know, but for the moment let's not reveal his name. MR. SCHULER: My position is we've got a
(23) _______ court order saying we can have the names, and the
Page 26
(1) addresses, as well, and phone numbers. He says he (3)(2) knows one of the names, and there's no stay been
entered based on any petition or writ of
(5)(4) certiorari, so Ithink it's a violation of the order not to allow him to answer the question.
(6) That's my position.
(7) MR. WAGNER: I understand, and I'll give
(8) P) (10)
0
D ow Chiet msoimcael wthaosuignhvtowlvehdeninwmeabkrienagk. trichlorophenol since approximately 1946,
correct?
(11) (12)
(13) (14)
A 0
YAensd. w in you
as the r time
trichlorophenol, as far as with the company, always
you know, made in the
199 building?
(15)
(16)
(17)
(18)
(19)
A 0
YNeost.having been you describe for
to Mid me, is
land, Michigan, before, the 199 building part of
can a
manufacturing complex, or does it stand by itself
som ew here?
(20) MR. WAGNER: I object to the form,
(21) vague. (22) A It's in the midst of a very large manufacturing
(23) com plex._____________________________________
(I )
(3)
0
And around the 199 buiPldaingge a2r7e other buildings where other chemicals or components o f chemicals
are made?
(4) MR. WAGNER: I object to the form of the
(5) question.
(6) (7) (8) (9)
A 0
YFreosm. a tim ing standpoint, do you reca
chioracne in the 199 building January o r February o f 1964?
w
as
firs
t
lnl tohtaictethdeIn
(10) A Y es.
(I I ) MR. WAGNER: Let me object to the form
(12) of that a s vague. It doesn't identify noticed by
(13) (u) (is)
0
tWheasc
thewchhoiomra. cne austic insolub
m ostly due le oils o f the
to the exposure to trichlorophenol?
(16) MR. WAGNER: I object to the form of the
(17) question, calls for conclusion,no predicate for
(18) the opinion.
(19) A Now I n eed a repeat.
(20)
(Th e r e q u e s t e d m a t e r i a l w a s r e a d
by the
(21)
REPORTER.)
(22)
(23)
A Q
IWbhealiteavree
tshoe.
caustic
in
s
olub
le
o
ils
,
is
th
at
a_____________
(1) by-product o f the manuPfaacgtuere2,8if you know?
(2)
P)
A 0
AIt'ws
aaswtea?stIedsidtrne'at hme.a
r
you.
(4) P) (6)
0
AStWreaamst,eosktarey.amC.an you describe fo r chioracne looked like that you saw?
m
e
w
h
at
the
(7) MR. WAGNER: I object as to the breadth,
() time frame.
(9) (10)
QA CDoidllietclotiooknsoofmbelathcinkgheliakdesteoennathgee faaccnee.?
(11) MR. WAGNER: Iobject to the form.
(12)
(13)
(u)
0A YDeids.Dow Chemicalknow that certain chlorinated organic compounds caused chioracne since 1941?
(is) MR. WAGNER: I object to the form,
(16) imprecise as to Dow and attributing knowledge.
(17) A S o m e people in Dow Chem ical knew th a t
(18) MR. LUTZ: Would you read that back.
(19)
(Th e r e q u e s t e d m a t e r i a l w a s r e a d b y t h e
(20) pi)
(22)
0
Do you kRnEoPwORwThERic.)h certain since that tim e period?
people
at
Dow
knew
that
(23) A Don D. Irish and others In the biochemical________
Page 29
(1) research department a re the only o n e s I know for
(2)
P)
0 Wsuoruel.d Dr. Rowe be one o f those?
(4) (5) () (7) (8)
QA IInbe1l9i4e4veorso'4.5, did Dow first test the caustic
picnhrsoioodlruuabccltneioeno?itlop
odretitoenrmoinf ethewhtreicthh
elorrtohpaht
enol
was
causin
g
P) MR. WAGNER: I object, no predicate a s
(10) to personal knowledge, calls for speculation
(11) otherwise.
(12)
(13)
(14) (15)
AQ IYwouasrenv'tieewmedpltohyeehdisatot rtyh,ahtotwimeveear,t dDidowyoCuhneomt,iacat l. some point in time, as to the trichlorophenol and history of chioracne at the company?
(16) A Y es, I did.
(17)
(ia)
(19) (20) (21)
0
And basMedR.oWn yAoGuNrEreRv:ieIwobojfetchte, choismtopryouinnd1,9v4a4goure. 'i4n5s,odluidblDe oowil pCohretimonicoafl fthirestttreicshtltohreopchauesntoicl
production to seeif it caused chioracne?
(22) MR. WAGNER: I object, no predicate,
(23) _______vague.______________________________
Page 30
(1) A I believe so.
(2)
P)
(4) (5) (6) (7)
0 Aetithsoemr beapsoedintoinn ythoeur1p9e5r0sso,naanldknthoewnl,eadrgide tohrisyoisur review o f the history o f this matter, at Dow Chemical, did a German company propose that there may be a compound, TCDD, responsible for causing chioracne?
(8) MR. WAGNER: I object, vague, no
(9) personal knowledge.
(10)
(11) (12)
(13)
A 0
IAbndelIiethvienksoth. at, in your m first got involved with the
epmroobrlaenmdain,
w1h9e64n,yyoouu
called it by the name TCBD, correct?
(14) MR. WAGNER: You mean TCDD?
(is) MR. SCHULER: Right.
(16) A Y es.
(17) THE REPORTER: Wait a minute, is it TCBD
(18)
(19)
(20)
0
i'll ask thoer TqCuDesDti?on again to make it your memoranda, TCDD was called
cTlCeaBrD, i?n
pi)
(22)
(23)
A 0
AYneds.I'm going been referring
ttoo
riet ifne
rthtoisitcaasseT,CaDnDd
since we have in the__________
2128
(317) 631-0940
i ..
bsa___________ LAWRENCE SILVERSTEIN - Kimberly Moyer vs. Dow Chemical - March 9-10,1993__________ x m a x
0)
isncitiieanlstifoicf plitreerfaertuernec,ea-ppPaaregnetl3y1those are the
0 ) MR. WAGNER: For clarification purposes,
(4) you're talking about the 2,3,7,8 isomer?
(5) (6) (7) (8)
O WtheascThCloDMraDRc.nthSeeCoHpuUrtibmLrEeaRaryk:ciRnuilg1ph9rti6t4inatthDeocwauCshaetiomnicoafl Company at the 199 building?
(9) MR. WAGNER: Iobject to the form, calls
(1o) for opinion, no predicate.
(11) (12) (13)
(u)
A 0
IpHotahtdeinnyktocushoee.vme ricbael eenvetor
ld that tested
iTnCDDoDww'satso
the m xicolo
ost gy
la b o ra to ry ?
(15) (is) (17) (is) (19) (20)
A 0
STPoorhiotnhr,tesoeb1ne9ts6at4ol,efhttamedryttohreeDcGoowleleramcntaidon
noct,ohymeerpsma. nayn,uBfaocetuhrreinrgs er
aovfotridicghleonroeprahtienngotlhweitchhseumgigceasl tthioantscoanusheosw to
chloracne in the TCP process?
(21) MR. WAGNER: Iobject to the form of the
(22) question.
(23) A Y e s._____________________________________
(1) 0 Do you recall what thosePasguegg32estions were?
(2) MR. WAGNER: Same objection, best
(3) evidence rule.
(4) A T he only o n e I remember specifically w as a
(5)
(6) (7)
Q Atenmd pwehraattuwraesltihmeitsfuogrgtehsetiopnrowciethssre. gard to tem p e ra tu re ?
(8) MR. WAGNER: Same objection.
(9) A I b elieve it w as 150 degrees, but to be honest, I
<io) don 't rem em ber whether it w as F or C , which m akes
(11) (12) (13) (14) (is)
Q
Da oliyttoleudkinfofewr,einnc1e9. 64, whether Dow Chemical, manufacture o f trichlorophenol, at least to the
in
its
extent you investigated it, was raising the
temperature above 150 degrees Centigrade?
(16)
(17)
(18)
(19)
(20) (21)
A 0
RYeusn. its m
tDhoatyboyu oknnoewminor1e9t6i4mwe,hpeltheaesr eD.ow anufacture o f trichlorophenol at the
Chem 199
ical,
in
mbuailnduinfagc,tuwrainsgrapirsoincgesitssatebmovpeer1a5t0urdeeignrethees
C e n tig ra d e ?
(22)
(23)
A Q
DI wo
aysoutokldnotwhewyhwaet trhee,
yteems.perature
was
th
at
w
as_____
(1) (2)
btheeinngatutsheadt tfiomreth?e manPufaagcetu3re3 o f trichlorophenol
(3) A I don 't know it with certainty, but I believe it
(4) w a s around 200 d egrees.
(5) (6)
(7)
0
Do you know why the temperature fo r the mthaant tuimfaec?turing process of TCP was at 200
degrees
at
(8) (9) (10)
(11)
A 0
NWoh.o that,
was responsible for making decisions as far as the manufacturing process is
like
concerned?
(12) MR. WAGNER:Temperature decisions?
(13) MR. SCHULER: Right.
(14) A E n gin eers or plant management, I don't know for
(15)
(is)
(17)
Q Dsuoryeo. u know who the person who would have been responsible fo r that decision at that time was?
(18)
(19)
(20)
A Q
DI dooyno'tu khnaovewswoimthecnearmtaeinsttyh that were involved?
awthyoouthreact
awllooufldp
eboep,
leno.
(21) MR. WAGNER: l object to the form of the
(22) question.
(23) A T he plant superintendent w as R ay Holmes,_______
Page 34
(D
(2)
0 AHt-tOhe-L1-M99-Eb-uSi,ldIinbge?lieve.
(3) (4)
A 0
YIseMs.r.
Holm
es
s
till
around,
to
yo
u
r
know
ledg
e
?
(5) A I don't know, to b e honest with you.
(6) THE DEPONENT: I'd like to request a
(7) (8) (9)
(dioD)
0
Let me atwsko-ymouinounteermesotrreooqmuebsrteioank.before you because i want to establish a param eter here,
ltehaevne,
we'll take a break. At what point chronologically
did your responsibilities, if they did, end with
(12) regard to chloracne and TCDD and the
((1143))
trichlorophenol process?
MR. WAGNER: I object, breadth and
( )(is) vagueness.
16 A I need to hear that o ne again.
(17)
(Th e r e q u e s t e d m a t e r i a l w a s r e a d b y t h e
(18) REPORTER.)
(19) THE DEPONENT: Did you make your
( D(20) objection?
2 MR. WAGNER: Yes. (22) A Then I can answ er. There's no ciearcu t cutoff
(23) time. The w ay th in gs w orked, about 1967 I took on
Page 35
(1) other responsibilities. (2) MR. SCHULER: Okay, let's take a break.
(3) ( R e c e s s .)
(4) (5) (6)
(7)
0
In 1964 wBYasMthRe. ScChHemULicEaRl o: r the oils that stoubbsetacnacuesitnegsttehde ocnhlroarbacbnites?, were they -
appeared was that
(8) MR. WAGNER: I object to the form of the
(9) question.
((1101))
(12)
(13)
(H)
((1i6s))
0 To your knowledge?
0AAYcnehdse.dmidicaitl
turn out that causing the
the conce chloracne
ntration was so
o f the high in
1964
that the rabbits tested by the rabbit ear test died?
MR. WAGNER: I object to the form of the
0(178))
(19)
((2201))
(22)
(23)
question, vague.
A Q
YNeosw., prior to your being given the industrial hygiene assignment for the 199 building, among
the
other responsibilities that you told us you had in
connection with the outbreak of chloracne, can you
describe for us what the worker safety routine was
(1) (2)
in the plant at the tim e bPeafogree 3y6ou made your recom m end ations?
(3) MR. WAGNER: I object to the form of the
(4) question, vague.
(5) A Only in general term s and with no certainty
(6) b ecau se that's been a long time. It w ould be
(7) basically skin protection and th e u s e of g lo v es
(8) when working in a re a s that m ay b e contam inated,
(9) plus personal hygiene instructions on w ashing
((1101))
(12)
thoroughly after any action.
Q So gloves were used and then washing. What type of gloves were used, do you recall?
(13)
(14)
(15)
A 0
AI hnyavoethneor you made
siadfeeaty. measures that were your recommendations?
in
use
before
(16)
((1187))
(19)
((2201))
A 0
IWdeoren'tthreeremaenmybtyepr.e o f and the manufacture o
barriers in the f TCP? When
p la n I say
t 199 barrier,
I
mtheaat tnowparostietcdtothnee wbeohrkinedrsw, oarilswoasr aitnaynthoinpgenlike
manufacturing process?
(22) MR. WAGNER: Iobject to the form,
(23)_________ vague, over broad.____________________
BSA LAWRENCE SILVERSTEIN - Kimberly Moyer vs. Dow Chemical - March 9-10,1993
Page 37
(1) A It w a s basically a clo sed p ro ce ss within v e s s e ls
(2)
P)
W
(5)
0
Aanndd wpiepreintghearnedjosiuntcshi.n the pipes, or were there places in which the chemical came out, or was it
a ll enclosed in piping and vessels?
(6) MR. WAGNER: l object to the form of the
(7) question, compound, vague.
(8) A I'm not really sure w hat the question is, here.
(1P0))
It w as basically c lo sed . There w ere exits for product and w aste stream s, and there w ere Joints
((1112))
(13) (14)
(15)
Q Pwthrieitohwrintoortkyheoerusprwipperienasrgca,rnyibyeiantyhgp.aedodf iptioronteacl mtiveeacsulortehsin, gdid other than the gloves, other than the normal clothing they m ight wear?
(16) (17) (18) (19)
(20)
A 0
IWhhoant etysptleyodforenc'tormemmeemndbaetrio. ns did as the worker safety and improving
you make as fa the protection
r
.for the workers from the potential for exposure to
TCDD?
21) MR. WAGNER: I object, over broad, time (22) frame.
(23) A At th e tim e I w as safe ty officer, I required full______
Page 38
(1) com pany-supplied clothing from the skin out,
(2) required show er tim e, at least tw ice a day for
P) lunch break and at the end of the shift, and then
(4) respiratory protection at any tim e there w as a
(5)
(6)
(7)
Q
Wrishkatotfypaeirboof rrensepmiraattoerryiaplr.otection, recall?
do
you
(8) A Two b a sic forms, depending on the nature of the
(9 ) action the gu y w as going to take, the cartridge
(10) type or air purifying, and in som e Instances, most
(11) of th e time it w as air supplied self-contained
(12)
(13) (14)
0
Wbrheaattthyipnegoafpcpoamraptaunsy-osruapipr-lileidnecrloetshpinirgatdoidr.you prescribe?
(15) (16) (17)
A 0
UThnedceorwv eeraarl,lss, hwoeeres ,thc oe yv emr aa dlles ,frgolmo v ae sn.y m aterial, if you recall?
p a rtic u la r
(18) (19)
AQ NCoottthoinn,gifoyuotuokfntohwe?ordinary, no.
(20) (21)
AQIAdnoynb'ot oktnso?w.
(22) A Y e s, a s a matter o f fact, I left out that w e used
(23) a lot o f disposal coveralls o ver the work clothes.
Page 39
(1) By disp osal, I mean u se o n ce and thRowe aw ay, and
(P2))
(4)
0
Dthidatyionuclpuudtethdebsoaofetstythreactocmomveerneddatthioenisr form o f writing?
win otorkthseh o e s .
(5)
(6)
(7)
(8)
A Q
IWbheoliwevaes sino.charge o f follow up to make sure that
there that y
owuaos
c o m p lia utlined?
nce
w
ith
the
safety
req
uirem
ents
(9)
(10) (11)
A O
iAwnadsw. ould you do the plant, prim arily
t?h
is
b
y
p
h
ys
ic
a
l
observatio
n
a
t
(12) MR. WAGNER: I object to the form of the
(13) question.
(14) (15)
A Q
IWbearseicthaellwy
olirvkeedrsapt
rtohveidpeldanwt,ithy
edso. ub
le
lo
c
ke
rs?
(16) (17)
A 0
TWohmat ywraesctohlelepcutiropno,syeeosf.
that?
(18) MR. WAGNER: Did you say double lockers?
(19) MR. SCHULER: Right.
(20) A The purp ose w as to sep arate contaminated work
(21) (22)
0 Wcleortehtehsefrreoamnystsrpeeect icallointshterus.ctions fo r washing
(23) the contam inated clothing or getting rid o f it,________
(1) one way or the other? Page 40
(2)
P)
AQ YWehsa.t were the instructions fo r that?
(4) A To the best of my recollection, w e Instructed
(5) Dow's own laundry, which did th e w ork clo th es, In
(6) special handling to avoid con tact with the
(?) contaminated clothing they w ere laundering. A s
(8) far a s the w aste disposal, there w as an operating
(9) w aste disposal department, and I do not reco llect
(10) - 1 do not recall any sp ecific interaction with
(11) (12) (13)
0 t/dhtaehymin, k,Istyotohubaetscahoidorrnyeeocsutt?rwecitohmymoue.nded two showers a
(14) (is)
AQ DWuhraint pgeariopderoiof dtimoef ?time, y es, I did.
(16)
(17)
(18)
(19)
A Q
AWnhdehnoIwwwaos ufuldllt-htiamt we osarkf,eittywoofufildcebreinatshheopwlearnot.n the way in and a shower on the way out, o r how
would it work?
(20) A No. A show er before the lunch break and then a
(21) (22)
(23)
0
Wsheorewtehrearet tahney esnpdecoiaf ltihnestsruhcifttio. ns fo r the showering, other than the norm al shower with
soap
(1) and water?
Page 41
(2)
(3) (4)
(5)
A 0
NWoatstthhaetsIhroewcaelrl.and wash tim e, memenptloioyneeeds?this earlier, was that
pI
athidinktimyoeufo
r
the
(6) (7) (8) (9)
A Q
YNeosw., while you were health particular plant, were there
doaffiilcyesraafet
ttyhe
m eeting s?
(10)
(11) (12)
A0fIoHdrootwhenloopntagrretdicmiduelaymor pbuelaarncstt,upa1ecl9lyi9fs?icearvlley.as health officer
(13) A It w as a matter of months, six or sev en m onths, I
(u) would gu ess.
(is)
(16)
07)
0foTrhtehneapftaerrtiycouulasrtpolpapnet,dwshearvt winagsaysohueranlethxtofficer responsibility, if you recall?
(is) (19) (20) (21)
AQ NThoe, tIrdicohnlo'tr,otpohbeenohlothnaetswt awsitbheyinogu.manufactured,
Swiatvsetxh,
at if
used in the you know?
m
anufacture
o
f
2
,4,5
-T
o
r
(22)
(23)
A Q
YDeids
.you
ever
serve
as
he
a
lth
o
ffic
e
r
fo
r
any
o
f______
(1) the plants where the finaPlapgreod42uct was made?
(2) MR. WAGNER: Silvex or 2.4.5-T? 0 ) MR. SCHULER: Yes.
(4) (5) (6) (7) (8) (9)
A 0
ANroe. you fa to know o
rmdileiasrcerinboeufgohr
mweithpthhyescichaellmy hicoawl pitrowcaesss
dtaokneen?inInsoomtheevr awtotordas,nwotahserthbeutilrdicinhglo
rophenol where the
2,4,5-T o r Silvex was made?
(10) MR. WAGNER: Iobject to the form of the
(11) question. (12) A My recollection is it w a s transported in rail ca r
(13) (u)
0 Ttaonakneor.ther building?
(is) (16)
((1187))
(19)
A 0
YDeids.you ever witness the final m process where the trichlorophe
anufacturing nol and other
elements were combined to make the 2,4,5-T o r the
Silvex?
(20) MR. WAGNER: Iobject to the form of the
(21) question.
(22) A I don't remember, to b e h o n est with you. I'v e got
(23) to quit sayin g t h a t________________________
XMAX
317) 631-0940
2129
lb
BSA
LAWRENCE SILVERSTEIN - Kimberly Moyer vs. Dow Chemical - March 9-10,1993
XMAX
(1) (2)
(3)
(4)
(5)
Q
Now, at the time that yoPuafigrset4g3ot involved this process, and the trichlorophenolproc
w ith ess and
the chloracne outbreak in building 199 in 1964, do
yoof uTCreDcDalilnwthhaetcthaeusmticeainssuorelumbelentowil?as for the amount
(6) A At the time I Initially becam e involved, w e didn't
(7)
(8)
(100))
(11)
0 DiknnoitoiyawollyuwwrhehacetanwllyianosiutiIafnilrltsyht-egnocotawiun,vsIot'milcveitdnalsk-oinwlughbaalbet tohoueilt.
mtricehalsourorepmheenntowl,
athsefomr
the anu
TCDD and the factured trichlo
ro
ph
e
nol?
(12) MR. WAGNER: This is not the caustic
(13) waste oils, but the TCP, itself? (14) MR. SCHULER: Right.
(15) (16) (17) (18)
A 0
ANtos.ome point were there measuring the concentra
m ethod tions o f
s developed TCDD In the
fo
r
trichlorophenol, for example?
(19)
(20)
(21)
A 0
YWehse.n did that recollection?
occur,
to
the
best
o
f
your
(22)
(23)
A Q
AEnadrlyw1h9o6d5e. veloped
those
m
ethods,
i
f
you
re
c
a ll? ______
Page 44
(1) (2)
(3)
A Q
TDthhoaetypoDuroowrjeemcatn?eamlybteicraslpleacbioficraatlolyrwy hino
Mwaidsliannvdo.lved
In
W
(5)
A 0
IHsahreolsdtiGll UarIo, uGn-ld-,Lt-oL,ywouarsktnhoewnleadmgee?I recall.
(6)
(7)
A To my knowledge, yes.
Q In M idland o r elsewhere?
(8)
(1(09))
( 11)
(12)
A 0
ILsahset
Irektnireewd
firtowmatsh
eMcidolmanpda.ny,
do
you
know
?
QA IAtnhdinwkassot.he m ethod that he developed the vapor chromatography or gas chromatography method?
(13) (14) (15) (16) (17) (18)
A 0
YAensd. do you recall, back in 1964 or 1965, anything afinbisohuet tdhetrimchelaosrouprehmenenotlsatshfaatrwaesrethetakaemnooufntthseof
cTCheDmDicthaal?t may have been in that particular
(19)
(20) (21)
(22)
(23)
A 0
YYYeeossu,.'irf Iey' moaustkrreiynimngegHmt oIbrgeeremttheaemhmbaeenardsaluenreyomnaemt hnotasut tnqhtuastefwsoteuiornend.? taken, through this gas chromatographic method, of
any amounts o f TCDD that were in the finished________
(1) (2)
trich tim e
lo ?
rop
he
n
ol
th
a
t
w
a
sPpa
groed4u5c
e
d
b
ack
a
t
th
a
t
(3) (4) (5)
AQ YAends,wgheenneryaolulysuayndunetdeectteacbtaleb,ley,ecaahn. you describe that a little more fully form e?
(6) A Below th e limit of detection of the analytical
(7)
(8)
(9)
0
Amnedthwohdatawt tahsatthetimseen. sitivity, If you know, o f the analytical method developed back at that tim e?
(10) A Early on, it w a s a s high a s ten parts per million
(11) (12)
(13)
O
Aonf dTCthDeDn .did that lesser amount?
im p rove,
la
te
r
on,
to
some
(14) (15) (16) (17)
AQ AOnvderifayopuerrieocdalol,fotivmerew, yheast.period o f tim e did the sensitivity improve and to what level did the sensitivity improve?
(18) MR. WAGNER: If you have a recollection.
(19) I caution you not to gu ess because there are
(20) people that would have that knowledge, but if you (21) know, please give him the information. (22) A Okay. O ver som e period of time after the
(23) developm ent of th e m ethod, it improved In sta g es
Page 46
(1) to one per million, one-tenth, .0 1 ,1think, part
)(2)
0 (4) (5) (s) (7)
0 Dpoeryomuilklinoonw. whether the final commercial grade
product o f 2,4,5-T or Sllvex was ever tested through the gas chromatographic method to determine the amount o f TCDD that may have carried over in the process to the final product?
)(8) MR. WAGNER: I object as to the breadth.
0 A That's a mouthful. You're asking if I know
(10) w hether any of the products w ere tested by the
(11)
((1123))
Q Aanndalcyatincaylomu teetlhl mode?, aYnedsy.ou can make it specific to point in time, If you would like, what the
(14) results were fo r the testing o f the final product?
(15) MR. WAGNER: Same objection a s to
(16) breadth and vagueness.
(17) (is)
A0 GAtewnehraatlplyoinnot Inn-tdimetee,citfaybolue riencparllo?ducts.
(19)
(20) <2i)
A
Q
AMnidd swixhtaitews.as the sen detection equipment?
s
itiv
ity
le
v
e
l
o
f
the
((2232)) AQ ICtaimn yporuovteedll moveewr htiamt teh.e level was, if you know,_________
Page 47
(1) at a specific point in tim e?
(((342)))
A
0
Iytewaahs.
Had D
one part
ow Chem
per million at so m e point in time,
ical determined that there was some
5) (6)
ascacfeepletavbelleotfoTtChDe Dcoinmiptsanfiny?al product that was
(?) MR. WAGNER: I object to the form,
(8) vague, undefined terms, and over broad as to time.
(9)
(1o) (11) (12)
(13)
QA TWhaesathnesrwe eerveisr annoy. manufacture o f 2,4,5-T or Sllvex that you're aware of, while you were with the company, that was completely devoid o f the TCDD contaminant, in other words, a clean product?
(u) MR. WAGNER: I object to the form of the
(is) question and you cannot detect - my problem with
(16) the form of that is it's impossible to detect the
(17) absence of anything in a chemical, so it's
(is) unanswerable in its present form.
(19) A G ive it to me one more time.
(21) REPORTER.)(20)
(Th e r e q u e s t e d m a t e r i a l w a s r e a d b y t h e
(23)(22) A I h ave no w ay of knowing. The answ er is I don't know.______________________________________
(1)
(2)
(3) (4)
0
DtriochyloourokpnhoewnwolhtoetherdthePetearergmewin4a8es wtehsetinthgeroIfttwheould
carry dioxin, the TCDD dioxin into the final
<-
2,4,5-T product?
(5) MR. WAGNER: Iobject to the form of the
(6) question, vague.
(7) (8)
QA YWehsa. t was the result o f that, what was determined?
(9) A Most of the 2,4,5-T contained undetectable am ounts
((1101)) 0 Wofotuhlde TthCeDsDam. e be true fo r Silvex?
((1123)) 0A IWdhoant'atbreomute2m,4b-De,r.was that ever tested, to your
(u)
(15)
kdneotewcletadbglee,atmo oduentetsrmoifnTeCwDhDe?ther that contained any
((1176))
(18)
0A IDboeyloieuvkeniot wwawsh. at the result o f that was at a
specific point In tim e?
(19)
((220D)
A
0
INnoa.ddition to also develop
ltahbe
smaafentuyfpacrotucreindgu
prersocfoershs,a
dn
didlinygo
u
((2223))
the dioxin TCDD in the laboratory?
A Y es._______________________________________
\M> 17\^1-noAn
BSA LAWRENCE SILVERSTEIN - Kimberly Moyer vs. Dow Chemical - March 9-10,1993
(1) (2)
Q What typo o fprocedurePs adgide y4o9u Institute at what point In time for that?
(3) A My recollection Is the late sixties I w rote lab
(4) safe ty procedures that basically instructed
(5) em p lo yees to avoid all contact and to w ash
m(6) thoroughly after any handling, Just In c a s e there
(8)
(9)
(10)
O Wwweaearsercintohgenorteaf cactlnoythointhgelrikperogcloevdeusreosrwbiothotrsegoar rd to the coveralls fo r the lab people?
(11) (12)
AQ YWehsa.t specifically do you recall about that?
(13)
(14)
A Q
AGnloyvtheinsg.
else?
(15) (16)
(17)
AQ NWoetrheitnhge elalsbepsepoepcliefiscuapllpyo. sed to wear respirators, also, or wasn't that in the recommendation?
(18) A I don't believe It w as recom m ended.
(19) MR. WAGNER: Just for your timing
(20) purposes, Larry has expressed a desire to g o to
(21) Max and Irma's, which is across the street, so if (22) you could shoot for a break, about live to 12:00,
(23) _______ w e'll beat the lunch cRowed._____________ ___
Page 50
(1) (2)
(3)
Q HthaavneTyCoDu Dhathdaatncyaeuxspederciehnlcoerawcniteh adtioDxoinws Cothheemr ical Company?
(4) MR. WAGNER: I object, no predicate.
(5)
(6)
(7)
(8)
A0 NDTCootDytDoou, mwknhyoickwhnwocwahuelesthdeegdrect.hhelorerawcneereinditohxeins, other than
trichlorophenol back in 1964?
(9) MR. WAGNER: I object, no predicate.
(10) (11)
(12)
(13)
(U)
A0 NWohtattoabmoyutkontohwerlecdogmep. ounds, such as furans, that
caused chloracne, in the trichlorophenol back in 1964? Are you fam iliar with whether o r not there were any o f those in the trichlorophenol?
(15) MR. WAGNER: Same objection.
(16)
(17)
(18)
(19)
(20)
A0 NDootytooumknyokwn,oinwtlheedgfien.ished product o f 2,4,5-T or
Siivex, whether those finished products, in your experience, were tested for either furans or other dioxins that were chloracnegenic in the sixties?
(21) MR. WAGNER: Same objection.
(22)
(23)
A Q
NWohtattoabmoyu
tkinnothwelesdegvee.nties?______________________
Page 51
(1) (2)
A Q
IDdooyno'tu
kknnooww.who
ha
s
that
info
rm
atio
n
o
r
kno
w
ledg
e?
(3)
(4)
P)
(6)
A Q
NWTCoa,DsIDodnmoeniog'thf,ttthobeebcaeonphcrooenbrnelessmtbwafiocthkr ciynuostuhto.emseixrtsieusstihnagt
the
end product Siivex or 2,4,5-T?
(7) MR. WAGNER: I object to the form of the
(8) question, over broad as to time, vague as to whom
(9) he's making reference.
(10)
(11) (12)
A0
Yes.
What
s
p
e
c
ific
a
lly
w
as
the
concern
regard
ing
the
customers using Siivex or 2,4,5-T end products?
(13) MR. WAGNER: Same objection. (14) A The con cern, a s I recall it, w a s that custom ers
(15) would not b e a s careful In protecting em ployees a s
(16) w a s Dow Chem ical, le ss controlled conditions for
(17)
(18)
O Athfteeretmhepl1o9y6e4ecsh, lionraoctnheerowutobrrdesa.k in the
(19)
(20)
((2212))
btoritechlhieelrvoceroh, pethhmaeticnwaoallmsplcaaannlutl,efatdhcebturyereDwrosawrseaCgahmredemeinticginagTl,CaInDdDs, ome correct?
(23) ________ MR. WAGNER: I object to the form of the______
Page 52
d) question, and no predicate,
p) P) (4) (5) (6)
A 0
YWeesr.e any che m ic a l
ocof Dmopwan'siecsutshtoamt Deorsw,
isnotlhdethseesnesep
roofdthuects
to, Siivex or 2,4,5-T, notified o f this problem
back in 1964?
(7) MR. WAGNER: I object to the form of the
(8) question.
0 ) A The form of your question is - 1think the answer
(10) (11) (12)
(is) (14)
0
AisreIydoouna'twkanroewo.f any testin Company did o f any o f the
gentdh
aptrDodouwcCtsh, e2m,4
,ic5a-Tl
o
r
Siivex, to determine whether those products were
toxic to humans?
(15) MR. WAGNER: Contains undefined terms
(16) and vague.
(17)
(18)
(19)
A 0
IYdouonw'terkennoowt.Involved correct?
in
anything
like
that,
(20) (21) (22)
(23)
AQ NYoou, mI deonnti'otnbeedlioenvee psoa.rt p er m illion contam ination level for TCDD. Was that an established level by Dow Chemical Company for Siivex and 2,4,5-T in the
(1) 1960s?
Page 53
(2) MR. WAGNER: I object to the form of the
(3) question. It mischaracterizes the prior testimony
(4) which was In reference to a detection limit
(5) (6) (7) (8)
A 0
ANsotfatroams tyhkenoonwe lpeadrgt or 2,4,5-T, was this a
ep iesr tmheillioannsTwCeDr.D detection lim it fo r
tihneS
iivex
equipment back then in the 1960s?
(9) (10)
(11) (12)
A 0
AWctoanssotatmhmeerinetaiamtinoeyn,tleyeesvtaeinhlgo.
fdoonneeptoa
rdt
epteerrmminilleio
nw
hoef th e
r
a
TCDD in Siivex or 2,4,5-T was safe to human
(13) beings?
(14) MR. WAGNER: I object to the form of the
(15) question, undefined terms, not enough there to
(16) meaningfully answer.
(17)
(18)
(19)
A 0
IDdooyonuotkknnoowww. in end product
hat the 2,4,5-T
doer tSeicivteioxninlim1i9t 7w5a?s
fo
r
TCDD
(20) A I do not know.
pi) 0 Do you know who would know that?
(22)
(23)
A Q
DNoo.you
know
what
division
in
the
company
was______
(1) responsible fo r determiPnianggeth54at?
(2)
(3) (4)
A 0
PDwroaosybobauabcklyknoainwgr1iw9chu7o5lt?uthrealhpearoddoufcatgs rdicivuilstuiranl.products
(5) (6) (7)
A 0
DNiod, yloduonw'ot.rk w ith anyone in agricultural products, in the
1th9a7t4d-7iv5istiiomne,
p e rio d ?
(8) (9)
(1o) (11) (12)
A 0
NWootutldhatht el tested the
prercoadlul.ct quality control final product, be in that
people, w division,
ho
had
agricultural products division, is that what
you're saying to me?
(13)
tu) (15)
A Q
IMWbiadesllaitehnvedeainsgor1.ic9u7l4tu-7ra5,l
pthreo
dhuecatdsqduivairsteiorns
loofciat?te
d
in
(16)
(17)
(18)
A 0
IAbndelwieev'eressoi.tting here that have DowEianco
otondtahye
ifnrosnotmoef
itb.
u
ild
inDgosyo
u
(19)
(20)
know the relationship betweenDowElanco and Dow Chemical Company?
(21) (22)
(23)
A 0
DNdoioviysisoiouankgonofooDwdo, waantCssowhmeemre
tpootihnat itn. ical that
wtimase,hewraesinth_e_r_e_a______
XMAX
(317) 63145940
2130
V -5.9L 7
bsa___________ LAWRENCE SILVERSTE1N - Kimberly Moyer vs. Dow Chemical - March 9-10,1993__________ xmax
(1) (2)
kInndoiwan?apolis that was rePnaagmee5d5DowElanco, If you
0 ) A I really don't know.
(4) MR. WAGNER: He reallydoesn't know.
5) Off the record.
(6) ( D i s c u s s i o n h e l d o f f t h e r e c o r d .)
(7) MR. SCHULER: Let's go back on the
(8) (9) (io)
(11) (12)
Q So I'm crleecaorradb. out this, the testing o f the final product Sllvex and 2,4,5-T for any contaminants back In 1974 and 75, let's say, would have been done someplace In Midland, Michigan, If you know?
(13) A I just have to g u e ss, y es. I w asn 't Involved.
(u) MR. WAGNER: Your role is not to guess.
(is) THE DEPONENT: Thank you, sir. I got
(16)
(17)
(18)
(19)
0
eWveans
thetrier,edagoaf ihne, agroininggmbyasceklftosa7y4Iadnodn earlier, if you know, did Dow have a
'7t
5kn, obwu.t
government affairs division?
(20) MR. WAGNER: Over broad a s to time.
(21) (22)
(23)
A 0
IDdidonyo'turkenmoewmabfeerl.low by the name o f Andrew A n d e rs o n ?______________________________
Page 56
d)
(2)
A 0
DI dido
nyo'turkenmoewmabneAr..P
.
B
eutel,
B
-E-U
-T-E-L?
(3) (4)
A 0
IDboeyloieuvkensoow.
w
hat
M
r.
B
e
u
tel's
ro
le
?
(5) A My recollection of A.P. Beutel is general m anager
(6) of the T ex a s division when I started work at Dow
(7) (8)
0) (10)
0
YaonudmfoernmtioanneydytheearTseaxfatserdwivaisrido.n earlier. What wofams athneufTaecxtausrindgiv?ision responsible for, what kind
(11) MR. WAGNER: Iobject as to breadth,
(12) time frame.
(13) (14)
QA IBnacsluicdiInngdaugstrriciaulltcuhraeml cihceamlsi.cals?
(15)
(16) (17) (18)
A 0
INAf noI dturtneodwemArsyntadknnedrosywoonlueidscg,oecrr.oercretlyc,t,yyoouuddoonno'ttrekncoogwnwizheo
the name?
(19) A The nam e is va g u ely familiar, but I have no
(20) (21) (22)
(23)
0
ArencdoMller.cBtieounteol,f ythoue sgaenidtlyeomu arenmoermwbheartehdefodrihd.is pbeoiinngt inthteimmea?n_a_g_e_r_o_f_th_e_T_e_x_a_s_d_iv_is_i_o_n_a_t_s_om__e___
Page 57
(1) (2)
A O
YBeust
.th
a
t's
ab
o
u
t
a
ll
yo
u
kn
o
w
ab
o
u
t
h
im
?
(3) (4) (5)
A 0
TDhidaty'osuakllnIorwema eDmr. bHeoreargbeoru, tHh-iOm-E, y-Re-aGh-.E-R? probably m angling that name, also.
I'm
(6) (7) (8)
QA IDroemyoeumkbnoerwtwhehantahmiser,oyleesw. as at Dow Chemical, to your knowledge?
0 ) A My only recollection of him is a s a chem ist
(10) (11) (12)
0
Dreidsehaerchhavseciaennyttihsint.g todo 2,4-D, to your knowledge?
w
ith
2,4,5-T,
Silvex
or
(13) (H) d5)
A 0
WI daosnth'terreema group?
egmrobuepr
chiamllehdatvhienpg
raondyu
cint svtoelwveamrdesnhtip.
(16) MR. WAGNER: I object as to the breadth,
(17) time frame.
(is) A Not in the sixties.
(19) 0 When did that come about, if you know?
(20) (21) (22)
AQ DIahnoyayvroeeucnroeollceidcatellioasn.u?ch a group, or you ju st don't have
(23) A I h ave no recollection._____________________
(1) Q Do you know a Dr. HlnmPaang,eH5-i8-N-M-A-N?
(2) A Yeah.
(3) 0 Who is Dr. Hinman?
(4) A For some period of time he was director of the
(5) (6)
0 Dboioycohuemkniocawl arpesperoaxrcimhaltaebly. what p oint in tim e?
(7) (8)
A 0
NS iox t.ieIst
wo rosuelvdebnetiegsu, ecsasninyogu.
be
th
a
t
s
p
e
c
ific
?
(9) (10) (11)
AQ LDaoteyosuixktnieosw. whether he did any research with regard to 2,4-D, 2,4,5-T or Silvex?
(12)
(13)
(14)
QA IWhaasvtehenroe kenveorwale2d,4g-eDotaf sthkafotracteaslle.t up within Dow Chemical Company, to your knowledge?
(15) (16) (17)
A 0
DNoid. you know O -T -l-S ?
a
fe
llo
w
b
y
the
nature
o
f
Chet
O
tis,
(18) (19)
A Q
IArnedmwehmabt weraCs hheistpOotsiisti,oyneas.t
the
com
pany?
(20)
pi)
(22)
(23)
0A DpI rdo. oiRnnot'iwtnketnhmoewefinfthtiieoissnoethdffeiircneiahwlisapsdoesaiptvioiossniittifoirnonmtthheaa tcaotmsopmaney. fellow from a German chemical company, by the name
(1) (2)
o f Oettel, O-E-T-T-E-L DPoagyeou59recall meeting with this gentleman?
(3) MR. WAGNER: I object to the form of the
(4) question.
(5) (6)
A O
NDoo.you
know
a
J.D
.
Doedens,
D
-O
-E
-D
-E-N
-S?
(7) (8)
AQ IDroemyoeumkbneorwthwehantahmiser.ole with the company?
(9) (10) dD
d(132))
(14)
A 0
WI rheemneymoubewrenreotinhvinoglvemdowreithabthoeuttrihcihmlo.ropheno process back in 1964 and sought to determine
l
teaxkpinogsuoref thleevewlsip, ewtaesstthseanpdrotcheesasirosfadmoipnlgesth, aist the
that how you did it?
(15) MR. WAGNER: I object to the form of the
(16) question.
(17)
(is) ;i 9)
A 0
YWeesr.e there any other ways exposure levels other than
tthhaatt?you
d
ete
rm
ined
(20) (21)
0A OPhbysseircvaal otibosne.rvation at the plant, Itself?
(22) (23)
A Q
YDeosy. o
u
re
c
a
ll
any
sp
e
cific
re
com
m
endations
w
ith
(1) (2)
(3)
(4)
regard to correcting opPearagteing60procedures or macnhadannu'g6fa5inc?gtuorepeorfattriincghlporroocpehdeunroelsisascofanrcaesrntehde in '64
(5) MR. WAGNER: I object to the form of the
(6) question, as far as operating procedures is
(7) undefined and vague.
(8) (9) (1o)
AQIWchaond'tidreycoaullparnimyasrpileycdiefiaclsw. ith in the '64-65 tim e period in the toxicology department?
(11) MR. WAGNER: I object, no predicate.
(12) A V.K. Rowe, the director, Dr. Kenneth Olson,
(13) (u) (15)
0
Wtohxaictoalbooguist tth. e m edical department, who deal with prim arily there?
did
you
(16)
(17)
(is)
AQ ADnr.dBwehnajat mabinouHt oinldperro.duction, who did you deal with prim arily there?
(19) (20) (21)
A 0
TStrhpicaehtcl'osifrioctopaolhlyebwnrooitlha, dwreahgoqardudeidstotyiotohuned,pIe'rmaoldwsuoictrhtri?oyn.
o
f
P2) A Ray Holmes, the superintendent, and Al Lueck, the
(23) assistant superintendent_________________
(317) 631-0940
LAWRENCE SILVERSTEIN - Kimberly Moyer vs. Dow Chemical - March 9-10,1993_________ xmax
(1) Q How do you spell his lasPtangaem6e1?
(2) (3) (4) (5)
AQ
DL-iUd -yEo-uC-dKe,aIl bweitlhieavney.one specifically involved in the production of 2,4,5-T,
tthhea
tewndas
product, orSllvex?
(6)
(7) (8) (9)
AQ NDootytohuakt nIorwecwalhl.o would have been involved In working on the process to reduce the content of dioxins In the final product after 1964?
(10) MR. WAGNER: 1object, no predicate.
(11) (12) (13) (14)
A O
NWCoha,es1mthrieecaraelllCya odsmponep'cat.inficy your knowledge?
tfhilea
t
oInnfodrimoxaintioant
Dow
was
fed
in
to
,
to
(15) MR. WAGNER: 1object as to the breadth.
(16) (17) (18) (19)
A O
NWoetretothmerye ksnpoewcilfeicd,gtoe.your knowledge, toxico f2il,e4s,5o-Tn?the different chemicals, 2,4-D, Silvex,
lo
gy
(20) (21)
A 0
YAensd.
where
were
those
kept,
If
you
know?
(22) A In the building w here toxicology w as located,
(23) biochem ical research department.
(1) (2) (3)
0
Prior to today, has yourPdaegpeo6si2tion been taken in any other cases involving allegations that either
2,4-D or Silvex or 2,4,5-T caused physical injury?
(4)
(5)
(6)
A 0
ANnodt any
twohmeny1ksnaoywalneydogteh.er cases, other civil cases, other than
tIh'mat
toanlkein?g
about
(7) (8) (9)
A O
NWo foaatstbyooemutterydr kteenprmoows, iAtlieogdnegnteat,kOIesrnatnahgteeaalglnirnsowutheper,o. ffocralasecsk?
(10) MR. WAGNER: 1object to the form of the
(11) question.
(12) (13)
A Yes.
0 Once or more than once?
(14) (15) (16) (17)
A 0
D1bladeoteoeynnso'ettuavrkreeeenmcntia?eelsml ?Wabtaewsrh.itabt pacokinitnInthteimeearitlymeaigyhhtaievseor
(18) (19) (20)
AQ AEnadrlydoeiygohutireesc. all who m ay have taken your deposition back then?
(21) (22)
A O
NWoa,s1itdtoakneont.in
M id la n d
o
r
som
e
other
place?
(23) A It w a s taken In Long Island, som ew here.
(1) (2)
(3)
(>
0 ObetheenrttahkaennthbaetfodreepinoscitoioPnnate,gxheta6ws3iythouanr dy ecplaoimsiteiodn aSlillevegxatpiorondsuocftds?efects in the 2,4-D o r 2,4,5-T or
(5) MR. WAGNER: 1object to the form of the
(6) question.
(7) (8)
AQ D1jiudsytoduoknnootwraemn Fe.mD.bAerx.e, A-X-E?
(9) (10)
A 0
Yes. Was
he
an
in
d
u
stria
l
hygienist?
(11) (12) (13) (14)
A 0
Y/yodeuso.nn'at mreemdeemabrleierrh, ibmu w ith the company?
tbdeoinygonuarmeceadllinw
the group that hen he was
(15) A He's been with th e com pany for a lot of years,
(16) m ostly in the w estern division. He spent som e
(17) tim e In th e industrial hygiene group in Midland.
(1.8) (19) (20)
0
TWihmeinnygoIus svaaygwueesitnermn ydmiviseimono,rwy.hat are talking about?
you
(21) A T here is a production division at Pittsburg,
(22) California, and research lab, also, and Rick w as
(23) th e industrial hygienist out there most of the
Page 64
(1) (2)
0 Ptiimttsebuhregw, CasalwifoitrhniaD,oiswthCahtermighicta?l.
(3)
(*> (5)
A 0
YW2,e4as-s,Dtwhoiatrth2d,ni4vo,i5sHi-oT.noirnSvlolvlveexd,
tIon
ymoaunr ukfnaocwtuleridn gg
ee?ith
e
r
(6) (7) (8)
A 0
DNoidt ytooumhyavkenaonwyleIndpguet. 2,4,5-T orSllvex?
Into
labeling
o
f
2,4-D
o
r
(9) (10)
A Q
NDoo.you
kn
o
w
who
was
resp
onsib
le
fo
r
th
at?
(11) (12)
(13) (14)
(15) (16) (17)
A 0
NWcoohn.etnamyoinuawtioonulodfstruicbhmloitroyopuhrerneoploorrtsthreegcaarudsintigc
insoluble o il Involved In the trichlorophenol
process as a by-product, would your reports
generally be submitted to the toxicology section,
Dr. Rowe and those folks?
(18) MR. WAGNER: Iobject as to the breadth.
(19) (20)
(21) (22)
A Q
YWeosu. ld the reports be governmental affairs
submitted to any section o r anythin
type o f g like tha
t
at Dow Chemical?
(23) MR. WAGNER: Same objection.
Page 65
(1) (2)
A 0
D1dooyno'tu rkenmowemMbaerrg.uerite
Long,
L-E-N-G?
(3) A Y e s.
(4) (5)
Q M arguerMiteR.. WWAhoGNisEMRa: rgDuideryitoeuLsoanyg?Marguerite?
(6) A S h e w a s a scientist. My recollection of her w a s
(7) a s a mem ber of the toxicology lab for so m e period
(8) of time. V ague recollection that s h e sp en t s o m e
(9) time In agricultural research departm ent at Dow in
(10) (11) (12)
0
DMoidyloaundk.now what toxicology lab o r a
h g
ericr ruoltluerawlares
with eith search?
e
r
the
(13) (14) (15) (16)
A Q
1DrideaDlloywd,oifnyooturkenmowem, hbaevre. any specific departm or division o r group o fpeople that were Involved with the registration o f agricultural pesticides?
ent
(17) MR. WAGNER: 1object a s to the breadth,
(18) time period.
(19) (20) (21)
A 0
D1widaysoauweavreer yourself?
tdheaatltwhiethyadnidy,oyfethaohs. e
folks
(22) (23)
A 0
DNootytohuakt n1orwemwehmobtheer.head
o
f
that
departm
ent
was
o
r
(1) anybody in that departmPeangte? 66
(2) MR. WAGNER: Sam e objection.
(3) W (5)
A O
NDoo.you to do w
kithnothwawt?hether
M
arg
uerite
Leng
h
a
s
a
n
ything
(6) A S h e may have, but 1don't know for sure.
(7) MR. SCHULER: You want to take a break?
(8) It's five to 12:00.
(9) MR. WAGNER: Sure.
(10)
( R e c e s s .)
(11) (12) (13) (14) (15)
0
Mr. SilveMrsRte. iSnC, HleUt mLEeRa:skByaocukionnitiathllye,raescowrde. begin this afternoon, did you review anything
before your deposition here today o f a documentary
nature?
(16) MR. WAGNER: That's a y e s or a no.
(17) (18)
A 0
YWehsa. t
d
id
you
review
,
sir?
(19) MR. WAGNER: To the extent you reviewed
(20) things with me, I instruct the witness not to
(21) answer. If you reviewed things on your own, feel
(22) free to tell him.
(23) MR. SCHULER: If you reviewed documents
(317) fisi-n<wn
2 1 3 1 D-3-3.
bsa___________ LAWRENCE SILVERSTEIN - Kimberly Moyer vs. Dow Chemical - March 9-10,1993__________ xmax
Page 67
(D of the company, I think it's included. Just (2) because you handed them to him -
(3) MR. WAGNER: His discussions or
(4) preparations with me before this deposition, the
(5) substance of that is work product.
(6) MR. SCHULER: I'm not asking for
(7) discussions. I'm asking if he reviewed documents.
(8) (9)
0 W hat haMveRy.oWu AreGvNieEwRe:d,Its'sir?work product
(10) MR. WAGNER: I'll instruct you not to
(11) answer.
(12) MR. SCHULER: All right we'll be back
(13) (H)
Q Have yoounrethvaietwoende,aIn'lyl gdueaproasnittieoenys,ousirt?hat
(is)
(16)
A 0
HNaov. e
yo
u
review
ed
any
Dow
C
hem
ical
C
ompany
(17) documents?
(18)
(19)
(20)
A Q
YWehsa.t have Company
you reviewed d ocum ents?
that
are
Dow
C
hem
ical
(21) (22) (23)
0
/w
so
ant toMbRe. when we
cWleAaGr NfoErRth:e come back
Spaumrpeoisnestoruf tchteionre.cord, at your expense, that I'm
not
(1) (2)
(3)
(4)
asking if you have reviewPeadgean6y8thing prepared by any attorneys o f any shape or form whatsoever. /'m asking you if you reviewed any Dow Chemical Company documents, not prepared by any lawyers?
(5) MR. WAGNER: Same instruction.
(6)
(7)
0 Hyoauver dyeopuoresivtiioenwheedraentyotdhainyg, seirls?e in preparation for
((98))
MR. WAGNER: To the extent that you reviewed things with me, I instruct the witness
(10) not to answer. If you did things apart from me -
(11) (12)
(13) (14)
A 0
SNoo,yoI huar tveesnti'mt.ony here to reviewed any documents
day is that w
that you haven't ere not handed to
you
by a lawyer, I guess, is that fair enough?
(15) MR. WAGNER: You can answer that
(16)
d7)
(is)
(19)
QA YLeetsm. e ask you if you have spoken with anybody other than the attorneys, regarding preparation fo r your deposition here today?
(20) A No.
(2 D (22)
O HParovteecytoiouneAvegretnecsytifoierdanbyeofofrietsthseubEcnovmiromnmitteeensta?l
(23) A No._____________________________________________________________
(D
(2)
0
Since leaving that correct?
Dow
in
19P7a9g,e1b6e9lieve
you
said,
is
(3) A That's correct.
(4) (5)
Q Dcoomypoaunmy,aainntyaicno, nesituhletinr pgearrsroanngalelymoernthtsrowuitghhDyoowur?
(6) A No, sir.
(7) (8) (9)
O
When I say Dow, I mean any o f its divisions DnaotwurEel?anco o r any subsidiaries or anything
like o f that
(10) (11) (12)
(13) (u)
AQ NDoo.you m aintain contact, and when I say m aintain contact with, either on a professional or personal level, with anyone you worked with at the company, Dow?
(15) A Yes.
(16) O Who particularly do you maintain contact with?
(17) A Primarily in the industrial hygiene and toxicology
(18)
(19)
O Aanredagsi,vae mnuemthbeernaomf feoslkosf.three or four o f those.
(20) (21)
A O
DWrh.oLaisrrDyr.RRaammppyy,?Gordon
Ingdol.
(22) A He was, at the time, the director of industrial
(23) hygiene, Dow Chemical U.SA , I believe.____________
(D O And during what years dPidaghee7h0old that position?
(2)
(3)
/itgaantyhmerofrreo?m what you're saying he doesn't hold
(4) A No. He recently got a new Job that I don 't know
(5) a b o u t but I don't know, 7 5 to '90 or '9 1, or
(6) '92, som ew here in that range.
(7) O Where is he working now?
(8) A He's still at Dow, but I don't know his new
(9) 0 o)
O SptoillsiintiMonid. land?
(11) (12)
A 0
AAnsdfaRraamspIyk, nRo-Aw-.M
-P-E?
(13) (14) (15)
A 0
RWw-ihtAha-?tMo-thPe-Yr.folks
do
you
s
till
m
aintain
contact
(16) A Bruce Houhman, m anager of Industrial hygiene for
(17) DowElanco. G reg Socha is radiation safety officer
((1189)) 0 Hhoerwe.doTyhoeuy'srpe efrllitehnedlas sfrtonmamMe?idland.
go)
(21)
AQ AS-nOy-oCt-hHer-sA?.
P2) A Patty Houhman, worked for m e a t Dow Corning when I
(23) w as manager.________________________________
(1) Q How do you spell her naPmagee? 71
(2)
(3)
(4)
A0
IWthhaint kw aits'shoefrfpicoiasliltiyo you?
nPawthriecnias,hHe-wO-aUs-wHo-Mrk-inAg-Nw.
ith
(5) (6)
A 0
ISshsehewsatsillatnheirned?ustrial
hygienist
at
Dow
Corning.
(7) (8)
A 0
NWoh.ere
is
she
loc
a
te
d
n
ow
?
(9)
(10)
AQ PIshsyhseicwailtlhy ahneorteheinr cthoemIpnadniya?napolis area.
((1121)) 0A SNtoil.l with Dow?
(13) A S he doesn 't work full time to my know ledge.
(14) 0 She doesn't work with Dow any longer o r part time
(is) or(16) A Last I knew sh e w a s part time with Dow Corning,
(17)
(18)
(19)
((220D)
0
Iinnd1u96st4r,iawlhheyngyieonuew. ere called in to help evaluate the chloracne problem in the trichlorophenol
process, and in the course o f your involvem ent .
with that, did you ever communicate to any
(22)
(23)
governmental agencies the fact that there was a substance in the trichlorophenol process that was______
d) causing chloracne in DoPwawgeor7k2ers?
(2) A No.
t
(3) MR. WAGNER: Iobject a s to the
(4) predicate.
(5) (6)
0 Dscidieynotiuficevoergr acnomizamtiounnisc?ate that fact to any
(7) MR. WAGNER: I object on the predicate.
(8)
(9)
(1o)
AOoNDutoisdtidytehouathteeIvrceeormmcoepmmanmbyeurinn.icaantyewthaayt?fact publicly
(11) A Not that I remember.
(12) (13)
(H)
Q Do you know if there were any claims by workers, as a resauglat oinfstthDeo1w9?64 chloracne outbreak,
(15)
(16)
QA NYoou. don't know one way or the other?
(17)
(18) d9) (20) (21)
QA HIdaoven'ytokuneovwerotneestwifieady oinrathnye coathseero. r proceeding involving any claim by any worker who got chloracne as a result of working at Dow, whether it was 1964 or any other time?
(22) (23)
AQ INaos.ked you earlier if you testified in any civil__________
(317) 631-0940
bsa___________ LAWRENCE SILVERSTEIN - Kimberly Moyer vs. Dow Chemical - March 9-10,1993__________ xmax
(I )
PI P) (4)
ItcneajsustreifyisefdrwohimneraeenxtyphocesareusrewesetworehPaaaaDtlglseooegwe7av3pteiorro,ndcsuiovciflt.pceaHsrsaeovsen, aylou where Dow Chemical Company was a defendant?
(5) (6) (7) (8) <9)
(1o) (11)
QA NLaenodt.mmeosshtoowf thyoesues,oImf neodt aolcl uomf tehnemts,thwaetrIehmavaerkheedre, pasaretixchuiblaitrsotnoethheapdpeepnosstiotiobneoDf Depr.oRsoitiwone.ExThhiisbit 10 to that deposition, and I 'll ask you, first of all, if you can identify that particular document?
(12) A T o the extent that it is, you know, entitled, and
(13)
(14) (is)
Q
Wo bhvaitoIsu sthl ye id e n tific a tio
Idworcoutme eitn,ty?eJsu, sItcgainveIdmeentaifgyeInt n fo r the purpose o f the record.
eral
(16) A it Is a description of the part played by my
(17) departm ent, the biochem ical research department,
(is) In D ow 's chloracne problem.
(19) MR. SCHULER: And we'll just go ahead
(20) and mark that a s Exhibit 1 to this deposition,
pi) MR. LUTZ: What exhibit was it to Rowe's (22) deposition?
(23) _______ MR. SCHULER:
10,_____________
Page 74
(1) (Plaintiff's Exhibit 1 w as marked for
(2) O)
(4) P) (6)
Q LookingidaetnPtliafiincatiftfi'osnE.x) hibit 1, It's entitled the Chloracne Problem, Biochem's Contribution. Who asked you to prepare this document, do you recall, Mr. Silverstein?
(7)
(8)
O)
(10)
(I I )
A 0
IAdt tohne'ttorpe,caInllhsapnedcwifriicttaelnlyle. tters, Mr. Lynn, and then there's some
it says handw
riting
th
a
t
tshaaytsyeoaurrlyhhainsdtowryritoinfg-?early Dow history of, is
(12) A This, I don't think is. I'm pretty sure that
(13) isn 't, and I know that Isn't. That and the date
(H) (is)
(16)
OlDtoooopkytholiuaktek'snmnoyowthwyaohnuodrsswe?rhitainngd.writing this would be at the
(17)
(18) (19) (20) (21) (22)
(23)
A 0
IIndtohne'tfirrsetcpoagrnaigzreapthhaot,f you make the comment
nPola. the
intiff's Exhibit re's evidence
1, th
at
oth
er
compounds, than the one already Isolated and
identified and studied, are capable of producing
trichlorophenol, and I've highlighted those words
there. Can you te ll me what other compounds you
(1) were referring to? Page 75
(2) A At that time there w a s nonspecific analytical
(3) evid e n ce that there w as a w hole s eries of things
(4) in that w aste oil, and th o se are the other
(5) com p oun ds I would b e referring to.
(6) (7)
O Bpoutintht ienytwimeere, insotht sapt wechiafitcyaolluy'rideesnatyifiinegd?at that
P(8)) AO AI'mt thloaotkpinoginattipnatgime e2, othf PislaisinMtiffa'srcEhxh1i1btiht ,1,'65.
(1o) (11) (12)
(13)
atondyothue, Isoencloynhdavfuellopnaeracgorpayp,hb,uatnItdsIa'lylss,htohwis this cToCmDpDo, udnody,oreufeserreintghatot?what appears to be the
(14)
(15)
(16)
(17) (is) (19)
(20)
(2D
AQ YAensd. others, which have been shown to cause chloracne, have also been shown by anim al tests and some human experience in other companies to produce liver damage if the exposure is more extensive. Again, do you know what those other compounds are? Can you identify them at this point in tim e?
(22) A T hey w ould be the fam ilies that I w a s then aware
(23) of that had ca u sed chloracn e In humans, such a s in
Page 76 (1) the thirties, the chlorinated naphthalenes, and (2) earlier Dow experience, before I came there, with
(3) materials they suspected, you know, of being the
(4) culprits, the chlorinated furans and that type of
(5) (6)
(7)
O Btinhuittnhyego,turyi'creehsl.noorot rpehfeernrionlgwtahsetereotoil?other compounds
(8) A 1don't remember if that was meant to do that or
(9) (1o) (11) (12)
Q Ynoout,retofebr ien hthoenleassttwseitnhteynocue. to some European yeoxpu'ereriernecfeerrwinigthtcohtlhoerarec?ne. Can you te ll me who
(13) A Well, there were, as I remember, three big
(u) companies In Europe that had had accidents In
(15) their plant that had caused some employees to have (16) the chloracne and also some liver damage In other,
(17) you know, some of their employees. That's about
(18)
(19)
O Dalol Iyoreumreemmebmerboefr tiht.e names o f the companies?
(20) A The one was Boehringer Chemical in Germany. Ido
(21) not remember the one in the Netherlands, and I
(22) (23)
Q Ydoounm't erenmtioenmobnepratghee 3o,naenIdnIF'llrashnocew, yeoituhtehris. ________
0) (2) 0)
(4)
section o f Plaintiff's ExhPibaigt e1,7t7hat folliculitis In rabbits appears to be produced, regardless of the severity o f exposure. Do you see that there?
(5) A Yes, this part that you've highlighted?
(6) 0 Yes.
(7) (8)
A Q
All Go
raihgehat,dl.et
me
read
the
whole
sentence
here.
(9) (10)
AO YDeosy,ooukraeyc. all where you got that inform ation from ?
(11) A It had to be from toxicology, our toxicology
(12) department.
(13) MR. WAGNER: For purposes of the record,
(14) if this is ever offered at trial, this document, I
d5) want to object to the highlighting of it and would (16) want a dean copy submitted, as opposed -
(17) MR. SCHULER: You'll certainly get a
(18) dean copy.
(19)
(20) (21) (22) (23)
0
In the next sentence you indicate there's evidence that unknowns, it looks like acnegens, may produce
folliculitis in rabbits with a shorter induction
period. Can you te ll me what you are referring to
there?____________________________________
Page 78
d) (2)
QA IAhreavyoeunroe fiedreriangwhtoat- that refers to.
*
(3) A I don't recall.
(4)
(5)
(6)
Q Itoditdhen'ct monetaennttsoocructoynotuamofifn. aAnrtes oyof uthereferring trichlorophenol waste oil?
(7)
(8)
(9) do)
(11) (12) (13) d4)
(15)
OAyIIP'omjluuasislnotttaodifkrfot'isnnogE'ftfxatkahtnlikbtohiinwteg1lwa,awshbtheopetuahrtereasryogoImruawe'praeh1st9oao4nlrk4pinnraeoggst.eaeab3rocouhtf,, and I can't make out the last sentence, thew ord pDtfhorooarydmtouweuca?tkswninoaswseswrhtehodawttnhthetaoretbs. eaIytinss,aaccyatsivntehyebouysoammnaiemktehaitnlhtgeasttosu. t
(16) A The handwritten Insertion appears to be the word
(17) p8)
Q Isphtheantaytoeu. r writing o r was that someone else's?
(19) (zo) (21) (22)
0ACaiIfratechnaacyntro'os'tusytsmeoeludal.rkoweIutr'oisttuiantttogtthoh?eeinhbdaointstdotimwncr,ittto.ernast cleraatscthteesll
tha me
t
(23) A I can't make out what It says, except for the last
2 13 2
(317) 631-0940
bsa LAWRENCE SILVERSTEIN - Kimberly Moyer vs. Dow Chemical - March 9-10,1993
Page 79
(1) word which is obviously experience, and it is not
(2)
P)
my writing.
0 Do you know whose writing it is?
(4)
(5) (6) (7) (8)
0)
(io)
(1D
(12)
QA NYoou. mI denotnio'tnraetctohgentoizpeothf paat gweri4tiningP. laintiff's Emxahnibufiat c1,tuthreartsIno f1t9ri5c5hlaornoupmhbeneor ol afnGdearmt laenast one French company had human experience w ith chloracne that caused them to shut down production plants acnodmtpoasntuiedsyytohue rperfoebrrleedmt.oAeraerltiheor,sBeotheehrsinagmeer, and you couldn't remember the names of the other two?
(13) A I believe so.
(14) d 5) (is)
(17)
(is)
(19)
(20)
(21)
(22)
Q Osthonemp1ea9tgh9einag4ndoth3faP4t9lhabainputpiifldfe'sinnEegdxsh,initbh1iat9t15t,h7yeohrueisttwaoelrkirceaabplloyrouIcntess isnasmolupbleles toeisltaenddocnoailnriemaaclsto, rapnrdodthuectcianu1s9tic9 were Aaaclrsetoivyeaocuatnirvedef.ethrraint gtatrofrroambbciot tleosrtsintiglls in 349 was there?
(23) A Yes._________________________________________________________
(1)
(2)
0
And when you say activeP,aagree causing chloracne?
8y0ou
referring
to
(3) (4)
A Q
NWoh.at
are
you
referring
to?
(5) A To cause folliculitis in the animal, or the rabbit
(6) ear, and there's a technical difference between
(7) (8) (9)
that and chloracne.
Q What is the difference between folliculitis and chloracne?
(10) A I'm not a medical person, so I really just as soon
(11) not give you an answer, if that's all right.
(12) (13)
(14)
Q
If you ca q u a lifie d
n't to
answ answ
e e
r r
it, if you don't feel something, te ll me
th
a
t
you
don't feel qualified to answer that.
(is) A I think that's a good answer, I don't feel
(16)
(17)
(18) (19) (20)
p i)
0
Yqouualmifieendti.on in the next sentence, page 4 o f Plaintiff's Exhibit 1, that over the years some
samples o f end products, such as Si/vex, and I
can't make out the next name, it's handwritten
over, can you make out the next one?
(22)
(23)
A Where are we?
Q That last highlighted sentence.__________________
(1) (2)
A 0
ORivgehrt.the
years?
Page 81
(3) MR. WAGNER: Are you asking what that (4) word is?
(5) MR. SCHULER: Yes.
(6) (7)
A 0
LWohoaktsisliRkoenRnoenl, ndeol,yRou-Ok-nNo-wN?-E-L
((98))
(10)
(11) (12)
(13)
A It's a agricultural product, but I could not give
0
Oyokauyt.heYocuhmemenictiaolnctohmatpRoonnennetl,s,Sollvkeaxya?nd 2,4,5-T had been tested on anim als and in no case was
chloracne activity detected in these products.
Where did you get that inform ation?
(14) (is)
AQ APrt oDboawblCyhferommictaol xCiocmolpoagnyy. ?
(16)
(17) (is) (19)
(20)
(21)
(22)
(23)
QA YInetsh.e next sentence you mention in 1962 there was additional testing o f samples from the then existing process from the p ilo t run with a decrease in the caustic concentration, and to follow on the next page, those samples were tested in anim als and that certain insoluble o il was found to be active. Are you referring to causing______
(1) chloracne there o r somePaogthee8r2problem ?
(2) A I'm referring to causing folliculitis In the
(3) (4) (5)
((76))
0
Tahneimnaelxttepsatrsa,gsrpapechi,fithceanll,yi.n your history you refer to the outbreak that occurred in 1964 of
chloracne and that the two samples o f the o il that
were tested were dram atically different than those
((89)) twehstaetdyobuefmoreea.nLbeyt tmhaet?show you that and ask you
(10) MR. WAGNER: I object to the form. (11) A Well, a s it sa y s , the sam ples killed the rabbits (12) in the test, in contrast to earlier te s ts w here
(13) (14)
(15)
0
Ythoeu'rreabrebfietrsridnigd tnootht ediset.rength contaminant there?
of
the
(16) MR. WAGNER: l object to the form of the
(17) question.
(18)
(19)
A 0
OSikmayp,lythtehfeacent tdhartetshuelrtabbits
died?
(20)
((2212))
(23)
A 0
AYsenends.teyonucessutbhsaetqI'ullesnhtolywreyfeoru,
oinntpheagneex5tocof uple
of
Plaintiff's Exhibit 1, that the concentration of
d) the caustic insoluble oilPsahgaed8t3o be diluted from
(2)
(3)
btheefourseutahle1a0npimeraclesnstutrovi.v1epde, rdcoeynot cuosneceetnhtarat?tion
(4) A Y es.
(5) 0 Where did you get that inform ation from ?
((76)) QA TDooxyiocoulokngoyw. who was conducting these tests a t this
(8) time in 1964?
(9) A To the best of my knowledge, it w a s Dr. Kenneth
(10) Olson.
(11) (12)
Q Htime ew?as a toxicologist with the company at that
(13)
(14) (is)
(16)
(17)
(18)
((2109))
A 0
YYoeus.mention a paragraph on
tptahgeeb5ototofmP
laoifnthtifef'sfirEsxthfuibllit
1
tha
t
the tests had been repeated periodically, to the
extent that over 600 anim al tests directly related
to the chloracne problem had been run since July,
saened tthhaetrela'sstasdenatteentchea?t's cut off there. Do you
((2221))
(23)
A Q
YaWelsasos,?tIh_sa_et_ein_ff_ot._rm__a_tio_n__y_ou__g_o_t _fro_m__t_o_x_ic_o_lo_g_y_, _____
Page 84
((P21)))
A Yes.
0 wAnads dwooinugldtthhaatttheasvtiengb?een Dr. Olson, as well, that
(4)
(5)
((67)) ((89))
0
The circMleRa.roWuAndGNthEeRs:enItoebnjceectw, tihthethpereidnisceartteio. n of the phrase in that particular sentence, is that
A Isth-oism?ething that you did, o r did somebody else edit
(10) MR. WAGNER: I object to the form of the
(11) question.
(12)
(13) (u) (is)
A 0
IThheorneeisstalyredfoenre'tnrceeminemthbeelar.st M r.Skelly. Was he one of the
paragraph to toxicologis
a ts
in
the analytical lab?
(16)
(17)
A 0
NWoh.at
w
as
M
r.
S
ke
lly?
(d198))
A Q
AAnndalwythicaat ldcivhiseiomnisotr
d
epartm
ent
was
he
in
?
(20) (21)
A 0
AIsnthalayttpicaarlt
olafbthoerabtioorciehse.m
ical
rese
a
rch
lab
?
(22) A No.
(23) Q Separate?______________________________
(** 17\ 01_riQi1A
bsa___________ LAWRENCE SILVERSTEIN - Kimberly Moyer vs. Dow Chemical - March 9-10,1993
Page 85
(D
PP))
A0
Yes, separate.
You mention in that same sentence isolated a number of fractions and
that Skelly among them
was
(4) the TCDD. Was he the first one in the company to
(5) identify that by-product?
(6) A May I see the reference?
(7) Q Sure.
((98))
A0
YWoausrMqru. eSskteiollny
again,
the first
please?
one at D
o
w
C
hemical
to
(10) Isolate the TCDD, to your knowledge?
(11) A I don't know the answer.
(12) Q Again, there's some editing of the last paragraph. (13) Do you know if that was yours or someone else's?
(u) A That doesn't look like my handwriting. I don't
(15) know whose it Is.
(16) Q In the next sentence you refer to two materials (17) that were identical from infrared melting point (18) analysis. Do you know what you're refemng to (19) there?
(p20i)) AQIWdaosnH'takronlodwGwillhinatththeaatnraelfyetricsatlola. boratory also?
(22)
(23)
QA YWeass. he the head of it?___________________________________
Page 88
O) 0 Referring to the last highlighted sentence here on
(P2))
page 6 of Plaintiff's Exhibit 1, you make the comment that wipe samples with no detectable TCDD
(4) but varying amounts of unknowns have shown more
(5) activity on the animals than can be accounted for
(6) (7)
by the low level of TCDD which may be present. Can you tell me where you got that information?
(8) THE DEPONENT: Okay?
(9) MR. WAGNER: Okay.
(10) A My wipe test samples were tested on the rabbit ear
(11) because of its great sensitivity. At the same
(12) time we had them analyzed by the analytical lab
(13) for the materials they could find on It, and that
(14) statement arose because wipe samples that showed
(15) very little or no TCDD by analytical analysis did
(16) produce an effect on the animals.
(17) 0 And so, I'm not sure I understood you, in other (18) words, the wipe samples were analyzed chemically (19) and then they were also tested on the rabbits?
(20) A Yes.
(21) Q And in the chemical analysis, even if there was no (22) TCDD collected, they might still be bio-reactive (23) on the animals, is that what you are saying?__________________
Page 86
0) (2)
A0
Not
You
to my knowledge.
mention on page 6
of
Plaintiff's
Exhibit
1
O) that the vapor phase chromatography, I guess it
(4) was called, sensitivity at that time was
(5) sensitive, could detect samples - 1guess of the
(6) TCDD, down to one part per million by weight, do
(7) you see that there?
((98))
A0
Yes.
And
there
is
a
subsequent
statement
that
the
(10) (11)
rabbits are sensitive to the TCDD down to approximately five parts per billion by weight, do
(12) you see that next sentence there?
(13) A Yes.
(u) 0 Where did you get that information, from (15) toxicology also?
(16) A The part relating to the rabbits from toxicology,
(17) and the other from analytical.
(18) 0 With respect to those two measurements, if the (19) machines were only sensitive to a measurement of (20) one part per million, how could it be detected, (21) and again, if you're not qualified or can't tell (22) me how they arrived at this, but how could you (23) arrive at the conclusion that the rabbits were__________
Page 87
(1) sensitive down to five parts per billion?
(2) THE DEPONENT: Okay to answer?
(3) MR. WAGNER: Sure.
(4) A Because the analytical samples, process samples
(5) had lots of interferences. Starting with pure
(6) material we could accurately dilute down to five
(7) parts per billion and test on the animals, so
(8) that's what what we did.
P) 0 So you took the pure and diluted the pure to five (10) parts per billion? You worked up instead of down, (11) if you will?
(12) A I don't remember which way we went.
(13) 0 Who would have done that research, do you know?
(14) A Probably toxicology - well, I know it was.
(15) 0 Would that have been Dr. Olson again?
(16) A To the best of my recollection, yes, Dr. Olson.
(17)
(is)
0 There's a lot of editing that went on on page 6 here o f Plaintiff's Exhibit 1. Again, do you know
(19) whether you did that or that was somebody else?
(20) A Ju st about impossible to tell, but I don't think I
(21) did it.
(22) Q And you don't know who did, correct?
(23) A No. I can't recognize that handwriting._____________
Page 89
(1) A That's correct.
(2) O And the chemical analysis was done with the vapor (3) phase chromatography?
(4) A Yes.
(5) Q At that time down to a sensitivity of one part per (6) million measurement?
(7) MR. WAGNER: I object, no predicate.
(8) A To the best of my recollection.
0 ) O There's a sentence scratched out at the end that (10) talks about the chlorinated dibenzofurans were (11) tested on animals many years ago and shown to be (12) quite active. Do you recall where that (13) information came from?
(u) MR. WAGNER: I object to the form of the
(is) question.
(16) A Somewhere In the files.
(17) O Toxicology again?
(18) A Yes.
(19) O And in the next sentence that was scratched out, (20) it says research was abandoned on these products (21) because o f their high acnegenic reactivity. Do (22) you recall what products you were refemng to (23) there?___________________________________________________________
Page 90
(1) A No, I don't.
(2) (3)
Q There's a handwritten page 6, is that in your handwriting?
(4) A That appears to be my handwriting.
(5) O That highlighted sentence, could you read into the (6) record for me?
(7) A Peaks coincided with some unknowns which were seen
(8) in wipe samples and process samples. Both the
(9) biochem lab and the Germans have reported animal
(10) tests with these compounds which showed acnegenic (11) activity.
(12) O What compounds are you refemng to there?
(13) A Well, let me see, I think it goes back to the
(14) impure chlorinated dibenzofurans that I didn't
(15) read. I just read the highlighted. (16) THE DEPONENT: Can Itake a break?
(17) MR. SCHULER: Sure.
(is)
( R e c e s s .)
(19) BY MR. SCHULER:
(20) 0 Let me show you page 7 of Plaintiff's Exhibit 1, (21) and I'll ask you to read that first highlighted (22) portion there.
(23) A The analytical laboratory and the toxicology______________
(317) 631-0940
2 13 3
D- a w ^
bsa___________LAWRENCE SILVERSTE1N - Kimberly Moyer vs. Dow Chemical - March 9 -1 0 ,1 9 9 3 __________ xmax
Page 91
(1) laboratory are presently conducting a project to (2) determ ine the analytical and animal test limits of
P) sensitivity for TCBD in various Dow products, I
(4) think the word is made, M-A-D-E, from
(5) trichlorophenol. This project Is aimed at
(6) developing a quality control specification for
(7) (8)
0
DT Co
ByoDu
iknncoown
wsuhmo
er p was
rinodcuhcatrsg.e
o
f
that
project?
0)
(10)
(11)
A 0
DNoo.you know developed?
w
hat
standard
w
as
u
ltim
a
te
ly
(12) A During the time l w as involved, our standard w as
(13)
(14) (is)
(16)
d7)
0
AnnodthIinthgindkeinteocntaebolef thinestheeomthaetredroiaclu. ments w e'll ogef tthteo t1h9e60vsa,riuopusumnteila1s9u6r9e,mwehnatst,wbaust tIhnethliempiteorifod
detection, if you know?
(13)
d 9)
(20) (21)
(22)
(23)
A 0
IYdouonh'atvree starting a
ma seemcbtioern, t page 7,
here In Plaintiff's E that deals with the
xhib 199
it
1,
building and talks about an anim al test that was
done, conducted in 1945,which showed the caustic
insoluble o il to be active. Do you know what_______
d)
(2) 0)
precau kbnuot wyotuh
tarieot nfwesrarwsedebreetoforperecreoycmoaPumuawtgieoeennrd9ese.2wditbhatchke
at that tim e company,
?
I
(4) A I don't rem em ber specifically.
(5)
((67))
(8)
0
What about 1957, recommended at
do you know that time?
what precautions
were
A Q
IOdnopnaogter8emo fePmlabine
rtifsf'ps eEcxifhiicbsit.
1,
yo
u
re
fe
r
to
O) (10)
(11)
(12)
(13)
itnhfeorBmoaethiorinngfreormSoahGn ivCaoumdapna,nGy i-nl-VG-Ae-rUm-Dan-Ay-aNs,king for Corporation. Do you know where that company was ilonctearteesdt iannidt?whether or not Dow Chemical had an
(14) (is) d 6) (17)
(18) (19)
A 0
IYhoua le tte
vmeennotiornecinoltlheectnioenxtosef nthteantcceomonppaangye, G8 itvhaaut daan. r describing the hazards and precautions for
safe handling o f 2,4,5-Trichlorophenol was sent to
yBooueahurinthgoerrthwaitthleattdear?ta sheet from biochem. Did
(20)
(21)
A 0
DNoo.yo
u
kno
w
w
ho
d
id
?
(22) (23)
A Q
NIt om.
entions
th
a
t
the
le
tte
r
an
sw
e
red
seven__________
(1) (2)
P)
specific questions regaPrdaingge 9o3ur own plant ewxepree?rience. Do you recall what those questions
(4) A I do not.
(5)
((67))
0 OJannpuaagrye199o64f Pfirlasitnmtifef'sdiEcxahl ribepit o1,rtyoofuarecafesretooaf chioracne, initiated a sunrey by the environmental
(8)
(9)
irnesdeoainrcghtlhaabtosruartvoeryy.? Do you know who was involved
(10) A That w as my a ssignm ent to the plant being referred
(11)
(12)
(13)
to there.
0
And that was, your boss?
I
fo
rg
e
t
the
fe
llo
w
's
nam
e,
who
w
as
(u) A Harold Hoyle.
(15) (16)
(17) (is)
d 9)
0 Hopoyelrea,toork'asyjo. bAbndeinwghesrteudyioeudrcelfoesretoly tahned a report being issued on February 5th, 1964, recommending changes in the procedure and the personal hygiene habits, that was your report?
(20) (21) (22)
(23)
A 0
IYopuremsuemntieonsoa. company by the name o Sprinkler as the company that came in
f Phoenix to change
some o f the equipment on the 199 building. Was
(1) (2)
that a company separatPeafgroem94Dow Chemical, a subcontractor?
(3) A To my knowledge, yes.
(4)
(5)
((67))
0 Awnodrkyeorus dmeevnetlioopnethdacthaioprpaacrneentinly tshoemperoocfethses ior f changing some of this equipment. Do you recall how many?
(8) (9) (1o)
A 0
DNiod, yIoduonev'te. r meet those chioracne that were emp
men that developed loyed by Phoenix Sp
rin
kler?
(11) (12)
A 0
HNoowt tdoidmyyokunfoinwdloedugt aeb. out
that?
(13) A I was told by someone.
(14) Q A t your company, Dow Chemical?
(15) A I would guess so, yeah.
(16) MR. WAGNER: Don't guess.
(17) THE DEPONENT: You are right
(18) MR. LUTZ: Does that mean you are
(19) changing your last answer to you don't recall?
(20) THE DEPONENT: I'll change my last (21) answer to I don't recall.
(22) (23)
Q You m enMtioRn. LaUt TthZe: toIphaodf ptoagsaey1s0oomfePtlhaiinngti.ff's______
Page 95
(1) (2)
Exhibit 1 that very stringent safety precautions were instituted at the 199 building. Those were
(3)
(4)
htheereo?nes we discussed earlier in your deposition
(5) (6) (7)
A 0
YYoeus.say these supervisor. D
include a o you rec
full-tim all who
e health that was?
(8) A Yes.
(9) 0 Who?
(10) (11) (12)
A 0
MpWoaysssiettiholfen. r?e
anyone
that
follow
ed
you
in
that
(13) (u)
A Q
YWehso. ?
(15) A I don't recall the name.
(16) d7)
QthWaatswtahsa
t a full-tim e position after permanently maintained
yo at
u le ft it, that build
in
g
?
(18)
(19)
(20)
AQ NHoow. many followed you, one other person o r more, if you remember?
(21) (22) (23)
AQITdheonc'ltosreumreesmthbaetry.ou refer to on page 10 that were put up around parts o f the process and that
(1) (2) (3)
you refer to being put upPiangNeo9v6ember and Decem ber of 1964, what type o f closures were they, do you recall?
(4) A It was basically a very large, metal, rectangular
(5) (6)
Q
Kstinrudcotuf arewaaroll uthnadt
the was
mp uatinupparroocuensds
iet?quipment.
(7)
(8) (9)
(1o)
QA AWwasailtl,cyoemaphl.etely self-contained, did it itcoopmepnleatteslyomenecploosientt?he process equipment, or was
(11) A It was a closure, as I stated, enclosing the
(12)
(13)
(14)
0
Wpraoscitescso,mypelse.ted enclosed, top or one o f the sides?
o
r
w
as
it
open
a
t
the
(15) A It was open only to let pipes and such things
(16) through it, yeah.
(17) 0 Do you remember what m aterial it was made out of?
(18) A No.
(19)
(20) (21)
Q On page 11 there's some comment and criticism s, I mguaeyshs,avoef twheritltaenngtuhaagt?e here. Do you recall who
(22) MR. WAGNER: l object to the form of the
(23) ___________ question._________________________
n 17\ Rn.nQdn
bsa___________ LAWRENCE SILVERSTEIN - Kimberly Moyer vs. Dow Chemical - March 9-10,1993__________ w a x
(1) (2)
0 Either the Insertions up Pheargeeo9r7the word out here, that says poor?
(3) MR. WAGNER: Sam e objection.
(4) P)
(6)
(7) (8) P)
AQ ITdheon3'4t9knbouwildwinghothcarittyioquueredfeorrteodoitnepdaigt,en1o1. o f Plaintiff's Exhibit 1, you talk about contaminated hpaehcrebhniecamitdeiecbsael2iwn,4gh-Dicp,hro2ics,4ea,s5sc-eTodmoIrpnSotihnlvaeentxbt?oufildaninygo. fItshethat
(10) MR. WAGNER: Phenate?
(11) MR. SCHULER: Phenate.
(12)
(13)
A 0
CThaen laI sste-e
the
reference?
(u) A Oh, the one that was poor, uh-huh. I'm really not
(15)
(is) (17) (18)
0
Ysuourereisfetrhtoe aanbsuwilderin. g superintendent at 349 the name o f Clare Bailey. Is that a man or a
by
woman, if you know?
(19) (20)
A Q
IIst wheass
taillmemanp.loyed
by
Dow?
(21) (22)
(23)
A O
IYEdoxouhnimb'tiet kn1nttioohnwat.atht ethree
twoepreo
fopbajegcetio12nsobf Pylwaionrtkifmf'sen
to
(1) (2)
(3)
(4)
(5)
working in 349, which cPaaugseed98the adoption of full-scale protective measures in that building in regard to the trichlorophenol process. Were any orefcthaoll?se objections in written form, if you
(6) A I do not recall.
(7)
((89))
(10)
(11)
Q Dhaovyeooubrjeemcteemd,baenrythoef tnhaemweosrkomf aenny?people who would
A 0
IYwouomulednnt'itonkninowpaarnagyrnaapmh tewsooof fthpaegfoelk12s.o f Plaintiff's Exhibit 1 that a health supervisor is
02)
(13)
nwohwo sthtaattiownaesd? at the 349 building. Do you recall
(14) A No, I don't.
(is)
(16) <17)
Q Ayot tuheditsocpusosfepdagDeow13iciindeth3e. fiDrsot fyuollupkanraogwrawphhat the components were o f that particular chemical?
(is)
(19) (20) (21) (22) (23)
A 0
INnoth, eI d2o6n7'tb. uilding, on Exhibit 1, you mention
tphaagt
eth
a13t iso
fthPelabinutiilfdf'sin
g
where the trichlorophenol from 349 is processed to
2,4,5-T acid and 2,4,5-T esters, and you mention
that in 1965, samples taken from that building______
(1) (2)
P)
(4) (5)
showed no activity w ithPoangeee9x9ception, and that is
the residue from the sodium salt filte r press
showed slight activity on the rabbit ear. Do you
know what that you're
raecfetimvitnygwtaos
shown there?
on
the
ra
b
b
it
ea
r
(6) (7)
A Q
WHehreer. e
the
heck
are
we
here?
(8) A That's not what -
0 ) 0 Right here, I'm sorry.
(10) (11) (12) (13) (14)
A 0
TYhouatd'sisttrhibeuftoeldlicthuilsitMisaarccthiv1it0yth. , 1965, that we marked as P laintiff's Exhibit 1.
m em orand um There is
iandheaxn.d
written statement at the Can you te ll me what th
end at is
that ?
says
u
n
it
(15) MR. WAGNER: i object to the form of the (16) question.
(17) A That was an indexing method used in the lab, (18) meaning write out, you know, the key word so that
(19) (20)
0 Fitocrofiulinldg bpeurrpeotrsieesv?ed, presumably.
(21) (22)
(23)
A 0
FW1i9lai6sn5gt,hoperruewrpcaoosmsitepmsu,atsentrruiizacalt?tliyo.n
o
f
these
things
back
in
Page 100
(1) MR. WAGNER: I object to the form of the (2) question.
(3) (4) (5)
QA ICthdaeoncnyh'otaurinetmeollfemdmiesbtewrirbh.uotitohne?se people are at the end in
(6) MR. WAGNER: I object to the form of the
(7) ()
0 Is that yqouuershtaionnd.writing, first o f all?
(9) (10)
A 0
ICdaonny'ot
uthrienakdththaet'nsammyeshtahnedrewtrhitaint agr.e
lis te d ?
(11) (12)
A O
AUnnddewrhdeirsetrwibausthioenloIcsaHteudtcahtethneretuimthee?r.
(13) A He w as a m anager in the Midland plant at th e time.
(14) G o ergea, sam e a s Hutchenreuther, G-O-E-R-G-E-A;
(15)
(16)
Smtaanehalginerg., SI c-Ta-nA't-Ere-Had-L--l-oNh-,GA, mansotuthtze,r major
(17) A-M-S-T-U-T-Z; J. Kelly, paren theses, W, period,
(18) disposal; Shannon, ditto marks under disp osal, and
(19) Leuck, L-U-E-C-K; Bailey, B-A-l-L-E-Y, and
(20)
pi)
(22)
0 ISdt cimsupeloansttlaio,l.nSs-WCa-hUJo.-LiKs-eAthll-yaT.t-ilIn.tdsaivyidsusaolm? ething
(23) A I don't rem em ber Mr. Kelly.____________________
(1) Q And Mr. Staehling, whePreagiseh1e01located?
(2)
(3)
A Q
MHer. wLeauscmk?anager
in
the
Midland
plant
at
that
time.
(4) A He w as assistan t superintendent at 199 building at
(5) ()
(7)
0 Athned tIimthein.k Bailey we have covered. And the last name -
(8) (9)
A 0
SWchualat wtl.as
h
is
p
osition
?
(10) A He w as plant superintendent, but I don't rem em ber
(11) (12)
Q Awthoenree.o f the buildings?
(13)
(14)
(is)
A Q
YLeeat mh.e show you can identify that?
th
is
docum
ent
and
a
s
k
you
i
f
yo
u
(16)
(17)
AQ YWehsa. t is it, first o f a ll?
((1is9)) A Ibt iioscthheem, aicraelproersteoafrcahmeetinlagbhoerladtoatryt.he (20) 0 What is the date?
(21) A Memo is dated March 29th, 1965. (22) MR. SCHULER:We'll mark that as Exhibit
(23) _______ 2.__________________________________
Page 102
(1) (Plaintiff's Exhibit 2 w a s marked for
(2)
P) (4)
0
P laintiff'sidEexnhtiibfiitc2atiisona.r)eport Mr. Silverstein?
authored
by
you,
(5) A If you referring to th e docum ent w e just looked
(6) (7) (8)
0
Aant,dywesh.at P la in tiff's
Ewxahsibthite2p?urpose
o
f
this
report,
(9) A To docum ent a m eeting that w a s held a t the
(10) biochem ical research laboratory on th e d ate
in)
(12)
(13)
(u)
0
iTnhdeirceaitsedso. me handwriting a to a B ill something o r other,
t I
the top, it says copy can't make out the
name. Is that your handwriting?
(15)
(16)
QA NDoo,yiotuisrne'ct.ognize the name, can you make it out?
(17)
(18)
AQ YBeestt,eBr silpl Hellatbheartsotnoeh..
(19) A H-A-B-E-R-S-T-O-H. That ap p ears to b e V.K.R.,
(20) (2D
Q WVh.Ko.isRMowr.eH. aberstoh?
(22)
(23)
AQIYdouonw'terreempreemsebnetra. t that m eeting o f the various______
2134
(317) 631-0940
D - d id jS
b s a ___________ LAWRENCE SILVERSTEIN - Kimberly Moyer vs. Dow Chemical - March 9 -10,1993_________ x m a x
((12)) rceoprrreescet?ntatives o f the cPhaegmeic10a3l companies,
(W(((3567)))) (8)
A 0
YA ensd. yo u referred
tmo
eenvtiidoennicneyfoourrurenkpnoorwt tnh
aatcMner.gReonws,eand
you
can take a look at that, if you want. Again, I'll
ask the
you, do you know what he context o f that meeting?
was
refem
ng
to
In
(1(09))
MR. WAGNER: Iobject to the form of the question.
((((11111234)))) ((1156))
A T he number of other com pounds in the cau stic
Q Ointshoelruthbalen othile. TCDD?
A 0
YWbeioascs. htheemloiccaal
trieosneoafrcthhislamboereatitnogrya,
t1t7h0e1
b
uildin
g
,
o
r
((1178)) (((((1222290123)))))
was it someplace else?
A 0
IBduot nit 'wt raesmonemthbeeDr wowhipcrhembuisiledsi?ng
it
w
as
in.
A 0
YOensp. age 2 that Dr. Ho
ofP lder
laintiff's Exhibit 2, you reviewed the m edical
m ention side o f the
Dow experience. He was the fellow that you
((2D) rdeivfeisrrioend?to earlier that wPaasgehe1a0d4 o f the m edical
((((((345678))))))
A 1 didn't s a y he w a s head of the medical division.
He w a s th e gentlem an 1 dealt with at th e medical
0
Sdoerprya.rtmAnednyt,oyuerse.fer to the fact that he said now have approximately 60 to 70 cases o f
we
Individuals with chloracne, ranging from two
(1(09))
severe cases to some very m ild cases that were d ifficult to diagnose. Are you referring to,
(((111123))) (14)
there, just the cases from the 199 building?
A 1 couldn 't tell you.
MR. WAGNER: 1object to the form of the question.
((1156)) (((111789)))
A 1 couldn 't tell you what Dr. Holder w a s referring
to at the time.
0
You mention that dram atic cases.
he showed slides o f the more Did you have a chance to observe
the slides yourself?
(20) (((222132)))
A 0
YDeids.he put them up on a screen,
in is
a th
slide at the
projector and way he did th
pu at?
t
them
A Yes.
Page 106
(((23D)) (4) (5)
0 WthiethtDoxoiwcoClohgeymliacba.l Company?
A 0
YYthoeaust.aclosroremcat?de
a
p
rese
n
ta
tio
n
a
t
th
at
m
ee
ting,
is
((67)) AO 1Itdmoenn'ttiorenms,ehmerbeera.t the bottom o f page 2 o f
(1((089)))
Plaintiff's Exhibit 2, that Silverstein described the plant study on washing o f contam ination o f tools and surfaces. Does that refresh your
((((11111234))))
recollection?
A 0
YA ensd. yo u recollec
can tion,
look at this to further If you would like. It's
refresh you at the very
r
((1156))
bottom o f page 2 o f Plaintiff's Exhibit 2. Was it your experience with contamination that in order
((1178)) ((1290)) (((222231)))
yttohoauret epmiatohraveegr rhiatapfdrohtmotheutorseoelosthraepnrcdohcoeetmheedicrawolsbithjreevcfeitgsr,oernthocauetsd in scrubbing with soap and water to do that?
MR. WAGNER: 1object to the form of the question.
A 1 need a rerun of the question b e ca u se it go t a
Page 107
(((23D))
O Olitktaley.loWnga.s it your experience w ith the contamination o f tools and other objects with this
(4) foreign m aterial that you either had to use the
(1(((((056789))))))
sssuocbarupsbtyabnwincagete?sry, osouaoputalinndedwtaoterermwiothveviigt oorrotuosuse
MR. WAGNER: Iobject to the form of the
question.
A Yes.
((1112)) 0 Dwiadsyhoinugfeweitlh, awnadtehraavlionngelowookeudldabtethsiusfnficowie,ntthtoat
((1134)) ((1156)) ((1178)) (((((1222290123)))))
remove the contamination?
MR. WAGNER: Iobject, no predicate.
A 0
MWyithrewcaotleler catloionne?is
it
could
be
done.
A 0
MYems.-hmm
-
yes.
I'm sorry, you said w ater alone?
A Water, detergents and vigorous scrubbing w as
0
Trehqeuqirueeds.tion, though, is, did udseeteorgf wenat?ter alone would be
you feel that the insufficient without
(((132))) (((546)))
O
Do you re showed?
m
em
b
er
h
o wPmaag ne y1s0l5id
e
s
th
ere
a
re
th
at
he
A 0
NYoou. m ention that he reviewed clinical studies that were being made on these people with emphasis
on
the liver function tests. Do you recall what he
(7) said about the im pact o f these unknown acnegens
(8) and the TCDD on liver functions?
(1(09)) AO 1Ydouo mnoetnrtieocnatlhl awthDart. Hheolsdaeidr a. lso discussed or
((1121)) ((((11114563)))) .
m entioned the incidence o f fatigue among the aabffloicutet tdhapte?ople. Do you recall what he said
A 0
ND oo.yo u to p ic a l
trreecaatmll Denr.tsHwoeldreert'rsieddisocnusthseion
of
what
((1178)) ((1290))
chloracnogenic condition of these folks?
A 0
Y1 douo mnoetn. tion a`Dr. Sadek,
a doctor in S-A-D-E-K,
the first fu ll paragraph. showed slides o f ears and
((2212)) lWivehorsiso fDrra.bSbaidtsetkh?at had been exposed to TCDD.
(23) A He w as, at that time, a veterinary pathologist in
((((1234)))) (5)
Page 108
A 0
D1tihdinyoku1fmeeisl stheadt awwatoerrdaloinntehweriteh,oautkdeeytewrogredn.t would be insufficient?
MR. WAGNER: 1object to the form of the
question.
(6) A Yes.
(1(((0789))))
0
You mention in the Plaintiff's Exhibit 2
next paragraph on page 3 that Harold G ill discussed
of
tthheatatinmaelyshies rbeyfevrarepdortophaalsime icthorfoomnaetopgarratppheyr, and at
((((11111234))))
meitihllieornafcoerttircicohrloprroopphioennico.l aInsdthfoatry2o,4u,r5-T acid, recollection o f the lim it o f detection o f the machinery at that tim e?
((1156)) ((1178)) ((1290)) (((222123)))
A At the time -
MR. WAGNER: 1object to the form of the
question, since the paragraph refers to two limits
of detection.
A My recollection at the time, for the sen ten ce
0
Yhoiguhmliegnhttieodn,, yaet athhe. bottom o f page 4 o f Plaintiff's Exhibit 2, some concern, and we
discussed earlier, about as a group, that we could
&
(317) 631-0940
BSA
LAWRENCE S1LVERSTEIN - Kimberly Moyer vs. Dow Chemical - March 9-10,1993
XMAX
(1)
PP))
not afford to sell contamPaingaete1d09products. Was that because o f the concern that the customers would not be using the products under the same
(P4)) cwoonrkdeitriosnwsooufldhebael?th control and hygiene as your
(6) MR. WAGNER: I object to the form of the
(7) question, over broad and vague.
(8)
,(iPo))
01) (12) (13)
(14)
A 0
cDiohomoynmoeuesnthltasyvocefaaannn'tyy
rInedmeepmenbdeerntht raetc. ollection o f o f the other manufacturers'
the
representatives at this meeting with regard to
Dow's disclosure o f this contaminant in both
trichlorophenol and potentially in its end products?
(is) MR. WAGNER: I object to the form of the (16) question.
(17) A I have no recollection of any comments by anyone
(18) (19) (20)
pi)
Q Datotyhoeumhaeveetinagnyartetchoislletcimtioen. o f what the reaction o f the other m anufacturers' representatives were from your observation, standpoint?
(22) (23)
A Q
IAdt tohnis'tproeimnteinmbtimere.
.
I'm
referring
to
the
date________
(I ) p) O)
(4)
P)
o f this meeting, which wPaagseon11M0arch 24th, 1965, hreadduDceowthedecvoenlotapmedinathtieonteocfhTnColDoDgyotrooathtteemr pt to chloracnogens in its end products o r its tric h lo ro p h e n o l?
(6) MR. WAGNER: I object to the form of the
(7) question.
(P8)) QA IYhouonmeesntltyiondoonnoptargeeca5llotfiPmlaeinfrtiaffm'seEsxthhibaitt w2 ell.
(io)
(I I ) (12)
thnaot tedveenteicf tthTeCDvaDp,oarnpahnaismeaclhrerosmpoantosgerampahyysdtiolles occur. Where did you get that inform ation?
(13)
(14)
(is)
QA IMdyidqnu'etsstaioyntihs,atw. here did you get that inform ation?
(16) A It would have come probably from toxicology. I
(17) was just reporting what Jack Peterson said at that
(18)
(19)
O Wpohiontis. Jack Peterson?
(20) A He was an industrial hygienist in the same group
(21) (22)
Q IIsnhbeioscthillewmitihcaDlorwes?earch with myself at the time.
(23) A No.________________________________________________________
(1) 0 Do you know where heP'salogcea1t1e1d now?
(2)
P)
(P4))
A 0
IY5booueflmPieleavneintithoifenf's'sinEintxhheSibaninte2xDtthitoeagltaossoitnmpraeeraatigirrresamapmhenpotlnespage
have shown activity on the animals. Were those
(6) a ir sam ples that you collected?
(7)
((89))
A 0
AY neds . w e re that what
ythoeuy'recorellefecrtreindgfrtoom?
the
199
building,
Is
(10) A I'm not sure, at this point, where they were
(11) (12) (13) (14)
0
Tchoellreecitseda.postscript on Plaintiff's Exhibit 2, that's page 6. Is that a postscript from Dr.
Rowe, or is that something that you wrote?
(15) A The V.K.R. was his standard way of initializing
(16) things, so I would interpret that to be from V.K.
(17) (18)
0 TRhoewlaes. t paragraph on page 6?
(ib) A Yes.
(20) THE DEPONENT: While you are collecting
pi) your thoughts, let's take a break.
(22)
( R e c e s s .)
(23) ___________ BY MR. SCHULER:_______________________________
(D
P(2))
O
Laeptpmeea
rsthoohwayveoubteheisn
doPcaugme e1n1t2. T one that was
hmisa
rdkoeedsntot
R
o
w
e's
deposition, either.
(4) MR. WAGNER: Before you move on to that
(5) document. I've asked Mr. Silverstein about the
(6) individual who he recalls having chloracne, and
(7) with your agreement that he - 1will let him
((98))
identify that person without waiving the right to object to others, revealing others' names, with
(10) your agreement if the court approves, that I can (11) still seek to expunge this individual's name from (12) this record so it's not public record if he later
(13) agrees with me or the judge later changes his
(u) mind.
(15) MR. SCHULER: I agree, that you know, (16) you've objected to it, and the judge has overruled
(17) it, and you certainly have the right to appeal or
(ia) petition for certiori, but I'm not going to
(19) stipulate to another objection. The judge ruled (20) on it (2D MR. WAGNER: I didn't say that I don't (22) want to, by letting him give you a name, let that
(23) __________ serve as a springboard for you saying, well, I've
Page 113
(1) waived it for everybody else; I can't object. I
((23))
can't go to the 5th D.C.A. I don't want it to be a waiver in any other context
((45))
MR. SCHULER: In other words, the fact that he discloses the name will not prevent you
(6) from taking the appeal?
(7) MR. WAGNER: Correct
(8) MR. SCHULER: I'll agree to that 0 ) MR. WAGNER: Go ahead.
(10)
(((111213)))
(14) 05)
((1i67))
0A ILwetismheyroMeusRtaw. tLeoUuthTldeZ.:quTehsetiomny.stery guest
Q
/yaosukreedmyeomubtoerieddenthtiafyt
any had
o f those people that sustained chloracne
a
s
a
result o f exposure to chloracnogens in your
experience at Dow Chemical, and you thought fo r a
minute, and I think your answer was you remembered
(((((2221ia0291)))))
(23)
A Iopnreeermspoeenmr.sobne,raonndlyI'oll naesknyaomueth, eRnoasme,eRo-Of th-Se-E. 0A AThmaat'ns oarma awno.man? Q Do you remember the first nam e?__________________
(1)
((23))
A No, I don't know. AQ IShtiallvaelivneo? idea.
Page 114
(4)
((65))
0
A
Do Othne
you know where Mr. Rose worked, in what pa lycothmaptahney?woDrikdehdehwaodrk19in9thbeui1ld9i9ngb,uyildeainhg.?
rt
o
f
((87)) AQ IDdooyonuotkrneomwewmhbaet hr iist.job function was?
(9)
((1101))
(12)
(13)
((1145))
0
A
HIhhiomaw?vdeidnoit
come Idea.
about that you
met
him
or
rem em b er
0 Wdifafesrtehnertethsaonmtheethointhgesrsig, nthifaicta'snwt ahbyoyuotuhriemmtehmatbwears
A Ohimnly? that I was acquainted w ith him.
(16) (17)
(is)
((2109))
(2 D
((2223))
0A IWdaosnh'tisrecmaseemobf echr.loracne worse than the others?
Q
A
And th Yheims.?
is
w o u ld
have
been
about
1964
that
you
m
et
0
A
NYsotoiul,l
wdI doithon
'ttnhhoeatv.c_eo_m_a_np_ya_in_d_ye_ao_r_as_tt_tih_ll_iisn__pM_o_iid_n_lta_wn_dh__eo_thr_e_n_ro_ht?_e_'s________
(317) 631-0940
2135
bsa___________ LAWRENCE SILVERSTEIN - Kimberly Moyer vs. Dow Chemical - March 9-10,1993
(1) (2)
m(3)
(5)
0 Okay. 1handed you a dPoacguem1e1n5t, and I'll ask you
to review that particular document, if you wouldn't mind. AQ JYuosut wloaonktamt Itettoofaremaidliatrhizeeeynotuirrseetlhf winigthoitr. -
m(6)
(8)
A0 ODokayyo.u recognize that as being a document that you
authored?
0)
(10)
A O
YL ee st's.
go
ahead
and
-
is
there
a
date
on
that?
(11) (12)
AQ OWnhatht ies lthaestdpaateg?e.
(13) A February 24th, 1976.
(14) (P laintiffs Exhibit 3 w as marked for
(IS)
T)(16)
(1 (18) (19)
O
BE
exhfoibreit
1iadsekntyiofiucastoiomne.)questions about Plaintiff's 3, Mr. Silverstein, do you know anything
about the facts o f this case, Moyer versus Dow
Chemical, et al, case?
(20) MR. WAGNER: To the extent you may have
(21) been told anything by me, 1 instruct you not to
(22) answer. If you've heard about it from a source
(23) other than a lawyer, feel free to give him that
Page 116
(1) (2) (3) (4) (5) (6)
A0
TShoeyoaunshwaveerni'st lnooo.ke witnesses or parties
d o
at any depositions r experts outside o f
of what
the lawyer for Dow Chemical communicated to you,
ythoisu cwaosueld? have no knowledge o f any o f the facts of
(7) (8) (9) (10)
(11)
A That is correct.
Q Plaintiff's Exhibit 3 appears to be a document that you identified, and it's entitled, quote, Chloracne in the Dow Trichlorophenol plant, close quote, Circa, 1964, correct?
(12) (13) (14)
(15) (16)
A O
ACnodrriet'cst.broken says dictated F
edborwunariyn2to4tvha,ri1o9u7s6s, eacstyioonus.
It
Fteesbtirfuieadrye2a4rltihe,r.19W76h,ydwoaysothuisredciactlla?ted on
(17) MR. WAGNER: Iobject to the form of the
(18) question.
(19) A Y e s, I do recall, it's b e ca u se l w as about to
(20) (21)
0
transfer to Dow Badische -
Which we spelled earlier, 1think.
(22) A - in Williamsburg, and wanted that done before 1
(23) left.
(1) (2) (3)
0 rWeqasuethsitseddobcyusmoemnet,oPnleaP,inaotgrifewf's1a1Es7xthhiisbidt o3,ne by you for
your own summary purposes?
(4) (5)
A0 1Wdhoynd'tidreymouemwabnetr.it done before you left?
(6) (7) (8)
AQ iYttimowueoh,uaislvdethbnaeot csctorlerircaetrclryte?ccoonllejecctitounreattothaisnpsowinert itnhat.
(9) (10) (11)
A O
TDlehoaavytion'sugc?konrorwecwt.hat
file
this
was
put
into
upon
your
(12) (13) (14) (15) (16)
A O
NThoi,s1ddoocnu'mt. ent appears to have been eevxehribqituneusmtiobneerds farobmouot tthhiesrplitaigrtaictiuolna.r
marked w dWoceuremyeonut
ith in
other cases?
(17) (18) (19) (20) (21)
A0
1 don't rem em ber specifically.
There appear to be some edit marks
at
various
points in this document. Do you know whether you
edited the document or whether it was edited by
someone else?
(22) (23)
A 0
D1 dooyno'tu kknnooww. w h eth e r
this
document
was
used
fo r
any
(1) (2)
purpose outside o f keePpaingge i1t 1in8your own We within the company?
(3) (4) (5)
AQ
D1dooynouotkknnoowww. h purpose outside
eothf tehrethcisomdopcaunmy?ent
w
a
s
used
fo
r
a
n
y
(6) (7) (8) (9) (10)
(11) (12) (13)
A0 O1dnopna'tgken5oowftPhlaatin. tiff's Exhibit 3 you mention
that in February o f 1964, the plant assistant superintendent and some operators were examined by the m edical department and were found to have chloracne. My question to you is, do you recall the name o f the assistant plant superintendent that you were referring to there?
0(14)
(15)
A YWehso. was that, sir?
(16) MR. WAGNER: Same understanding with
(17) referring to identifying the person's name?
(18) MR. SCHULER: Yes.
(19) (20) (21)
A0
IAcnadnthaantsisw the routing
tehre? MAr.l slips fo
LLuueecckk,wLh-oll1-Eth-iCn-kKa. r some o f the other
pmpeemaroerdanodna?
(22) MR. WAGNER: Object to the form of the
(23) question.
Page 119
(1) (2) (3)
A0 YDeosy. ou recall whether Mr. Lueck had a severe, m ild
or moderate case o f chloracne?
(4) (5)
A0 1Ddooyno'turkencoawll wthhaetr.e Mr. Lueck is located now?
(6) (7) (8)
A O
NDoo.you kn C hem ical
oCwomif phaen'sy?s
till
em
ployed
w
ith
D
ow
(9) (10)
A0 TAot Mmidylaknndowsolemdegpel,aycees?.
(11) (12) (13) (14) (15)
AQ ADso fyaoruarsem1kenmobwe,rtthhaetn'sawmheys o1sf aaindy noof theearolipeer.rators, who you referred to on page 5, who reported to the m edical department or were examined by the m edical department and were found to have chloracne?
(16) (17) (18) (19) (20)
A0 NWoh.en you say operators, do you recall how many
there were in the plant, or is that just a generic description for the people who worked in the process in the plant?
0(21)
.(22)
A YThees.latter?
(23) A The latter, yeah.
(1) (2) (3) (4)
0
Ywoeuremtheen tfioirns tofunllp-taimg ee
7Ptahgaet y1o2u0, Larry Silverstein, safety officer. Are you
referring to in any of the plants o r this
particular building 199?
(5) (6) (7)
A0 RWeefreerrthinegretooth19e9r s. afety officers fo r other
manufacturing buildings?
(8) (9) (10) (11) (12) (13)
AOIYthdoauot
mnoetnktionnowo.n page 8 o f Plaintiff's Exhibit 3 thorough safety training indoctrinations fo
r
a ll persons working in that plant were held. Do
you recall the frequency o f those safety training
indoctrinations?
(14) (15)
A
Q
IWdeoren
'tth. ose
m
eeting
s
tha
t
you
conducted?
(16) (17) (18)
A0 IDdidonyo'turehmaveemabneyra. ssistants that helped you to or
that would have conducted meetings like that?
(19) MR. WAGNER: I object to the form of the
(20) question.
(21) (22) (23)
A0 RWcoeenprdeeuathctetterhedeathqneuyseaesstssioaisfneta.tynttsrathinaintgwoinudldochtarivneations
XMAX
:!
nV
(317) 631-0940
bsa___________ LAWRENCE SILVERSTEIN - Kimberly Moyer vs. Dow Chemical - March 9-10,1993__________ xmax
(1) fo r persons working atPthaegpe la12n1ts?
(2) A No.
O)
(4) P)
(m6)
Q YtEhouaurtomypoeeu,nIwtnioelnaretoeonn1pe9a6og4fe,ttho1e0tapolekfrPstoloancinsotmiwff'hpsoaEnwxiehesinbwtittho3o had experienced a sim ilar problem and claimed to have found answers to it, and you mention the one
(8)
(9)
(10)
Fhreelpncrehfrceosmhpyaonuyr arencdoalleGcteiormn aant acollmabpoauntyw. hDooes that the companies may have been?
(11) A Well, I think I'v e mentioned Boehringer In
(12)
(13)
Q DGoerymouanreyc. all the French company or the other -
(H) (is)
(16) (17)
(is)
(19)
(?o)
(21) (22)
(23)
AQ 1YthtohauitnmwkhetinhleteiothnFeroecnnapcuhasgtIices iPn11rsoooglufilPb, llPae-inoRtii-lfOfin's-GtEh-xelh-nLibeiwt 3 process s till contains a few parts per m illion of the known acnegen that caused our trouble In the old plant, it Is orders o f magnitude less than was found to be In the old plant's C l oil. With rneegwaprdrotocethssatasstabteemingentth,aatrperyoocuesresftehraritnwgatos the purchased, if you will, from the German company
(1)
and that was Installed aPtaMgiedl1a2n2d sometime after 1964?
(((453)))
AQ
YAensd.you m ention tha magnitude less than
twthaes
contaminant was orders
found in the old Cl oil.
o
f
(6) Do you recall what the numbers were?
(7) (8)
(1(09))
A Q
NNoow. , I'm going to jum p over to page 14 o f your
m3, eamn doryaonud umme nwtieo nhathvaetmy oaurkreredcaosllePclatiionntifwf'sasE,xahtib
it
(11) (12) (13)
(H)
the beginning o f the company's quality control gtthhuaaindt ceoolninmeep,powarrattwsptiethhramytotihluleior rpnercboodylulweccettigmiohnutsototfcdToaCnyDt?aDin. leDsoses
?*K (is)
(16)
MR. WAGNER: Object to the form of the question.
(17) (is)
((2109))
(21)
QA AYneds.then you go on to say that improvements in the
acnoanltyroticl laiml mitewthaosdrecdaumceedabtoo.u0t5s,oatnhdatntohwis
quality stands,
you said, I believe, at .01 parts per m illion in
(22)
(23)
sthtaenfdinaarldptrhoadtuecxti.steIsdt,htaotythoeurlimrecitoollretchteion, when
(1) you did this memorandPumagien 1F2e3bruary o f 1976?
MR. WAGNER: Iobject to the form,
P) compound.
(4) (5) (6) (7)
A Q
TAondthwehbenesytooufmmeynrtioecnotlhleact tthioens,tyaensd.ard parts per m illion in the final product, are
ywoaus
.01
referring to the Sllvex and 2,4,5-T?
(8)
(9)
(1o) (11) (12) (13)
(u)
AOIIqndutoah
enontexret csaelnlt.ence you mention that a ll o f th lity control analysis data fo r the productio
nis
from the new plant has been retained by plant
supervision and Is available if needed o r desired.
What type o f data, as you recall, would be kept by
plant supervision?
(15) MR. WAGNER: I object to the form of the
(16) question.
(17) (is) (T9)
AQIrWehfheoernrnineysgot
luyrceofeurldtonp'tlaanntsswuepretrvhisaito to?
n
,
w
hat
are
you
(20) (21)
AO FPolarntht astuppaerrtiicnutelanrdbeunildt ing?
(22)
(23)
A Q
YIne os .th e r
words,
if
I
wanted
to
get
-
if
I
w anted ______
P)
(2)
(3) (4)
to look at that documenPtaagtioen1o24r data, to the best of your recollection, anyway, back In 1976, that data would have been located in some file at the plant. Itself, 199?
P) (6) (7) (8) (9) (10)
(11) (12)
(13)
A 0
YYoeus.mention In the next paragra Instituted, although not quite so controls by analysis backed up
ph rig by
that there was id, quality anim al testing
for the end product Into which the trichlorophenol
went, namely the esters, and so there was quality
creofenrtrroinlgdathtaeraevtaoilathbeleeonnd pthraotd, uacst,wteollt.heAreesyteorus
2,4,5-T?
(14) (15)
A 0
SLuetrem. e
see
the
statem ent
(16) A It would refer to the e ste rs specifically, a s I
(17)
(18)
O Trehaedesitt.ers o f 2,4,5-T?
(19) A If you're - Hyou're using 2,4,5-T to denote the
(20)
pi)
0 tWrihcahtlIo'mrorpehfeernrionlg, ytoesIs. the
end product -
(22)
(23)
A Q
Y- ethaaht.
the
trichlorophenol
was
a
com
ponent
o f? _____
Page 125
(1)
(2)
A O
MThme -ehsmtemrs.
o
f
2
,4
,5
-T?
(3) MR. WAGNER: Object to the form of the
(4) question.
(5) (6) m (8)
A 0
YWehsa.t about wfoarsmin?form a
ttihoen
,atmheinseafmorem
,indfoormyoautioknnoIwn
tihf ethaemreine
(9) (10)
AQ BY ye sam.oifn- e, do you mean A-M-l-N-E -
(11) (12)
A O
-Rimghet.aning
the
amine?
(13)
(14)
(15) (16)
(17)
(18)
OAsIYraedofgeuoatmynrdpoeirtnnegktcionatnhou,ewtioo.hnnapsnadbglrinoegc1ho5u,rretlahboatofyfrivaoeutoporyrrehspaixanprdealdigngeaso f the TCDD. Do you know where that would be located within the company?
(19) MR. WAGNER: It's the one he provided to
(20) the government?
(2D (22)
Q Do youMkRno. wSCwHhUeLreERth:atYweos.uld be in the company?
(23) A No, I don't._______________________________
(1) (2) 0)
(4)
0
Going back to page 13P, yaogue m12e6ntioned that there awcnaesgaelsno-pdreovdeulcoipnegdmaalitsetrioalfskbnoywthne company. Do
you know where that would be kept?
(5) MR. WAGNER: Object to the form.
(6) A No.
(7) (8) (9)
0 Ttehsetirneg's, aanfteinrspeargtioen1h3e, rise,threagt ainrdyionugrhuman h a n d w ritin g ?
(10)
(11) (12)
(13)
A O
UThnaftohrutumnaantetleysittinagptpheaat rysouto'rebree,fyeerrsin. g to, that refer to the testing that was done on ja
does il
Inmates, I think it was the Harrisburg prison?
(u) A I don't know at w hat prison, but ft s a y s the
(15)
(16)
Q Dcoonysouultriencgadllethrme naatomloegoisftth, eyedso. ctor who did that?
(17)
(18)
(19)
A 0
SKoligymoua'nre. page, the
refemng to the Kligman handwritten page 13?
testing
here
on
(20) (21) (22)
(23)
A O
YT he es .re 's rabbits
aangdrahpuhmhaenrsetothaTCt dDeDa.lsIws
tithhartessopmonestheinogf
yo
u
prepared, or was that prepared somewhere else?
(317) 631-0940
2136
BSA
LAWRENCE S1LVERSTEIN - Kimberly Moyer vs. Dow Chemical - March 9-10,1993
XMAX
Page 127
(1) (2) (3)
A0 AI pndrewpahreered dthidisyooruiggientatlhley,inyfeosr.m ation to prepare
this from ?
(4) A The human data cam e trom Kligman's report. The
(5) (6) (7) (8)
0 Banaicmk ainl d1a9t7a6,cwamheenfyrooumpDreopwarteodxitchoisloregpy.ort, was
it v
your understanding that the alid scientific experiment?
Klig
m
an
w
ork
w
as
a
(9) MR. WAGNER: Object to the form of the
(10) question; undefined terms, vague and over broad.
(11) A At th e time it w a s considered, 1 believe, to be
(12) (13) (14) (15)
0 Avanldidwionufoldrmyoautihoanv.e gotten the inform ation
regarding the Kligman prisoner experiments from the toxicology department?
(16) (17) (18) (19)
A0 YToesy.our knowledge, were any follow-up studies done
o19f t6h4oasendDwohwowsohrokweresdtheavtidweenrceeeoxpf cohsleodratconTeC?DD in
(20) (21) (22)
A
Q
YCeasn.
you
fe
ll
m
e
w
ho
conducted
those
follo
w
-up
studies?
(23) A Epidem iology section of the sam e laboratory.
(1) 0 O f the toxicology laboraPtaogrye?128
(2) A Well, toxicology, epidem iology, industrial hygiene
(3) w ere all In health and environmental research back
(4) (5) (6)
0 Dthoenyo. u recall the name o f the individual or
individuals who conducted the follow-up studies?
(7) A Dr. Ralph C ook, M.D., w as the head of
(8) (9)
0 Wepaisdaenmyioonleogeyls. e involved besides Dr. Cook?
(10) (11)
A0 YDeoayho,uarencuamllbaenryooffftohlekso.ther names?
(12) (13) (14)
A0
Not for that time period.
Dwoeryeoduorneec?all for how long
the
follow
-up
studies
(15) MR. WAGNER: Object to the form of the
(16) question.
(17) (18)
A0 1Hdoownl'otnugndweerrsetathnedwyoorukrerqsufoesllotiwone.d Dafote1r -1964?
(19) A I really don't know the answ er. There's a
(20) publication on it, but I don't remember when it
(21) (22) (23)
0 Dcaomyoeuoruetm. em ber what decade it came out, the
sixties, seventies, eighties?
Page 129
(1) A 1think it w a s the seven ties, but even that is
(2) (3)
0
vague.
Do you
re c a ll
the
results
o
f
the
fo llo w -u p
study?
(4) A To my recollection, there w as no e x c e s s of any
(5) d ise a se found, and th ey w ere looking especially
(6) for ca n cer and found no statistical significance
(7) in term s of th e fate o f th o se people who p assed
(8) (9) (10)
0 Dsocnoi.eynotuifircejcoaulrlnwahleotrhneor tth?e study was published in a
(11) (12)
QA YDeosy.ou recall whatjournal it was published in?
(13) A 1 believe it w a s the Journal of Occupational
(14) (15)
0 AMneddiincdiniree.ctly i asked you this before, but do you
(16) recall what year it may have been published?
(17) (18) (19) (20) (21)
A0 A1dsofanr'tarseymouemr rebesrptohnesyibelayri.s concerned, 1take
it from what you're telling me that you did not participate in the follow-up study, is that rig ht-
(22) (23)
A
0
-Nao,stahnatin'sdnuosttri-a
l
hygie
n
is
t?
Page 130
(1) A No.
0(2)
(3)
D id you?MR. WAGNER: Object to the form.
(4) (5)
A0 YWehsa. t did you do?
(6) A 1 estim ated the categories of exp osure for the
(7) (8)
0 Wwoerrekeyrosubr reeinsugltsstucodmiemd.itted to w riting?
(9) MR. WAGNER: In a form other than the (10) article that was published?
(11) MR. SCHULER: Yes.
(12) (13) (14)
A0 D1dooyno'tu rreecmaellm. ber what the results were o f your
estimation of the exposure?
(15) (16)
A0 ANnod, s1isr.ay that, 1mean, can you give me a range?
(17) (18)
A0 BNuotttahantuinmfoerrmicaatliornanwgoeu.ld be in the article?
(19) (20) (21) (22)
A0
DIenxidpthoyesouuarredtsiocilnaen,cycotohnrinnregeccettilo,syneewoatihthh.etrhtehafonlleoswti-mu
a p
te stu
d
y
o f the 1964 workers?
(23) A Not to my recollection.
(1) (2)
Q To your knowledge, anPdathgies 1w3a1s an in-house Dow study, correct?
(3) MR. WAGNER: Object to the form of the
(4) question. Let me ask a clarifying question. Do
(5) you mean all the authors were Dow employees?
(6) MR. SCHULER: Correct.
(7) MR. WAGNER: Okay.
(8) (9) (10)
A0 AYneds.there wasn't anybody brought in from the
outside, any independent laboratory o r scholars or
(11) anybody to take part in the study?
(12) MR. WAGNER: Objectto the form of the
(13) question.
(14) (15) (16)
AQ
NDoo.you know whether there that died from cancer?
was
anyone
in
that
study
(17) (18) (19) (20)
QA 1Wdeolln, 'ytoruemwoeumldbne'rt.remember then if there was athneyno,nIeatshsautmdeie?d from a specific type o f cancer,
(21) (22) (23)
A
Q
THhaavet'syocuorpraerctitc, ip1watoeudldin naonty studies done within the Dow
other epidem iological Chemical Company with
(1) regard to exposure to TPCaDgeD 1in32humans?
(2) (3) (4)
A0 NIsotht taht athte1orenclyalol.ne that you're aware of, the
1964 group?
(5) (6) (7)
A 0
YDeosy. ou kn study that
odwidwnhoet tehveidr aennycoencehwloarascinncel?u
de
d
in
that
(8) MR. WAGNER: Iobject to the form.
(9) (10) (11) (12)
A0ILdeot mn'et kshnooww.you this document, and I'll ask you if
you can identify that, and it's been marked as Exhibit Number 17 to the deposition o f Row.
(13) THE DEPONENT: You guys have the worst
(14) copying machines in the world.
(15) MR. SCHULER: We got it from Dow
(16) originally.
(17) (18)
0 Would yMouRi.dWenAtGifyNtEhRat: foitr'sthneorteacllohrdis, fpaleualtse?
(19) A The docum ent is a memo with a date that is
(20) illegible, entitled the Hazard of M onsanto T Acid,
(21) by L G . Silverstein. Is that March 14th? I ca n 't (22) tell.
(23) (Plaintiff's Exhibit 4 w as m arked for
orp
cr
BSA LAWRENCE SILVERSTE1N - Kimberly Moyer vs. Dow Chemical - March 9-10,1993
Page 133
(P1)) P) M(5)
((67))
Q 2Th4i5sTwaacsIiddaetmnhateitfmiDcoaotwtihoahnta.y)dopuuhracdhadsoendefrroemgaMrdoinngsasnotmo,e correct?
AQ
TAhndatt'hsecmo rarteecrital to contain TCDD
pinurccohnacseendtrfarotimonMs aovnesraangtoingw
aasb
found out
(8) ten parts per m illion, according to this, correct?
P) MR. WAGNER: Object to the form of the
(10) question.
(11) (12)
A 0
II'td's
ltihkee
btoo
tstoeme
iot,f
htheerefi.rs
t
paragrap
h.
(13) (14) (15)
A 0
AYensd.you were constituted a
hcaoznacrde,rnIsedthbaet ccaourrseectth?is
p
rod
u
c
t
(16) MR. WAGNER: Object to the form of the
(17)
(18)
Q In your oqpuiensitoinon?.
(19) A That's correct.
(20) (21)
0 Asonmd eprpoodinutc,tcwoarrsescot?ld to Rlverdale and Woodbury at
(22) A My recollection -
(23) _______ MR. WAGNER: Object to the form of the
Page 134
(P1))
question. A - w a s that it w as proposed to b e transferred to
P) som e other place, and th o se two nam es sound
(4) (5)
((67))
(8)
O
fWamelli,liloaro.k Iadt tohenomtermecoarlalntdhuamt itahndapspeeenief dth.e pmreemdiocraatnedquumesrteiofrne,sWheosoydobuurryreacnodlleRcivtieornd.aAlesaare
what type o f companies?
(9)
(10) ((1121))
A 0
IDhoanv'teyonuo sidtaetea.in page 4 already sold to those two
that the prod com p anies?
uc
t
w
as
MR. WAGNER: Object to the form of the
(13) question.
(14) A No, I don't read it that w ay, but I s e e in
(15) paragraph two, I'm talking about the requirements
(16) if w e p ro cessed it in 199 and 349, and my
(17) recollection Is that's what w e planned to d o with
(18) it when w e got it, and It s a y s Dow's involvement
(19) In shipping this material to Riverdale concerns
(20) me. It d o esn 't s a y w e shipped it. I don't
P1) rem em ber it being shipped. I don't know. I just
(22) P3)
Q DdoidnD'tokwn,oiwn twheha1t9h7a0ps,pteonyeodutrokniot wledge, purchase
(1)
PP))
2,4,S-T o r 2,4-D from anPyagoeth1e3r5manufacturers fo r resale to chemical suppliers?
MR. WAGNER: Object to the form, over
(> broad, vague.
(5)
((67)) (P8))
(10) (11) (12) (13)
A 0
IWdhoonwootukldnokwno. w
about
som
ething
like
that?
A 0
IDdooyno'tu kknnooww twhhaettehiethr tehre.re was any follow up from rthigishtm, iet'ms horaarnddtuomm,alokeokosulti,kiet looof Mksalrickhe -Myaorcuh're
15th, 1965, do you know whether there was any
follow up from this memorandum we marked as
Plaintiff's Exhibit 4?
(14)
(15)
A My recollection is that th e material In question w a s re p ro ce sse d within Dow Chem ical until it w as
(16) non-detectable by analysis, and then it w as
(17) p ro cessed , but that's strictly m y recollection at
(18)
(19) (20)
O Dtthhoeisyreoppuorikonncto.ewsswinhgo?would have been responsible for
(21) (22) (23)
A 0
DNoo.you recall any com plaints from Dow customers from, say, 1964 through 1976, regarding any_______
O) (2)
chloracne from any o f tPhaeg2e,41-3D6o r 2,4,5-T or Silvex products sold by Dow?
P(4)) qMuRes. tWioAn.GNER: Object to the form of the
(5) (6) (7)
A 0
INf oth.ere were some complaints, w involved in responding to those?
ould
you
be
(8) (9) (10)
A 0
DNoo.you know who would be involved complaints from customers?
in
responding
to
(11) 02)
03)
(H)
(15) (16)
QA NDoo.you recall any complaints from any Dow customers o r end users of 2,4,5-T o r 2,4-D or Silvex from 1964 through 1975, regarding It causing - the causing o f cancerIn any users o f 2,4-D, 2,4,5-T o r Silvex?
(17) MR. WAGNER: Object to the form of the
(is) question, vague, over broad as to time, as well.
(19)
(20)
pi)
(22)
A 0
ANnod. I there
awsesruemseucyho
ucor amnpslwaienrtsw,
oyuolud
wbeo
uthldensoatmbee
if
involved in responding to them, correct?
(23) A That's correct.______________ .________ ______
(1) (2)
Q Are you being paid fo r yPoauger ti1m3e7 in testifying in this case today?
(3) (4) <5) (6)
AQ YAensd.what's the compensation understanding that you have regarding your time for the preparation or time in deposition here for this case?
(7) A My present em ployer is being paid for m y time
(8) spent here, and I will receive my normal
0)
(10)
0 cTohmatpisenFsaalltoiownEfnrovimronhmime.ntal Engineers, Inc.?
(11) (12) (13)
(u)
d5)
AQ TAhndatw'shcaotrisreycotu. r understanding o f the compensation arrangement to Fariow Environmental Engineers, Inc., fo r your time involved in the preparation or testimony in this case?
(16)
(17)
A 0
AFnodr
mthyats'serfovricperes pinarlaetgioanl
aanredadse, pit'ossi$tio15n0timane?hour.
(is) (19) po)
A 0
AYneds.is it your Company is p
auynindgertshtaant damingouthnat ttoDFoawrioCwh?e
m
ica
l
(21) A My understanding that Dow Elanco will p ay Fariow,
(22)
(23)
Q Ayneds.Dow Elanco is, to the best o f your knowledge.
(1) a division o r a part o f DPoawgeC1h3e8mical Company?
(2) MR. WAGNER: Object to the form of the
(3) question.
(4) (5) (6)
A 0
AInresoyomuegwetatiyn,gyaens.y portion or do you get paid a salary
of as
that you
$150 directly, r compensation?
(7) (8)
AQIDaomyopuaigdeat asnaylatyrpye, yoefsc.redit fo r that b illing ?
(9) (10)
(11) (12)
AQ NInoo. ther words, you hire your tim eout, your employer charges fo r your time, and you get paid a straight salary?
(13) MR. WAGNER: Object to the form of the
(H) question.
(15)
(16)
d7)
AQ AThndatI'sascsourmreectt.he salary is based to some extent on what you produce?
(18) MR. WAGNER: I object
(19)
(20)
(2D
A 0
wI/hadasidst yunom'tueupnyroodduerrussctaealnainrdy.teisrmb
ased to som s o f billing?
e
extent
on
(22) MR. WAGNER: Same objection.
(23) A It's a straight salary, annual com pensation, at
XMAX
(317)631-0940
2 13 7
i\ D - W 3
BSA LAWRENCE SILVERSTEIN - Kimberly Moyer vs. Dow Chemical - March 9-10,1993__________ xmax
Page 139
O) (2)
(3) (4)
0
Ithuinsdpeorsintatn. d that, but I assume that it's based, to some extent, on what you produce for the
company, billing-wise, right?
(5) MR. WAGNER: Object to the form of the
(6) question.
(7) (8)
0)
A0 TDhoaytoius knnootwcowrrheocJt..E. Johnson was at D ow Chemical
Company back in 1969?
(10) A T here w a s a Julius Johnson who w as a v ice
(11)
(((111234))) (15) (16)
0
Lperet msideesnhtofworyoreustehaisrcdho,cIutmhiennkt.that's been marked as Exhibit 24 to the deposition o f Row, and I 'll
ask you if you've ever seen it before?
A I have never seen this before, to my knowledge.
MR. SCHULER: So we have a record here,
(((111789)))
(20)
(21) (22)
(23)
let's mark this. (Plaintiff's Exhibit 5 w as marked for
Q Aphasangpdeaswr.troiitDdtfeeoPnnlyatmoiifnueictmirafefto'scirooaEngnx.nd)hiuzibmeitw5h,heotrheme, araepy'sphaeaavres ptorebpeartherdee th a t? ___________________________________
Page 140
(1) MR. WAGNER: Object to the form of the
(2) question, calls for speculation.
(3) (4) (5)
A0 TAhnde yaonus'wveerneisvenros,eIednotnh'attrheacnodgwnriiztteenthmate.morandum
before?
((76))
(8)
(9)
A0 TLhetamt'se rsihgohwt, yIohuavtheisndoot.cument that's already
marked as Exhibit 20 to Row's deposition, and I'll ask you if you've seen that before?
(10) A I don 't rem em ber if I'v e ever see n it before.
(11) (Plaintiff's Exhibit 6 w as marked for
(((111234))) 0 ItnhaPt,laMinrt.IifdAf'esxneEtsixfihigcinbastitiot6hni-s.)baesfaorme eI mgebteinrtoof the safety
((1156)) mdeepnatirotmneednth, iIsthnianmk ey,otuhtaetshteifiewdaseaarlmieer,mabnderIo f the
(((111789)))
(20)
scaomrreecdt?epartment that you were a member of, is that
A0 AFonrdahepewraiosdalosfotaimn ein, dyuess.trial hygienist?
(21) (22)
(23)
A0
Yes.
He m
entions
in
P
la in tiff's
Exhibit
6
that
there
was some reports o f chloracne from what's called a
(1)
((32)) (4)
Tordon, T-O-R-D-O-N, pPlaagnet. 1A4r1e you fam iliar with the chemical, Tordon?
A0 DInoaesgeTnoerdroanl sceonnstaei,ny2e,s4.-D?
(5) ((76))
A0 IDTdooorydnoo'tunk?knnooww.o f any of the chemical components o f
(8) A I couldn't nam e o n e of them, for you, no, I'm
(9)
(10)
0 Asorerryyo.u fam iliar w ith a product named Kuron?
(11)
((1123)) (((111456))) ((1187)) (19)
A0 NHoo,wI'ambonuottE. stron?
A0
A
D
v
o
agu
you
e fam
know
iliarity with that
whether either K
term.
uron o
r
Estron
contained 2,4,5-T orSiivex?
A0 IIndyoonuor tasksniogwnm. ent in connection w ith the 199
building, did you have occasion to deal w ith any governmental entitles regarding workers' safety in
(20) 1964, '65 o r '66?
(21)
((2232))
A0 NHoo.w about later years?
A No.
Page 142
(1) 0 Did you, yourself, Mr. Silverstein, ever contract
(2) a case of chloracne?
O) A No.
(4) 0 Did you participate at all in the decision by the
P)
(6)
Dow Chemical Company to withdraw 2,4,5-T or Silvex from the market?
(7) A No, sir.
(s) 0 Were you aware that that decision process was (9) going on at Dow Chemical Company at any point in (10) time?
(11) MR. WAGNER: Object to the form of the (12) question.
(13) A No.
(14) 0 Have you participated in any groups or. I 'm not 0 5) talking aboutjust in connection with your (16) employment with the Dow Chemical Company, but even (17) since your employment at 1979, participated in any (18) groups that have studied safety of 2,4-D as a (19) herbicide?
(20) A No.
(21) 0 Do you belong to any professional organizations, (22) you told me what your educational background was, (23) but do you belong to any professional_______ _________________
Page 143
(1) organizations or have you in the past belonged to (2) any professional organizations in connection with (3) your employment?
(4) A Yes.
(5) 0 What organizations?
(6) A The American Industrial H ygiene A ssociation and
(7) the Health P h ysics Society, and S ta te chap ters of
(8) the Industrial H ygiene A ssociation.
P)
(10)
0 Have you held any positions with those organizations at one time or another?
(11) A Yes.
(12) O What type o f positions have you held?
(13) A Well, I w as a m ember of, chairman of the
(14) Laboratory Accreditation Com m ittee for the
(15)
(16)
0 HInodwulsotnrigalaHgoygwieansethAast?sociation.
(17) A 15 years a go . Let's se e , I can tell you, 1975,
(18) '76, '77.
(19) 0 Any other positions?
(20) A I w as president of the now defunct Northeast (21) Michigan section of the Am erican Industrial (22) Hygiene A ssociation. T hat's it, I believe.
(23) Q Do you have a cumculum vitae that you maintain,____________
Page 144
(1) listing your educational background and various
(2) organizations that you belong to?
-
(3) A Yes.
(4) 0 Do you have a copy of that with you?
(5) MR. WAGNER: I haven't seen it. I'll be
(6) happy to get one for you.
(7) MR. SCHULER: I think I asked for that
((98))
to be produced. If I don't have it, I can't ask any questions about it.
do) MR. WAGNER: I didn't recall that, (11) frankly, but you may have. Have you got one here? (12) THE DEPONENT: All right, if we're going
(13) into this, I need to take a break.
(14) MR. SCHULER: That's fine.
(is) (Recess.) (16) MR. SCHULER: Okay, let's go back on the
(17) record.
(is) Q Let me show you this document that you handed me,
(19) Mr. Silverstein. If that wasn't intended to go
((220D)
(22)
with it, you can take it off, if you want.
A You want the document?
Q I'm asking you to identify it for the record.
(23) A I'm sorry, I s e e - 1 didn't realize w e w ere going_______
\
BSA LAWRENCE SILVERSTBN - Kimberly Moyer vs. Dow Chemical - March 9-10,1993
Page 145
(1) on th e record. This Is a letter describing the (2) Industrial hygiene s erv ice s offered by Farlow
(3) Environmental Engineers, Incorporated.
(4) (Plaintiffs Exhibit 7 w as marked for
(5) identification.)
(6) 0 And this document here, if you would identify (7) that, please, sir.
(8) A This Is my resum e', that of Lawrence G.
(9) Silverstein, most recent cop y, to my knowledge.
(io> (Plaintiffs Exhibit 8 w as marked for
(11) Identification.)
(i2> 0 Looking at your resume' that we have had marked as
(13) Plaintiff's Exhibit 8, you make the statement in
(14) here that you have routinely worked with attorneys
0 s) on cases involving real or perceived injuries
(16) related to exposure to hazardous materials in the
(17) workplace. And my question to you is what kind of
(is) numbers are we talking about here where you work
(19) routinely with attorneys for real or perceived
(20) Injuries related to exposure to hazardous
(21) (22)
A Mmaytderriaaflts?a t the docum ent you are holding said
(23) occasio n ally, or w ords to that effect, that_______
Page 146
(1) routinely is a word substituted by my present (2) supervisor, when he revised my resum e'. I have
(3) d o n e it occasion ally, is m ore accurate.
(4) Q Tell me about your occasional experience, then, at P) working with attorneys in personal injury, toxic (6) tort cases?
(7) A It's been -
(8) MR. WAGNER: Let me see it for a second,
(9) excuse me.
(10) Now, the question said the word toxic (11) tort, and Iobject to the form. The resume' (12) doesn't say that
(13) A I w a s goin g to s a y -
(14) MR. WAGNER: Listen to the question, and
(is) I object to the form of the question. It's
(16) (17)
0 How lonugnhdaevfienyeoduabsetoenwahagtutnoxfoicrthoirret ,ist.hat's what
(is) I'm asking?
(19) MR. WAGNER: I object to the form. You
(20) don't have to answer that one.
(21) (22)
0
How long have you been working with attorneys cases involving injuries from exposure to
in
(23) hazardous substances, as you so eloquently worded
Page 147
(1) it here?
(2) MR. WAGNER: Object to the form of the
(3) question.
(4) A I'm trying to recall my first such e v e n t I
(5) b elieve it w as in the m id-seventies, and the only
(6) o c c a sio n s on which I h ave worked with attorneys
(7) sin c e th e m id-seventies w ere involved with c a s e s
(8) having to do with Dow Chem ical Com pany.
(9) O And can you give me some idea of the numbers of (1o) cases that you've been involved in since the in) mid-seventies?
(12) A L ess than half a dozen.
(13) 0 And can you tell me what types of chemicals were (U) involved in the half a dozen cases?
(15) ' MR. WAGNER: Object to the form of the
(16) question.
d7) A In all but o n e instance it involved the dioxins.
(18) 0 Can you give me the names of some of the cases?
(19) A That, I cann ot do. I don't remember.
(20) O Would the bulk of your being involved with (21) attorneys have been on Dow Chemical Company's (22) behalf?
(23) ________MR. WAGNER: Object to the form of the
Page 148
((21))
P)
(4) (5) (6)
A Yes. question. 0 Iaagsasuinmsteaadnioaxttinormneaynwufoaucltdunre'trhwirheileyoyuoutowteesretify
working for Dow Chemical Company, o r maybe I'm wrong. Has that ever happened?
(7) M R. W AG N ER : O b je c t to th e form o f th e
((89)) A Was theqrueesatiqoune. stion?
do)
(Th e r e q u e s t e d m a t e r i a l w a s r e a d b y t h e
(11)
REPORTER.)
(12) M R. W A G NER: S a m e o bjection, I o b ject to
(13) (14) (15)
((1167))
A I don't kthneowfo.rm. A0 IYTdohuoandt''sot nka'ntwoknhwoo.wleY?obuigausnkievde,rshea.s that ever happened?
(is)
(19)
(20)
(2D
Q Six cases doesn't sound like an universe to me. A GyWoihvuaertsmaetrtevoitrchneeesyqsinuhteahsveetipoyanosuat?gwaoirnk,epdlewaitshew. ho have hired
(22)
(Th e r e q u e s t e d m a t e r i a l w a s r e a d b y t h e
(23) _________ R E P O R T E R . ) ____________________________________
(1) (2)
(3) (4) (5) (6)
(7)
(8)
(9)
A IYa'dtotoulikrsneaetiydo,,tqhouirmeesdytiomknneo.twhIel'Pevwadeggoneered,1vi4fnoe9grr baoenfeythnthepinqagiud.ebstyioann.
Q Well, le t me explore that a little bit. You said
that you've routinely worked w ith attorneys on
ctoa
seexspoinsvuorelvitnoghraezaalrodropues rmc eaivteerdiailns
ju rie s in the
rela
ted
workplace, and let me ask you what attorneys
you've worked with in that context?
(10) M R. W A G NER: O b je c t to th e form o f the
(11) (12)
(13)
(14)
05)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
(23)
A IChhaevme iwcqaoulrekCsetoidomnwp. iathnyaettoxcrnluesyivserleyp. resenting the Dow
0
And I assume Rivkin, Radler
in the past that law firm fo r the
was tim e
probably the period you're
A Itadlkoinn'gt kanboowutfforormsuthree.m id-seventies?
0
A
YDtheoasty.yoouurewmoerkmedb
ewritthhe?
n
a
m
es
o
f
a
n
y
o
f
the
la
w
yers
0A IWrehomweemrebethreoyn, ethbeyotnhees nthaamt yeooufrSemamemPbieerrc?e.
Q Maybe I can shorten this up by asking you, have_____
(1) (2)
(3)
you been hired by any Plaawgyeer1s50other than lawyers representing Dow Chemical Company to work on this type o f case?
(4) M R. W A G N ER : O b je c t to th e form o f th e
((65)) A No. question.
(7) (8)
(9)
(1o)
(11)
0 Syoinuceo ryyoouuler ffitrmDobweeCnhreemtaiicnaeldC,oomthpearnthyainn 1th9i7s9, have case, have you or your firm been retained by any other attorneys for Dow Chem ical Company other than the attorneys in this case?
(12) M R. W A G NER: O b je c t to th e form o f the
((1u3))
(15)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
(23)
A Icdoonnfu'tseiqnvugeentsotuiomnnde, e.nrostparnedditchaeteq. uestion. It was QOkay. Have you ever testified in trial,
Mr. Silverstein, on behalf o f Dow Chem ical Company A Ninoa.ny case? Q Itnheyostuartelismt eonftpyuobuliccaot-iaountsh,oyroeud laisnt eopr iydoeummioalokegical
study on dioxin-exposed workers.Was that the study we referred to earlier o f the 1964 workers_____
XMAX
(317) 631-0940
2138
BSA
LAWRENCE SILVERSTEIN - Kimberly Moyer vs. Dow Chemical - March 9-10,1993
XMAX
(1) af D ow C hem ical? Page 151
(2)
m(3)
(5) (6) (7) (8)
A
0
AY ensd. y o u r
name
is
on
that
study?
A
0
YOeths.er
than
the
case
that
we
have
at
hand
here,
the
M oyer case, is your company, Fartow, being paid by
DowElanco o r Dow Chemical in any other cases,
presently?
(9) MR. WAGNER: Object to the form of the
(10) question.
(11) (12)
A
0
N1 dooont'ht
ekrnoonwe.s
th
a
t
y
o
u
're
involve
d
in
?
(13) (U) (15) (16) (17) (18) (19) (20)
A
0
NYoounme teontmiony,kanlsoow, liendygoeu, are a senior IH, 1assume
rsriers. ume, that's ind
uhsetrreia,
lth
a
t
you
hygienist, for dioxin, and then in Agent Orange
investigations. Is that in connection with the
1964 incident that we've discussed here, o r is
that some other position that you held at the company?
(21) (22) (23)
A
0
TWhheenfoyromuehra. ve
d
ioxin
here,
and
then
parentheses,
agent orange, are you equating the two?
Page 152
(1) (2)
A O
NWoh,ysdirid.
you
p
u
t
the
agent
orang
e
in
pare
ntheses?
(3) A B e c a u se to th e lay people, agen t oran ge is more
(4) (5) (6) (7)
O
fWamheinliayor uthsatantedimoxainna,gperreosuf imndaubslytr.ial hygiene rtheeseAaiHrcAh manedaAn?1HA accredited laboratory, what
d
oes
(8) (9) (10)
A
0
AIsmthearticthaen laInbdourasttorirayltHhaytgyioeun'ereArsesfeorcriinagtioton,. was that the laboratory at Dow Chemical?
(11) (12) (13) (14)
A O
YInecs.onnection w ith your Corporation, 1think you
wsaoirdk
yaot
uDsotwartCeodmthinegre
in
1979, have you testified in any lawsuits?
(15) (16)
A O
ND oo.yo u
consider
dioxin
to
be
a
hazardous
m
aterial?
(17) MR. WAGNER: Object to the form of the
(18) question.
(19) (20) (21) (22) (23)
A O
YYoeus.m en in d u s tria
tion in this letter describing your l hygiene services that you were
the
first manager o f industrial hygiene and safety for
the Dow M idland plant. Are you referring to that
(1) (2)
199 building or the comPbagineat1io5n3 o f buildings there?
(3) (4) (5) (6) (7) (8) (9) (10)
A O
AItnrdefyeorus mtoetnhtieonMiindlthanednepxrtosdeunctteinocnedthivaist itohnis. facility was claimed to be the largest chemical
production plant at one site at that time. What
I'm trying to get at here is, you're referring to
the production o f a ll chemicals generically that
were done at that location at Midland, or specific
types o f chemicals?
(11) MR. WAGNER: Object to the form of the
(12) question.
(13) (14) (15) (16)
A O
ILde at,
ot mn'et umnadkeeristtcalnedaryeor,uthr eqnu.esI'tmiotnry, inbgutto- ge were you the safety officer for the overall
t
production facilities for Dow?
(17) (18)
A O
YOeksa.y.
(19) (20) (21)
A In Midland.
O
And that encompassed, 1assume, the many different types o f chemicals?
p
ro
d
uction
o
f
(22) (23)
A Yes.
Q N otjust trichlorophenol o r 2,4,5-T o r Silvex or
(1) 2,4-D, but other chemicPaalsg,ea1s5w4 ell?
(2) (3) (4)
A
0
YHeosw. many a count?
chem
icals,
do
you
know,
did
you
ever
get
(S)
(6)
A O
I1nhtahveehnuondIdreedas. ?
(7) (8) (9) (10)
A
0
EDaidsiylyo.u ever have any input into any standards through OSHA or
NthIeOwSHrit,infogr
oefxam
ple,
for dioxin o r any related m aterials?
(11) A 1 didn't understand your question. 1 m issed a key
(12) (13) (14) (15)
O
LweotrmdesorempeepaltaitceD. id you ever have an into the writing o f any OSHA o r NIOSH
ystiannpduat
rds
fo r dioxin o r related m aterials?
(16) (17) (18) (19) (20) (21) (22) (23)
A Q
NNoow. , I've asked here in the notic
efoor
fsdomepeoasidtiodnit,iotnhaalt
dhoacdutmo
ednotation,
with documents that you produced o r were produced
at your direction in the course of your employment with Dow Chemical Company that pertain to
research, analysis, formulation, study or
production o f 2,4-D, 2,4,5-T, Silvex or any
(1) (2)
product containing thoPseagcehe1m55icals. Do we have any of those documents here today?
(3) MR. WAGNER: He didn't have any, no.
(4) MR. LUTZ: Not today, or he didn't have
(5) any period?
(6) MR. WAGNER: He didn't have any
(7) documents responsive to the subpoena.
(8) MR. SCHULER: You're not saying Dow
(9) doesn't have the documents; you're saying he
(10) doesn't have the documents?
(11) MR. WAGNER: That's correct, it was a
(12) (13) (14) (15)
O
YMoru.
dons'ut mbpaoinetnaaintaonhyimdo. cum Silverstein, you don't have
eanntys,cios
pthieast
oc
of rrect,
documents you generated at Dow Chemical Company?
(16) (17) (18) (19)
A
0
TYhouatd'socno'trkreeecpt,a1ndyofinleostahtahvoemceowpiitehs.any o f work product from that, what was it, 20-year
yo
u
r
employment history?
(20) (21) (22)
A O
NDoo,y1oduohna'tv.e cop published on the
ies o f the article that epidem iological stu
you dy?
(23) A 1 believe 1 do have a co p y of that.
(1) O Do you have it w ith youPhaegree t1o5d6ay?
(2) (3) (4)
A No, I don't
0 Trehqautewsoteudldhaelsreo. fit the description o f what 1have
(5) MR. WAGNER: 1didn't know that you had
(6) that - 1 asked - 1 think I've got a copy.
(7) THE DEPONENT: Did you ask me if 1 had a
(8) copy of that?
(9) MR. WAGNER: Yes.
(10) THE DEPONENT: No. 1 have it at home,
(11) but not here.
(12) (13) (14) (15)
Q
Let m show
e sMhoRw. WyoAuG, NbEeRfo:reI'1vree you this particular doc
agdotfuartchoepry, .le t m ument that your
e law
y
e
r
has given to me, and I'll ask you to identify it.
(16) A It is a co p y of a published article. You want the
(17) (18)
0 Yperse,cpisleeatsietl.e?
(19) A Mortality Experience of Em ployees Exposed to
(20) 2,3,7,8-Tetrachlorodlbenzo-para-dioxln,
(21) p aren theses, TCDD.
(22) (P laintiffs Exhibit 9 w as marked for
(23) identification.)
( i. !\
(3171 631-n<WI
BSA
LAWRENCE SILVERSTEIN - Kimberly Moyer vs. Dow Chemical - March 9-10,1993
XMAX
(1)
((23))
Q
Ian
cmidineunteta,llwy,itlhe
t me ju stPgaogeba1c5k7, to digress regard to Farlow, how many
fo
r
employees are In Farlow?
M(5)
A 0
AA nbdo uitt's2l0o.c a te d
here
in
Indianapolis?
((67))
(8)
(9) (10)
(11)
AQ AYnesd. in the organization of the company, you m ention that you're director-industrial hygiene safety and training. How is the company broken down? Are there other specific sections of the company?
((1123))
A Well, there's an engineering group. That's pretty much the rest of the company, except for
(H)
((1156))
Q Hadomwimniasntryaptieoonp. le are In the Industrial hygiene safety and training area?
(((111789)))
A 0
AT hn dr eyeotuortsaell.f,
and
who
are
the
others?
A An industrial hygienist and an instructor,
(20)
(((222123)))
0
tWrahiantianrge sthpeecniaamliesst involved?
o f the
other two
people
________THE DEPONENT: Is this all pertinent?
Page 158
(1) MR. SCHULER: Sure.
(2) A Linda Jackow iac is the industrial hygien ist
P)
W(5)
Q DpRrouessysoideuellhnFot oaldrrlavoincwyeiopsfrftiechsieaidltserhaniiptn, itinrnegathssepurececorim,aalpinasytnt.hy,ing
((67)) ((98))
(10)
(11)
(((111234)))
like that?
A Q
NDoo.you
have
any
stock
in
the
company?
A O
NLooo. king at this article we Plaintiff's Exhibit 9, the m
have marked as ortality study done
on
the 61 workers involved in the 1964 chloracne
incident, it's mentioned in the head note to the
article that there were three deaths attributed to
((1156)) ycoauncteelrl omuet,oafnthdeygourocuapn, wloiothk 1a.t6theixsp-ected. Can
((1178)) (19)
MR. WAGNER: What kind? It says what kind at the very end. MR. SCHULER: That's what I'm looking
(20) (21)
((2223))
0 /yoknuowwhyafoot urth. teojlodumrneael iasrlaietrt,hbeuttoups. uIadllyoint 'tteslelse that on this. Can you te ll me again whatjournal
Page 160
0) question.
(2) A From memory, I characterized the exposure based on
(3) my familiarity wfth the plant environment,
(4) physical layout and that type of thing, plus the
(5) data in terms of wipe tests and air samples taken
(6) through the event. And with all that Information,
(7) I could - 1did the best I could in Judging high
(8) (9) (10)
0
Dveidrsyuosu lqouwanetxifpyoitsaulrleo,rijnu setspsuetnict ein. categories, high, low?
(11) (12)
(13) (u)
(is)
A Q
SNyoooubt aqcsouerardnectoitnflyiew,dthh,arnotouy.oguh
just said, using the
if I understood wipe tests and
the a ir sampling, and what was the third thing,
observing the workers, also?
(16)
(17) (is)
A 0
YYoeus.ju st kind exposure?
o
f
put
them
in
groups
o
f
high
o
r
lo
w
(19)
(20)
A0 TOhthaet'rsthcaonrrtoecthte characterization o f the
(21) (22)
ethxepsotsuudrey,wI earsesuthmoesethoaftDthr.eCoothoek,r ceossnecnlutisaiollyn?s in
(23) ___________ MR. WAGNER: Object to the form of the_________
Page 161
(1) (2)
0 Would thqautebsteioanf.a ir statem ent?
(3) (4)
A Q
YIseDs.r.
C
ook
s
till
w
ith
D
ow
?
(5) (6)
A 0
Nis oh.e
s
till
around,
s
till
alive
?
(7) ()
A 0
YWehse.re
is
he
located
now,
if
you
know?
(9) (10)
A O
YWehse. re?
(11) (12)
A Q
ADloswo
iCnoMrnidinlagn
dC?orporation.
(13) (u)
(15)
QA YHeosw. many hours, if you know, has your company billed for your time so far in this m atter?
(16)
(17)
(is)
A O
NHoownem. any hours this m atter?
have
you
accum
ulated
to
date
in
(19) (20)
A O
CI haanvyeonu'tgriveealmlyecaanlceuslatitmeadtey?et.
(21) (22) (23)
A
0
OOaskthaPeylra,tihhnaatinfnf'gsthEoisnxahjriubticsittle9a,thdmaoitny'suontueo.hwa1vb5eemaenrtaypyobrotehd.eurc_e_d_______
(1) this was published in? Page 159
((32)) ((45))
A I b elieve it w a s the Journal o f O ccupational
Q
CMaendyicoiunete. ll me ap p ro xim a te ly?
the
y
e
a
r
o
f
p
u
blica
tion
((76)) ((98))
(10) (11)
A 0
SIsotmheerwe know?
hceornetininu
etdhefoslelovwe
nutpieosf,
thI tishignrko.up,
if
you
A 0
IBduot ynoouthkanvoewn.'t been?
participated
in
it,
if
there
has
(((111234))) AQIYthhoeuaevmxepenonostitournpeasthr,taaitcnyidpoauI'tmewdet,rryecioninrgvretooclvtre.edadinacnaolcbuvlaiotuinsgly
((1156))
very technical -
MR. WAGNER: Ithink he said
((1178))
(1)
0
Okay, lecthmareaactsekriyzoinugt,on-oittcloalockuslalitkinega. table that you may have done. Let me ask you to just
(20) (21)
take a look at that and te ll me how you characterize the exposure.
((2223))
A Q
YWoeull',rwe
hraefteevrreirnygotuonteheids
ttoabrelefe?
r
to
answ
e
r
the
(1)
M (3) (4)
(5)
()
(7)
documents in your possPeasgseion16, 2including reports, ayrotiuclheasv, eo retvraenr fsocrmripetsdrreelgatainrdgintgo tahneycoapuisneioonf soft tissue sarcoma o r the toxicology o r health effects of exposure to 2,4-D, 2,4,5-T, Silvex, 2,4,5-T or any product or substance containing any o f these chem ic a ls?
(8) A No. You asked if I have any documents pertaining
(9) to all that, right?
(10) 0 That's correct.
(11) d2) (13)
(14) d5)
(16) (17) (18)
AQ TDhoeyaonushwaever iasnnyod,oIcduomneontts. in your possession relating to any instance since 1981 that you have been employed by a party or his attorney in connection with or related to litigation involving personal injury or the risk o f personal injury allegedly cause by exposureto a pesticide, herbicide o r other chemical o r substance?
(19) A Oh, boy, I have, in my files at home, a statement
(20) I made. I don't think it waseven a deposition.
(21) I do not know what case. Ido not know for sure
(22) if it's involved with your materials or not, but
(23) that's the only thing I can remember, and I do not
(317) 631-0940
2139
I? 9 3 ^
i
BSA LAWRENCE SILVERSTEIN - Kimberly Moyer vs. Dow Chemical - March 9-10,1993__________x m a x
Page 163
(1) h ave a co p y of that with me. When I s a y at home,
(2) I mean at hom e In Midland, Michigan, becau se I
(3) (4)
Q Adisdtnat'temmeonvtemitaddoewInnchoenrnee. ction w ith litigation?
(5) A Y e s, but I h a ve no recollection of what c a se, what
(m6)
(8)
0
Wmhaetenryiaolus.say deposition o r
-a
statem
ent,
a
re
you
talkin
g
about
a
(9) A I don't e ven know if it w as a deposition, to be
(10) honest with you. I believe it w as a statement (11) m ade, and I w a s a sk ed to review it for accuracy (12) and sign it if I agreed it w a s accurate.
(13) M R . S C H U L E R : I w ould ask that that
(14) statem ent b e produced, as w ell, since you have
(15) th at in yo u r possession.
(16) M R . W A G N ER : I ha ven't seen it, so I'll
(17) have to g e t i t I d o n 't kn ow if it's a w ork (18) prod uct statem ent o r n o t
(19) A I just have no Idea what it relates to, but in the
(20) interest of outright honesty, I had to tell you (21) I'v e g o t it. I don't know what it Is. (22) M R . W A G N ER : I'll have to look at i t I
(23) __________ need to m ake a teleph on e call._____________________
Page 164
(1) ( R e c e s s .)
(2)
(3)
W
(5)
(6)
Q Let's goBbYacMkRt.oSwChHeUreLEwRe:were. You had mentioned that you had some type o f statement or affidavit or something along those lines In your records, Mr. Silverstein, at home?
(7)
(8)
0 On someMRot.hWerAcGaNseE?R: In Midland.
0) (10)
A
0
YDeosy. ou
s
till
have
a
home
th
e
re?
(11) (12)
(13)
(14)
A
0
AY ne sd. I've I'm In a
wrehqipuseaswtehdetrhea,tbbeecparuosdeuIcceadn.
tOasbkviyoouuslayny
questions about it.
(15) M R. W A G N ER : In the break I tried to get
(16) in touch with a D ow law yer to find out - it's the
(17) first I heard o f the s tatem en t and I tried in the
(18) quick brea k to find out w hether or not it is a
(19) w ork product statem ent o r w h at it is, and I w as (20) unsuccessful in tracking dow n th e law yer I need to
(21) talk with. (22) T H E D E PO N E N T: I'm certain it's not a
(23) __________ deposition. T h a t I know,__________________________
Page 165
(1) M R . S C H U L E R : But, I m ean, m y position (2) for th e record is I'm obviously here, I've
(3) requested th at certain docum ents b e produced, and
(4) if th at d o cu m en t fits th e s u bp oen a and w as not
(5) p rod uced, I can't ask an y questions about it (6) w ithout seeing it
(7) T H E D E P O N E N T: You d o understand it's a
(8) copy?
(9) M R. S C H U L E R : I understand. C opies are
(10) not an issue here. Th e issue is th e statement, ( 11) itself. A nd I reserve the right to question this ( 12) witness on an y items that are not produced that
(13) fit th e description of th e su bp oen a that he m ay
(14) (15) (16) (17) (18)
((2190))
0
Let me ghoavdeo. wn the next request was for
rem aining a ll docum
documents here. ents relating to
The
every instance since 1981 that you have been
wemithpoloryreedlabteyda tpoalirttigy aotriohnisinavttoolrvninegy ipnecrsoonnnaelction
injury or the risk o f personal injury allegedly
(21) (22)
(23)
caused by exposure to a pesticide, herbicide or other chemical o r substance. Other than the document you mentioned, do you have any other________
So
Dy
Page 166
(1) documents that would fit that description?
(2) A N o.
p) O The next request was for all documents relating to
(4) any opinion you have communicated or formed since
(5) 1981 In connection with any employment or
((67))
professional services rendered as an expert witness or consultant, including but not limited
(8) to deposition transcripts, contracts, reports,
(9) trial transcripts, correspondence, or documents
po) summarizing any opinion formed and the grounds for
(11) your opinion. Do you have any documents that fit
(12) that description?
03) A N o , sir.
(u) Q Do you have any documents in your possession that
(is) you obtained from the defendants in this case or
(16) (17)
their attorneys, through either this lawsuit or other lawsuits?
(18) A N o , s ir.
(19) Q Do you maintain files at home with regard to the
(20) cases in which you have consulted attorneys in
(21) other lawsuits?
(22) A NO.
(23) Q This statement or affidavit or whatever it is that______________
Page 167
(1) you do have, what kind of a file do you keep that (2) in?
(3) A M is c e lla n e o u s .
(4) Q In that miscellaneous file folder, Is there any
(5)
(6)
other documents that pertain to litigation concerning Dow Chemical Company or any other
(7) company, for that matter?
(8) A N o.
(9) 0 Have you ever been retained or testified on behalf (10) of a plaintiff injured as a result of exposure to (11) a chemical or toxic substance?
(12) A N o.
(13) O In your connection with your employment with Dow (14) Chemical Company and subsequent employment with (15) Dow Coming and your subsequent employment with, (16) as a consultant with Fariow Environmental (17) Engineers, do you have an opinion as to whether or (18) not there is any safe level of exposure to TCDD?
(19) M R . W A G N ER : O b ject to th e form o f th e
(20) question. (21) A N o , I d o not. (22) M R. SCHULER: That's all I've got.
(23)____________T h an k you._______________________________________
Page 168
(D M R . LUTZ: No questions.
(2) M R. W AG NER: H e 'll read it.
(3) A N D FU R THE R T H E D E P O N E N T S A YETH N O T
(5)
_______________ LA W R E NC E G. SILVERSTEIN____________________
Page 169 (D STATE O F IN D IA N A )
) ss: (2) C O U N T Y O F M A R IO N ) (3) I, Aprille R igsbee Lucas, RPR, Notary (4) Public in and for th e C ounty o f M arion, State of (5) Indiana, do hereby certify th a t th e d e p o n e n t
(7)(6) herein w as by m e first duly sworn to tell th e truth, the whole truth and nothing but the truth,
(8) in th e aforem entioned matter;
0 ) That the foregoing deposition was taken <io) on behalf of the Plaintiff; (11) T h a t said deposition w as taken a t th e (12) tim e an d p lace heretofore m entioned b e tw ee n the
(13) hours o f 8:00 a.m . and 6 :0 0 p.m ; (u ) T h at said deposition w as ta ken do w n in (15) stenograph notes and afterw ards redu ced to
(16) typewriting u n der m y direction an d thereafter (17) presented to said witness fo r signature; th at this (18) certificate d o es not purport to ac k n o w le d g e o r
(19) verify th e signature hereto o f th e d epo nen t;
(20) I d o further certify that I am a (21) disinterested person in this cau se o f action; that (22) I am not a relative o r attorney o f an y o f th e
(23)_____________parties, o r otherwise interested in th e ev e n t of
Page 170
/srn fi3i-0Qn
(
bsa____________LAWRENCE SILVERSTE1N - Kimberly Moyer vs. Dow Chemical - March 9-10,1993
(1) this cause of action, and am not in the employ of
P) the attorneys for any of the parties. P) IN WITNESS WHEREOF, I have hereunto set W my hand and affixed my notarial seal this 15th day p) of March, 1993.
(0 Aprille Rigsbee Lucas, RPR My Commission Expires:
P)_________ September 2 1,19 9 6 __________________________
XMAX
(317)631-0940
2140 V - * 2-37
' Company,unti1 December of'19 79. ' ' .....>- .....>.,..A ir . ....................... .... .................. .....iv*..."v....i,,^,.....a ^^^&i5/23^:^mI:i;wasAmanager of industrial hygiene for the Dow Corning
- Corporation f r o m !December, 1979-to September 1, 1990,
' "'when? I? retired.
ii
6/22 8/9
Educational and employment background.
8/16
9/1
' 10/11
t X * <1* h*
10/16
10/20 12/11
To .the best of my recollection, I had no primary
responsibility for manufacturing operations during the
time period from 1971 through 1976.
*i
iiWfl
I believe about 1972 Dr. Ralph Danger became the Michigan:
division industrial hygiene manager?? so he would have had
trthe iiasic; responsibility ,,for that ."vHe is now deceased;'?
-ce .
* / A .*
<, * * ,,, >* ' ;
My boss between >1970 and 1975 would have been Harold R.
4, W
:v.'-vv-y-Vif'
AV
^ fXt jfu
V Hoyle,<who' was/head, o f industrial, hygiene.- `
' i, ;i><,r-
uC?
s -- A *
There may have been four or five industrial hygienists at
-.^Midland,*.-Michigan "involved iinrthefmanuf acturing process
.from 1970 ito 1975, b u t 4not'full-time'to my'recollection. ,
f" *
n ` *$ $
have not ^reviewed jftheAdeposition of.Dr: Rowe.. a,"V -:`
,`cV f . ^ A
''"-A '
'>* A - V
'**
Ipi
.
r cA
rA A
A * it*
w V \v ^ ^ \ 1
...^"Industrial^hygiene was part o f ;the biochemical research
department when^Ijoined insthe 'fifties.Somewhere in '"
, the time period of 1970 to 1975 the name was changed to ^ A
health and environmental
>12/19
13/2 13/7 ;
Dr. Hoyle reported to v
/ 75, for part of that perilocdi ;aanywaayy.
. .................... `V
vA (
A.
-A
Dr. Hoyle is stillialive and in:Delray Beach, -Florida:A
.... ... The other "industrial a hygienists'.were Arnold ^Schaffer,
''" '
Richard D. Olson, George Florez, Edward J.. Schneider and .
k'W-A
.r,`
14/16 15/5 15/13 15/23
The,, other,,role I played, was,, as chief (health ^physicist ,7,
-
which-? isy'rad iat ion Services Program,
wshaifceht'y;o/foffefriecder^;DSofworV;stetriveilc;eDso'w?tNuocl'etahreii?Mf?ff'Wi^^ lA
nuclear ploowweerr industry.
< ~ v v ^ ,t
.- - ; / ' ' ' s i- ' - ' *. > / ,
Back in the 1960s, I was given some responsibilities with
regard`to doing some industrial hygiene work regarding ,,
the process for the manufacture 'of tricKlorophenol by '
Harold R. Hoyle.
. ,, >u . 7
- .'
................................................ / . ,
-w ^ '
I guess I was selected because I was a good c,industrialf l;
hygienist and I was available. j
" v,
- i" / -
1-1
' ,"
N '
i fS h ' 4 v \\ ' - ,, ,
"To the best of my recollection/,' in the yearly >sixties .I
was doing :industrial hygiehe^in^^e^-MidlMid'^liivislonr^^fr
....."... *.......... ...........
st^^fori'ithe^lf#s^
v % .....
.. ^r ^f:^^oroP^eno^ '^erms of-'monitoring^th safetv"^ - *'V.- workers `was i n " t h e
1 ~
r
s
,17/5 ,,
t ' ' ,;V*v 'j 4VjJ' **,U
7 17/9, , vSs.- -
2 ,4 ,S^T/r.Silvex/ or
... ^ ^
______
'Cr-imay'have worked with the "industrial hygiene; aspect of
rithe production of some, agricultural chemicals prior to
*, 1 9 6 4 but r just d o n ' t rrecall.anywspecific project; .>
*i ? **S,W^hf * ftJV? '
' ^**?*',> 4 ir1 , <
,I think^one..time before'1964 we iinvestigated a case of
y,chloracne'l JRoughly 1963\or so.
18/8
vV L i ,i
That case of chloracne was in connection with a different process', called Dow, 6-X.. That was a hexachlorophenolic compound that,I cannot name for you at this point.
>1- *
,
v
1f*i
t
HV
'a
V
v
20H//5R .v..-';!: : f vTTPhVei'lrpl! aawn+t* A4t, Vhiaa+t*[" IT :aa im referrinwgr fp+to^s4is ff::^tVhea S^bmui iv ll d/fil1!nwgrfsr; housii wnrgr
J 1*
the
'
pr
-*
o
d^uction0prorcl ess,
r
e
fe
\
rri ^ 1f
ng^t Vf
o
trichlorophenol. L] *
*
20/21
There was only o n e ,physical building that that applied
to, and that was 199 building. *
.><>:*>;>
21/15
One of my responsibilities was to check exposure levels '
* 1T
of the\workers in the plant'to TCDD.
vV< J ?'i,*
` r '( ' \ ,,f'i. ^L?/;,3M:r^ ^;,, vSj.VL.-.;^)-,. . '*n,,- ywr w ir^-J' . , ,.
21/20
During 'my'vhealth officer - duties ;it was one of my
<-i
* ^ ^^ / v-,.".,/-'`"r,<r*i:1
responsibilities to correct operating 'procedures where ,excessive exposures may be occurring and to .identify
/areas where difficulties with exposure may occur.
f
22/8 -
V T * , * . a k * * r / sr> * " * , * v s r i*t-ta-* *
--";
` ; I also served as kind of a liaison between the toxicology i f
{. */.*//'s.&f?}:Ai.i ; department :and medical department and production -/y .^.-y
U, * ^ 1^-jt'
- ---
s - / " ~-y- , l' ? T T
......
- 22/12 1 Prior to 1964/ there-had never*been^a-caseof* chloracne
Hj ;/'lS",w.; //'ft/,'
in a Dow worker working with trichlorophenol that I'm
a w a r e o f / " .'"H \
U+iy&'s * / '/
22/16
* <v( *
\
.* - J
V'' - , - ' u>
" 'f .
I do not remember any cases of chloracne prior to 1964 m
a Dow .worker'working with the finished product of 2,4^5-'
T,*or Silvex, or 2,4-D. ^
" "r
** * ^
;
'
" 23/2
":v^:.v'vr:.::' '
I don't remember any cases of cancer in Dow workers that' ,-/ x;.were exposed to trichlorophenol, 2 /4,5- T , Silvex;or.2,4-D
in:the manufacturing process.'
"'
W i 23/15
Back in 1964, those workers that came down with / chloracne, would have gone to the medical department first, the medical department would contact Harold Hoyle and then he would tell me and I would investigate it. .
}*''
2143
, '<11 .
26/22 .^;'The >199,/buildxng^'was ,in .the midst ,ofi-va^ery 'alarge ;.^ ^ri;
",
,,/ mVwfahhneAuWrfeAacottKhrAeVirngMVcMchAbeKmm1piMlc^eaxIl/Ms'l*I'a"AoVnrd.sMacAroMomMupAnoWdnAeMinVttA'sarAoe+fVo"tchAheAerMmiSibMcuaeilIlsAd'.ienaVgrMse, ,<#* ?<.
n'Wii;-*,/1_'V. ,made -- > - ^, , .-r
^ '< * i( '',* 'ii * ' ' ' i
'?
^ ,, , -* * \ *1'.' 1 * '* t
27/10., ,r w A . T h ,. chloracne in. the 199 building was first noticed in
* ' ' January or February of 1964.
27/22
I believe the chloracne was mostly due to the exposure to the caustic insoluble oils of the trichlorophenol.
28/2
The caustic insoluble oils is a waste stream.
28/9
The chloracne that I saw looked like a collection of blackheads on the face. Something like teenage acne.
28/17
Some people in Dow Chemical knew: that certain chlorinated organic,compounds caused.chloracne since 1941.
,^
28/23
D o n tD. Irish and others in the, biochemical research
30/1
Based on my review of the history in 1944 or '45, I
J
' K f s .1 believe Dow first 'tested r,the"wcaustic insoluble", oil ^v;^ ' portion of /the jtrichlorophenol? production! to isee if it ,:'*.
caused chloracne. .JS \
v,
V'
30/10
I believe at some point in' the 1950s a' G e r m a n ,company
proposed that there may be a compound, TCDD, responsible
for causing chloracne.
i
^ ^^ " 1,
30/16
In my memoranda, 'when I first got involved; with the
problem in 1964, I called it TCBD. '
"
,,,y
31/11
I think TCDD was the primary culprit in the causation* of
the chloracne outbreak in 1964 at Dow Chemical at the 199
building.
,r
, 1? ' \ 1
I'W iif
MM
\\
V '3-HI
33/18
raising its temperature to around 200 degrees., , , ' 1. ,
.........'
v ''
I don't know with certainty who, the person would.have,
*)-tt1^?
been that was responsible for, that decision.
33/25
The plant supervisor at the 199 building ws Ray Holmes, I believe.
34/22 35/11
There's no .clearcut cut-off time as to when my
responsibilities ended with regard to chloracne and TCDD
and the trichlorophenol process. . The.way things worked,
' : ...... ....... '...Vabout 1967 I took on other responsibilities. ,
., .
In 1964 the chemical or the oils that appeared to be
causing the chloracne ?was tested on rabbits .t\ t' '
35/18
It turned out that the concentration of the chemical was :
W .__
so, high that the rabbits tested by the rabbit ear test
36/5
I can only describe the worker safety routine at the plant at the time -before I made my recommendations in ;general terms and-with no certainty because that 's ?been , a long time.. it would be basically skin protection'and the use \ of gloves when working > in areas that may be contaminated; plus personal hygiene -instructions on washing thoroughly?after!-:any action. .
".5'`V.': I
" Sn>: ,i '/ !
The manufacturing process in building 199 was basically
a closedkprocess within vessels)and piping and;such.
>, -
t ' *y
^
f
1. 4 -
'
37/9 : There? were exits for product and waste streams, and there
were joints within the piping. - -
I- - v . - ,in' . ' / ^ :
'
37/23 , At the time I was safety officer, I required full company
supplied clothing from? the ;skin out, required shower
\ O -A afa-
..
*
iiStfi'-SJ
of&the tishift fi;and^thensrespiratoryiprotectionf *-*-'*'"
TherPiweree^tttwwoc^Sbbaassixc~iiforinsiomrespiratorsffdependingfonj
thefnature^pf/cthey a
^ m v a 's ^ g b J M g ^ t o lt a l
" ' ^ io ffa u
Ith P
39/16
;i'l>.;-'.i= '7 ,.-.^/jyii.^.-' j'*K ' -/, .':' '.-i-^'-.;l"'-i:"->;'A;*;-:.-vi-v'.:>*.^s/v:-.-'-r-.jur.! The workers' were provided_with double lockers. The
>.;purpose was to separate contaminated.work clothes from
, street-- clothes': yj... ,.-/,,..'.,, '.i- . y ,
40/4
We instructed 'Dow's' own laundry, l which ""did the 'work
, clothes, `in special handlings to avoid contact! with the / .
1contaminated clothing they were J.laundering. . A s far as
i&Ei JM
the waste disposal, .there was an operating waste disposal 1
. ;department, and I do not recall any specific interaction ti
with.them. *
" > *'^
* ,, v> /
^ <,*'
$ $ $ $ $ $ $ * ? /$ -i- ^ '**, y 7 "<- \ i * " *' ' " - * i V '*'t$ y - ?
^
40/16 ^ i , When 'I, was'^full-time safety; officer ?in t h e y p l a n t , ; I f
j '& lste sfe recommended two showers a'day.' A shower before :th lunch v,,^> '
vS liM wv-break and then a shower at-the 'end of t h e '1shift
T*
' % v ' 4 1 / 1 3 ^ ' I served'as7 health officer^ f o r 'building 199 for six orvfcf;f\'
?y;';:: ^
jij
>fr>;&: i^is'.;ev</e, nU-m1" o) n* ths, ,
I would
> V
guess. ^
\
, >,.1 !
,-"*/
Vi, ?,
,1.
' '
V'
1.*V, .***t*77
41/22 ,` - The trichlorophenol that was being manufactured was used
in the ^manufacture of 2 , 4 , 5 - T o r Silvex.
. ;> v * ^
, 42/12 'y^\y.7 :-':vV^>^r;}'
, ' 43/6
My recollection is * that the- trichlorophenol was y, '-/"
transported in rail car tanker to another building ,,where
the 2,4,5-T or Silvex was made.
<'
At the time I initially became involved,;!we didn't k n o w 1
w:
what was in the caustic insoluble oil.
' 43/22
In early 1965, the Dow analytical laboratory in Midland developed methods for measuring the concentrations of
2146
V " :-`
T -*
'' *
> 'V'W"
f " %j **> j <rf*' " ^ .......... -^- - -T - '- y - v
"
45/22 /> Over some p e r i o d ,of\ t i m e 1 after the development of the -
.- , m e t h o d , i t improved in stages to one million, one-tenth,
' ;-T,. 0 1 , X; think,-part per million. '
46/0.7,
'W-
The results for the testing of the final product by the analytical method was generally non-detectable in products. That was in the mid sixties.
47/2
The sensitivity level was one part per million at some point in time. .. f . _ v
47/9 48/7
Dow had not determined .that1there was a safe- level of
TCDD ^inv its final-product >that was acceptable" to the
company.
y.-
v
*i 1^4vVIj.
r % \^ b >
j , -* '
There was testing of *t h e 'trichlorophenol- to determine
whether: it would carry,dioxinV^the*TCDD dioxin-into the. -
final 2,4,5-T product:- The result>J-'"most-of the 2^4',5-T
contained undetectable amounts of the TCDD.'
48/16 49/3 '
I- believe 2,4-D was^ tested?;tof determineV whether that '
contained any detectable amounts^of TCDD. X ;do not know
the result
-i
" .....-- '
M y recollection is:the l a t e 'sixties I wrote slab safety
procedures that basically instructed*employees vto;avoid'j
all contact and to wash thoroughly after any- handling,
just in case there was -contact. Employees were also to
wear gloves. Nothing else specifically. .
j
50/22
To my knowledge, the finished product llof 2,4^5-T ;or
Silvex, were not tested for either f u r a n s o r . other ,* ></;
dioxins that were chloracnegenic in the s i x t i e s .I :don't
know about the seventies.
<* `i-V
.'vat**#
.v
^ " ' ' M r , S ,0y.,'vA'nv-
j> J o /
56/5 . v _My recollection of A. P. Beutel is general'manager of ;the
Texas ^division when I started work at Dow and for many
'years.'^afterward.'- ` , They were responsible, for the" '
manufacturing of basic industrial chemicals.' " *
\ V4- I*..;
56/19
^ The name .Andrew Anderson is vaguely familiar;* but I "have no recollection of the-gentleman-or what he did. V ;
57/9 58/4
My only recollection of Dr. H o e r g e r ;is as a;;chemist research scientist., I don't' remember, him-having any m v o i v e m e n t with 2,4,5-T, Silvex/ or.;;2-,4-D. I) *
.....4 .'- " '%
f period of time, D r .^Hinman was director of the
................... .............1 T" - " --------------- '
58/18
I remember Chet Otis, I don't know his official position.
"fjsVVvf **^ v|:|in^thei1com^any.\^v^%\'''v'-
V/S?
59/5 " > X do not1'recall meeting Mr. Oettel'from, Germany.
'
i
-
v 5*
" >-
'N ,
' 59/7 i},f I ,remember the name J. D . Doedens. I remember:" nothing
... .<J .....* more about h i m . ...
> r*1 < 1 3, V *
^
1
.. .....
/
?*vU- A^,- * .
; 59/17 , .When I.was involved with the'trichlorophenol process in
1964,^the process of determining exposure levels was
\ ` ' 1` ,,>, j,taking,|of the wipe tests.and the air samples and physical
-s \H ,', '-f * -tf " / observ^ a.tli-on at the" p^ l a nSt^ -."f
, _/ s:T 'r
* )u,>-T ?
60/12.' 'In '64-'<65; in the toxicology department,
d e a l t 1 with V.J K. Rowe, t h e 1 director, and
iOlson; the toxicologist.
mi
'S V -'^ V >\r
:Y&v'i
8
'
I primarily Dr. Kenneth
, mm
^l4M r
I know F. D. Axe. ,. %He was, an industrials hygienist with
/ t h e company for. a Jlot of years'. 4 "jJ , f>, v',, 'i ,>;/?\ / v . ' > i * ' ' , / / /
r_* ' '
/ /////*
There is a production division.at Pittsburg, California, '/ v
and research , lab, ,also,,. and; he/wasj^the., industrial
hygienist out. there .most1 of the t i m e ;he {was with Dow
Chemical'.'-/-'', .
*$ ?y.
./*> - .nv/v^ *
6 4 / 9 , , :^:v;.l.vhadino`1finputVinto''labeling of.-2,4-D,/2,4j5-Tor Silvex .
`/ y'-.V c'l'yitv viV*k'-; ,,*^r ri'^aK'-'-in<;f'-'di?-'3a',I^"^ don't'ji kriow. who4i*" w- a. sV'.^`f.? rest-Op'- onAsibft. l4eTjv'- * f_or t; hat,V-.-, t,.-,-v<r/' '_ .v .:/;//-.}</jr,-l .'
w
w -V / .. - 4
- /
64/19 ~ I would . generally submit -my;, reports regarding y
#v
1 contamination^ of trichlorophenol t o / t h e toxicology _Sv; '
; ;>section/
K f &^ I
1`^
f_
;,,= ;//vi/ "'/Vi.Vf:*'? V-/ > ;V; .//-*
' .V,
Leng/was ..a^scientist.;-.My recollection^ of her
was" as a member'of theStoxicoloigy lab f o r some period of v ^ r/
- time. Vague recollection that she spent some time in
"V- '^/agricultural researchvdepartment. at Dow in Midland. .
/!?!
ll|i
///t/
65/19
I was aware that Dow had a specific department that was ,
involved with \ the registration u of
j? i * , ^f j *^ pesticides.
",
'^
.. /P
agricultural , 1
68/16
I have not reviewed any rdocuments in preparation for a
today's deposition t h a t ;were not handed to me by a
lawyer.
'
'-
68/23"
I have not testified /before the EPA or any of its subcommittees.
s
69/6
Since leaving Dow in 1979, I do not maintain any consulting arrangements with Dow.
\ p-JZ ltp
1st, ii.
^ v -- / . 'U '^ '- V V ^ P i ^ ^ - n r a i n c o n c a c r , y x ^ f a | n u i n i M r ^ o & t o j J c s j i : p r i m a r i l y ^ i
'\, ^
,the V-ndxistr a 1'/'1hhyyggiieenneei^fandd^.tfotxoixciocollooggyy/aaareas' off DovH%?.Dr
% ,',M > > i^1, ; T ^ ^ ^ ^ i ^ r r y i R a m p y l T ^ Q . ^ ^ ^ t h e ^ i ^ d t ^ c f r i n d u s t e i a l ^ h y g i e r i ^ M
' ,,'
at'?Dow ^Chemical U^S.'A^i Gordon^IngdoljU Bruce': Houhmanir- ,,"
' ' - ^ - ^ i^ ^ ^ ^ ^ ji^ a g e ^ o 'fiin d u s t r ia lM h y g ie n ^ fo r S D o w E lw ic O if.G r e g f^ o c lia ^
*r
-' ' I r i ^ . 1 9 6 4 Y w h e n ^ I ^ w a s V c a i a ' e d p i :n ^ i H e r S evaiuat'eliihe^ ^
',,ch!v:.v/^n l1 Aovraarcmnaefproblaew mA 'ii-naMn, ^r n.Atlhr eY *fit>ri i^hloropherioiiprocess^iSditi^Mi^^P nots,communicate ^to vany,'Igovernmental^'agenciesx-the-i/.fa c t ^ t i r a ^
7 2 / ii';
'73/5\ \ -5^ i r `
74/1 75/2
75/22
-\
76/13
77/11
79/23
I have never testified in any civil cases whatsoever whereiDowiChemical&Company was a defendant.
Plaintiff's Exhibit- 1 marked - Chloracne Problem/ Biochem's Contribution.
At that time there was non-specific analytical evidence
that there was a whole series of things in that waste
oil; and those are the other compounds I would be
referring to.
The other compounds, that I refer to at page 2 y;of
Plaintiff's Exhibit 1 would be the families that I was
then,aware of that had caused chloracne in humans, such ::
as in the thirties, the chlorinated naphthalenes,, and '
earlier Dow experience, with materials they, suspected of
boefintgh,itnhge.-c,ul'pri-its,,,*tt*j jhie&a,v *'<c**h
l
o
r
i
n Ki
a
t
e
d
furans and vn- '??-? /cVi
that s.i; ?
ty,-Ap1efJ\-)a $*v->- i:. V-? 'I *
As I remember, there were three big companies in Europe
9 m mthat >had had accidents /in ,their ^plantl/that*., had/ causedi f` H
some employees to.have'the chloracne and also,some-liver1;
damage in some ,, other employees. ' , ,One, ^company ,i,was
Boehringer Chemical in Germany.VlrX doVnot r e m e mberthe
one in the Netherlands "or ,the one .in'* France.' ,,
i ; > ' <f
t
\
j
xi
In Plaintiff's Exhibit 1 it states that folliculitis in
KXSi^hf-rabbits appears to ,be produced,, < regardless 'of*.the
severity of exposure. I ^had,>to;>have ,received that
information from our toxicology department -a
y " *." i-! a \ v" 'iO s **" t ;
i
'n ^ ^ 1 \
tf ^ "
'a^ r t`
On page 4 of Plaintiff's 1, when .Irtalk, about something
^
that happened in 1957 historically sin the <199 ,and -349
buildings, that there were process samples tested on
animals, and the caustic insoluble; oil and coil reactor
10
2150..
li*
S filS l
m y& `' '` y'ftM' \`Ka
:> .SV| ^-I \ t^,/\1sttti9ehen6sas:4tttem,ydwihefnibrs^ecctifohotorelnrysert-tar;.eacldsniterTw^etheofaerenelsrdea;Ja'`dm?tthrropl-iletieta<hrsaetthtekieoisul'al'tt`etslwbldsyrwl^e1d1alitseikhfr^^feeeti`hr>,,rtahaltnee'blts|orbt^chaicbatfus|rtbr*hrliitteenshd^,ofdt.oshiedeil *'M\s' l^| r
82/18
I am referring simply to the end result.
#
83/6
Where -1 stated that the concentration of the caustic
insoluble oils had to be diluted from the usual 10
percent to . 1 percent concentration before the animals
M-'M-a:-'-.' survived, I received that information'from toxicology.
83/9
To the best of m y .knowledge, Dr. Kenn e t h ..Olson was conducting these tests at this time .sin 1964 '. ,,,,,
84/1
On page 5 where I stated that the tests had "been repeated
periodically, to the extent that over 600 animal'tests
l' directly related to the chloracne problemhadbeen run
, ,f since July, I received that^information frpm'toxicology
` ii
% y,r& :
,v; 'w
yy
'* 84/181 ' - Mr. Skelly was^an'analyticalchemistin theanalyticar 5 -
"Mylaboratories, which is separate from t h e ' biochemical
^ A * l *. "
%-mM, ^
^
*-*-*" ^
* '
,\ 85/22
Harold Gill ;wasi?ihithe analyticaliilaboratory also. :?
v''
86/2 On page 6 I stated that the vapor phase chromatography
/ sensitivity at thattime could detect samples, I guess of
* v TCDD, down to'one part per (million b y 'weight, 'and a
,subsequent:-statement that the rabbitsare sensitive to
the TCDD down to approximately five parts per billion by
* 'weight.
`t
86/16
The;information relating to the rabbits I received from toxicology, :ithe other part from -analytical
.87/4
mm.We could arrive at the conclus ion that the rabbits were
P'W?
A.. ...,,.k. 'if.
. V i - t o -V ' r,J ^ ! " / ' '
* ' '
down^toi five ^ a n a l y t i c a l w s a m p l e s ' ^ process
interferences ;to5`;Startiricr/jwithl
d*& *'
j w :,,
, *%n
................... .......... .............
_
...... ......^ .......
..........
,, J3W *
\'
- -'-
'
,,
..-
tt.th-5e
could'find
on Tit?
~ 7- m ^ r v n
aVn.'.d,4-
i
m. y. --'*.s..t-iaL.t~eJm-ent'_'.,;_^x -.'''_ ^w_ipe
^'samples
................. ...
J''......... k
'
.W^ h
?':1:-*
present"^/arose, because wipe rsamples ^that' showed very
> little7or'no TCDD by analytical-analysis did produce an
effect'?,on;the. animals.
-.
\ K` ^
,(
-O
.~.................>.*..ji...,...i.5..V..^...?../............*.".*...i..."..*.V....
t
-
,
~
`V ' s
,I ,
t
r *v. . ^ -*#r * ej* y
r
f*
, ,, ,, .
89/1 , .. .In t h e > chemical analysis,*ev e n r if there 'was no TCDD
90/7 -
.v On,, page' 6 "Peaks coincided \with ;some unknowns which .'...
. w e r e seen in'wipe samples and'process samples, -Both <.the ,.- ^
/ biochem;lab and
*! 4vl'-'5 xl\ w--- -k ..
the
Germans vh a v e f!r**eported. .l . j i_ _ i _________j !, ______________ `
>ai
n.
imal'
l_7* __l-j
t
e
s
t
s
L
^ v//
i
_ ,*'
* i u c u u u i ^ w u i f U D - ' ' ju A t s - n s i A A l i y i>u u i i c A
u x i A i u v i u ^ y u e s , ' ; ` rn
back ;..to/,...the':.impure' chlorinated ,dibenzofurans,H that?> I i/ -" '
didnft freeid^ I just; read the highlighted.-:/
/?&`^ ^ V
90/23
On page 7 - "The analytical laboratory and the toxicology-
*`l A laboratory^;;are^i^presently^rconductingfi>`aJ/: project^ t o # C P
1
determine .the -analytical and ,animal test 'limits'-,, of
.--A....
-' ~ _ ;,
' sensitivity for. TCBD in various:Dowiproducts,/made-from -trichlorophenolV This project1is?aimed at d e v e l o p i n g ^
- v i ; 'A .'
, ' 4*' :
- quality control specification f o r 'TCBD ' in "consumer
t.; products."
< -> ,
91/12
During the time I was involved, `our standard was nothing
detectable in the material.
v
93/5 `
On page 9 of Plaintiff's Exhibit 1 , I refer to a January 1964 first medical report of a case sof chloracne, initiated a survey by the environmental research laboratory. That was my assignment to the p l a n t .being referred to there.
12
2152 ..
\ O 'J-jH i
+>* caused the adoption of full-scale protective measures in that building in regard to the trichlorophenol process I wouldn't know any names of the folks who objected.
99/17-
A handwritten statement at the end of Plaintiff's Exhibit 1 says unit index. That was an indexing method used in the lab, meaning write out, the key word so that it could be retrieved. For filing purposes, strictly.
100/11
Hutchenreuther was a manager in the Midland plant; Goergea; same as Hutchenreuther; Staehling/ another maj or
105/23 107/10
I, '-was , present' "at '<t h e ^ m e e t i n g \ of 'the^various., ~
representatives of* the chemical companies.
^ . ' "
When Mr Rowe referred to ievidence/for unknown acnegens,- , he was referring to ;the number of other -compounds in the ^ ^ caustic insoluble oil other :than the .TCDD^. ;v
D r . Sadek was at thatvtime ;fa'.veterinary^ pathologist >in
the toxicology lab with?DowiChemicar Company. - \<\i*. ^ / !
1*
-i ^ / V*
^
^^ ^r^v >
It was my experience with the contamination of tools and*
other objects with this'foreign material that.you either ,y
had to use the substances I.outlined to remove it or to
use soap and water with vigorous scrubbing^ ^
13 -- 2153
<r* \* > " V ' WIP
110/20 J a c k :Peterson was an vindustrial-hygienist-in the-same' if;
. group in biochemical research with myself;' at :the;;time
J -`
'
< * ^
i ' ;y
- l^
113/20
I remember only one name of a person who sustained * v
chloracne as a result of exposure to chloracnegens in
your, experience at Dow Chemical, and t h a t , is. Ros e ; ^ ,
That's a man. I don't remember a first name and ;Ii have
no. idea'if he is still alive.,<
\
l'' ,
t
,K
>1
{
5
4 A ^'>-1--'v
114/11
I have no idea why I -remember.him. -- O n l y --thatriI was
' acgua inted with h i m .
I. know-nothing.'about-*, the 'facts - of-this "case ; 'Moyer v.
'
-118/19 ' Page ,5 of Plaintiff's.3^states^that-in-February,of 1964 x 4
\ y '' z? - ?, the -plant" ssistant^supe^interderit-- ;ai&||spme-- operators --
'i
were^ examined by the'medical: departmentiand were found :to
121/11 . \ V-'- " ;/
1
121/14 --
'
:'.Vi:s*x -
y* r h * - ,, y :V
I' .went >to- Europe in l a t e ' : 1 9 6 4 ' ' t o ~ - t a l k * t o . . ' . c o m p a n i e s w h o
had- experienced a 'similar-problem and -claimed-to-have
found answers to it." The German company was Boehringer.
I^mth. -iKnk- t. h&e?? French
. company
is
Progil.
- -y '* -v/ '
`\ r.-i
Sir1'
f
vr,'V.'i,v
4i Jv:-iV. . '-
-.*1-j4\
.. V
.
'i.
.- .-tiV 1 : -- v
-
7. 1
\*
5
: \ O -Xl
124/16' 125/5 '
I t ,is `stated;; in- the ne- x^ t, -,',parag r a pX.h ^ ti . hx - a t_ a - t. J.h1 e r e y, was ''\y % % '
;:instituted ^ although ;notiquite so|rigidpquality controls t
y b y \ analysis rbacked up by animal,;-testing for.'the' end
<Sp>
product-into which the trichlorophenol~went,<namely the
esters rJ and so there was quality, control data available
on that, as, well. " That would "refer to the esters
specifically, asiI/read it. 'i * ^ < v> ! ' ^ $ c*'*-"*
TIig stsrs of 2'4 5-T.
? M-i *
*
126/17
The shuman' testing ithat" I referred -to -was & done in a
prison/-, I don't know ,what ''prison/ but1 t h e d o c t o r ' s name
was ;Kligman.
A, V f
T v f
1 lA^ fit * L
3" '
127/1 The graph that deals with' response of rabbits and humans
' \ r j "l "" to TCDD I prepared originally. ' V
v ,
v
" .i1'52'77 / 4 The human data came 'from Kligman's report. The animal
r data' carnet from*Dow-toxicology.
;
.;:C127/11 At the'time; I believe ,the Kligman report'was considered
'X, o
127/16
; -c
to be valid information.
*. ,*';/
,
-?
>
"v " *
T_x
I would h a v e , received the information 'regarding the
Kligman prisoner experiments from 'the',, toxicology
department.
/- -
^Lr
f r`
fli `
i
127/20 , Follow-up studies were done of t h o s e 'D ow workers that
were exposed to TCDD in 1964 and'who showed evidence of
v chloracne by the epidemiology section of the same
' \Y vf`\i laboratory.
J
-- '
128/7, `' Dr . R a l p h Cook was the head of epidemiology, and a number 1 of other folks but I don't recall their names.
15
\ v
132/23 133/5
y(V ; ',!' 133/19 134/15
:Plaintiff's Exhibit 4 marked (nemo;entitled the Hazard of Monsanto,T Acid: by L. G . Silverstein).
This was a memo thatiI had done regarding some 2,4,5-T acid 'that Dow h a d 1 purchased from Monsanto. And the material .was found to contain TCDD in concentrations averaging about, ten parts per million.
I was concerned because this product constituted a hazard
in my opinion. ,
<
I * see jin paragraph .two, I'm talking ` about the^ requirements if, we processed it" i n "199 and 349; and my recollection is that's what we planned to do with it when we got i t . and it says Dow'si involvement ini shipping this
135/14 1
My recollection is that the material in question was -reprocessed ilwithin * Dow^: Chemical^iuntil A it was ,non-
detectable by'^ahalysis, and, then it ^was processed, but that's strictly my recollection'at this point. >
''
136/5
- 1 3 7 / 7 vv 137/16
No,' I do not recall any complaints from,'Dow customers from 1964 through 1976 regarding5any chloracne from'any .... ;.
of the 2,4-D or 2,4,5-T or Silvex products, sold by Dow.
Nor do I recall any^ complaints regarding the causing .of
cancer in any users of- 2,4,-D, 2,4,5-T or 'Silvex.vM* f f
Mv ,
j /,
p r' e' (si *e n t "e mv' p^l b y e r S F a r l b w
^
E
-j
r *i v. i r o 1h m
," e h tva, r ;,,E
h vg/i
h
'e<e
r
'` V s ;i;
'. Tr+h_>c
;
,
i
f
j
i^fkyi&. ^i !
,|iS' A;
'
is being paid for my time spent; her, and I willyreceive
my normal compensation from him.-
`,
For
my services *"
in
'
legal
areas,
" '' `
it's $150 an hour.^
'"} ' ' V" ' " T\v ^ v 'V '*
j* tn
-,i`"
' ~ " V l 6 ......
" W ......... * W ' ; y
m -\ '
S .I&
-i,'*
: ...................
;
....... '
2156
..-r/r-r-A= .... \.* i i'/,r * r 2 X ) rX 2 h *
141/11 142/3
v .: v v -N,v
I am not fami liar with Kuron . I have a vague familiarity
w i t h :the term Estron.
/- mm...
No, I never contracted a case of chloracne myself.
" ``/ H
142/7 143
I did not participate at all in the decision by the^Dow Chemical Company to withdraw 2,4,5-T or Silvex from the market
...... ......... *......V" v .... ......
.......
............. ........ ....... ... -S... ............
Lists professional organizations Silverstein is, a member .
of. .
. J
"l ^V '
'C'V .-v r;
V-T.` S 'i.f-sr-i h ` u' ' 1'
145/4
Plaintiff's 7 marked (letter ^describing .industrial
- ' ,, 1\ hygiene Jf services .offered,, by?*/Farlow- Environmental
. 3 Engineers,'Inc.). < v %
,r *
^ / M fr ' ('114455//110 ' "Plaintifff'sS'"'r"`8 ^-marked -(* ressuummee - - o f - 'Lawrence ^uGG/ .
Silverstein)w
147/4
- - r*V *
s i ' ^ x ^ - v V S S ? < i' , j-
'/ ,, v */
-I'm trying.to recall the,first such event when I worked
with attorneys1in cases involving injuries from exposure 4
to, hazardous substances. I believe, it was in t h e m i d -
' seventies/and the only occasions,on which I have worked
with attorneys since the mid-seventies were involved with
cases having .to do with" Dow-`Chemical-Company/-' 11
- -//r
, /, 1"'7 <'/;1: / ^ v . %-*
147/12
I've probably been involved in' less than half a dozen
cases since *the mid-seventies.
-
147/17 149/12 *
In all but one instance it involved the dioxins:
SSfrSfli ' V ,v
I have worked with r attorneys representing the
Chemical Company exclusively. ?' '
17 i- 'S i
2 15 7
Dow
-V v
154/16
f '156 **
:i%
:a
Plaintiff's 9, marked (article "Mortality*Experienceiof
Employees .Exposed dioxin, TCDD).
^
to' 2,3.7,8-Tetrachlorodibenzo-para-
V " ',
\ 7 ... *'
^
> *v ,
>.
C. & '
V i *f
' 'it 1T1..i:--.--iv-:.?.v-s-'-''-i.r' J--
,
159/9
In Exhibit 9, the mortality study done on t h e *61^workers ^
involved in the 1 9 6 4 'chloracne incident, it's mentioned i -
'in the}head note *to ,,thej5article ,that there were^three t
deaths ^attributed, to cncer out. o f r,the group,|>with flA 6
expected.5^<-- -:VKvI I do not?,know if there was a continued follow up <of^ this group.^ * B u t 'if therehas beenX/l `have' not
participated in it.
*,
^
160/2 161/3
.v ^
From, memory, I characterized the exposure >based on -m y ; ^
familiarity with the" plant, environment, physical, layout
and that type of thing, plus the data in terms of wipe
tests and air samples taken through the event. And with
all that information I did the best I could in judging ^ ^
high versus low exposure, in essence.
^ j f < -n.
"
\ r ), J ,
'.
1, *
,
' ,'%%
<*
^v
' ' f -Wfo
t
;Other than to the characterization of the exposure, the " * i;
'other conclusions in the study were those of Dr. Cook
'essentially.
t:'-y '
.:Y 'Y -Y Y ': - ".' YYO/Y^^Y: Y^^-Y-Y V.''i.-
-
161/11
Dr. Cook is now with Dow Corning Corporation in Midland. ; <
161/21
I have accumulated maybe 15 hours to date in this matter.
18
2158
><rf > ^ k
t ->- ;> lJ-N*'.*/>> '!: .y tV->^fr^..'1ii.':,:.V.'-1 .'v' 3 - . -. m ... .-,f;> .-`.'.v:
....
~ -v/( >A i'% \
\ Jf
-1 -,.,:-V;.'- Y-Y ' i
4 t- V -1- i
* *
*
\ . -V
$ i0 V 'f V
? ** *
*> n * * `-yf?:>\; :^ i . :-;Y
^1 -f- - * i>
N yj a ' YY
vXJ
* V i -
, '
,, *? * *
1 , f r
"i
* \
*> 0 - jt. * **
S ^ t r ^ ^ tNA '\ % 1
B$;*
*
J * * *
v ;- r : r : ^ r ' ' ................
i... ....... __ '^^A^*V'->-:yKV>::V-;-*-=( .--- - r
-'i-ijY,i'lVv.S>'VY^."VYlVYlv^;---Y,,,-Y.i\Yvr:':^
: . .t
.,.,
l+ *f* > T > V
i,,
T' ,
-f vf H
J " : *V li
Bl ^
*,, 13''` !T>,-._T -K>^v.^
? , OJ
' -V -.r "^
**
^ T- i-,
rr
V tv ^ ' n P 1*
19
,- V
f` V 1
^.Ui V A'UX *f 'I . \Q
STATE OF FLORIDA COUNTY OF ORANGE
) ) SS: )
IN THE CIRCUIT COURT FOR ORANGE COUNTY, FLORIDA
KIMBERLY MOYER, as Personal
)
Representative of the Estate of)
ROBERT W. MOYER, II, Deceased, )
Plaintiffs,
v s.
DOW CHEMICAL COMPANY, et al., Defendants.
)Case No. Cl 89-8657 )Div: 32 Thom p s o n
)
)
) )
)
FORM LASER BOND A PENGAD/INDY 1-800-631-6989
The deposition upon oral examination of LAWRENCE G. SILVERSTEIN, a deponent p r o d u c e d and sworn to before me, Aprille Rigsbee Lucas, RPR, a Notary Public at large in and for the Sta"te of Indiana, taken on behalf of the Plaintiff at DowElanco, 9001 Purdue Road, Quad III, Indianapolis, Marion County, Indiana, on March 9, 1993, at 10:00 a . m . , taken pursuant to the Florida Rules of Civil Procedure in the above-captioned matter.
ASSOCIATED REPORTING, INC. TWO MARKET SQUARE CENTER 251 EAST OHIO STREET SUITE 940
INDIANAPOLIS, INDIANA 46204
2160
APPEARANCES
FOR THE PLAINTIFF:
Richard D . Schuler, Schuler, Wilkerson, Williams, P .A . 1615 Forum Place West Palm Beach, FL
Esq. Halvorson
33401
&
FOR THE DEFENDANT DOW CHEMICAL:
Alan F. Wagner, Esq. Carlton, Fields, Ward, Emmanuel, Smith & Cutler, P.A. First Florida Bank Building P.O. Drawer 190 Tallahassee, FL 32302
FOR THE DEFENDANT HELENA CHEMICAL:
H. Roger Lutz, Esq. Lutz, Webb, Bobo & Baitty, Two North Tamiami Trail Sarasota, FL 34236
P.A.
INDEX
DIRECT EXAMINATION, Questions by Mr. Schuler
PAGE 4
FORM LASER BOND A PENGAD/INDY 1-800-631-6989
v_ 2161
.J.
EXHIBITS
PAGE
Plaintiff's Exhibit 1 - Chloracne Problem, Biochem's
Contribution
73
Plaintiff's Exhibit 2 - Memo dated 3-29-65
101
Plaintiff's Exhibit 3 - "Chloracne in the Dow Trichlorophenol Plant" Circa, 1964
115
Plaintiff's Exhibit 4 - Memo entitled Hazard of Monsanto
T Acid
132
Plaintiff's Exhibit 5 - Notes to J.E. Johnson dated
11-25-69
139
Plaintiff's Exhibit 6 - Letter from F.D. Axe dated 4-22-66
140
Plaintiff's Exhibit 7 - Letter on Farlow Environmental
Engineers, Inc. letterhead
145
Plaintiff's Exhibit 8 - Silverstein resume'
145
Plaintiff's Exhibit 9 - Article entitled Mortality Experience of Employees Exposed to 2 , 3 , 7 , 8- T e t r a c h l o r o d i b e n s o - p - d i x o i n (T C D D )
156
FORM LASER BOND A PENGAD/INDY 1-800-631-6989
I 2162
4
1 LAWRENCE G. SILVERSTEIN,
2 having been first duly sworn to tell the truth,
3 the whole truth and nothing but the truth,
4 relating to said matter, was examined and
5 testified as follows:
6 DIRECT EXAMINATION,
7 QUESTIONS BY MR. SCHULER:
8 Q Would you state your name, please.
9 A Lawrence G. Silverstein.
10 Q What is your present address? 11 A Home address is Carmel, Indiana, 790-A Indian 12 Trails, is the street address, 46032.
13 Q How long have you lived in the Indianapolis area,
14 sir?
15 A Since October 1st.
16 Q Of this year, 1992?
17 A '92, correct.
18 Q Prior to that where did you live?
19 A Midland, Michigan.
20 Q How long had you lived in Midland, Michigan?
21 A 37 years, with a couple timeouts for transfers. 22 Q Are you presently employed?
23 A Yes, sir.
2 16 3
5
1 Q What company employs you?
2 A The Farlow Environmental Engineers, Incorporated.
3 Q Where is that company located? 4 A It's at 9202 North Meridian Street in 5 Indianapolis. 6 Q What is your position with that company? 7 A I am director of industrial hygiene, safety and 8 training. 9 Q What type of company is Farlow Environmental
10 Engineers, Incorporated? 11 A They are a consulting engineering firm that 12 specializes in hazardous waste site evaluation and
13 remediation. 14 Q And you, prior to working with Farlow, w o r k e d w i t h 15 Dow Chemical Company? 16 A Yes, sir. 17 Q When did you cease workingwith DowChemical 18 Company? 19 A December of 1979.
20 Q After December of 1979, can you give me a little
21 history of your employment with various companies?
22 Or if you were retired, tell me that.
23 A I was manager of industrial hygiene for the Dow
2164 'X ) ''e S ^ |
6
1 Corning Corporation from December 1979 to
2 September 1st, 1990, when I retired.
3 Q Dow Corning Corpo r a t i o n is also located in 4 Midland, Michigan, is it not? 5 A Correct. 6 Q And if I recall correctly, Dow C o r n i n g C o r p o r a t i o n 7 is a 50 percent joint venture between Dow Chemi c a l 8 Corporation and Corning Corporation? 9 A Yes.
10 Q Did you transfer from Dow Chemical to Dow Corning? 11 A Yes. 12 Q And let me go back to your history with Dow
13 Chemical Company, and tell me a little bit about 14 your educational b ackground before you started 15 with the company and then the hist o r y of y o u r 16 various positions with the company, Do w Chem i c a l 17 I'm talking about now, not Dow Corning. 18 A Well --
19 MR. WAGNER: I'll object to the breadth,
20 since that covers about 40 years, but go ahe a d and
21 give him an overview. 22 A Educational background is aBachelor of: Arts
23 degree in chemistry, 1954, State U n i v e r s i t y of N e w
. 2165
V-astii-